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“Antimicrobial Resistance is a fundamental threat to global health and safety” 
(WHO, 2016). 
Nisin, a 34 amino acid lanthipeptide, is currently used as a food preservative 
worldwide and has been used for decades without significant bacterial resistance 
having developed. It is an extremely active molecule which kills a range of different 
bacterial species. However nisin, along with some other similar peptides, suffers from 
low stability and solubility at physiological pH, which severely restricts its possible 
use in human and veterinary medicine. This research is concerned with increasing the 
stability of nisin in physiological pH systems; the stability of the dehydroalanine (Dha) 
at position 33 was examined as one of the project aims, along with the generation of 
novel analogues of the nisin tail and also the incorporation of a cyclopropyl amino 
acid as a Dha bioisostere moiety conserving the native conformation. This 
derivatisation of the tail region of nisin may increase its stability while preserving its 
bioactivity. These peptides were studied to examine their stability, reactivity and 
conformational changes using NMR, UV-vis and Circular Dichroism (CD) 
spectroscopies. The ionic strength effect on both Nisin A and Z was examined using 
a variety of NMR techniques and CD spectroscopic studies using a wide variety of 
salts, varying the charge density of anions and cations present in solution. The results 
of these studies are outlined within this report. Using 1H NMR, nisin was also studied 
in different pH environments in attempt to shed light onto the cause of the solubility 
issues encountered at physiological pH. The pH region in which nisin starts to break 
down is in the region in which the pKa of the histidine side-chain lies. Using 1H NMR 
the pKa values of the histidine imidazole side-chains of both nisin A were also 
investigated. While displaying nisin’s ability to bind metal ions in solution at 
physiological pH, and the observed  increase in the solubility of nisin in physiological 
pH systems, could allow for nisin to be used in either therapeutic or veterinary 
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1.0.  Introduction 
The overuse of general broad-spectrum antibiotics has led to an increase in the 
occurrence of antibiotic-resistant organisms. The rise in bacterial resilience has 
created a major health issue in hospitals worldwide, as often patients are already 
immuno-compromised and are prime candidates to contract infection. A number of 
bacteria found in hospitals have become resistant to many conventional antibiotics 
including Methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-
resistant enterococci (VRE), which are the most common pathogens found in hospital 
settings.1 
During the twentieth century, with dramatic advances in the diagnosis, management 
and treatment of antibacterial infections, many believed that infectious diseases caused 
by bacteria would be eliminated by the turn of the century. The over-prescription and 
misuse of antibiotics has led to conventional therapies becoming inadequate, and has 
become known as the “The Antibiotic Paradox”.2 
Antibiotic resistance is now recognised as one of the primary global threats to public 
health; a report from the World Health Organisation (WHO) released in September 
2017 states that “the world is running out of antibiotics”.3 There is a lack of new 
antibiotic therapies in the pipeline, as the majority of drugs currently in clinical trials 
are derivatives of current antibiotic compounds. The report puts into perspective the 
over-arching need for the development of new antibiotics which have novel 
mechanisms of action, to aid in the combating of these antibiotic-resistant bacteria.3 
The diminished pharmaceutical investment in antibiotic research is only one factor 
that has contributed to the increase in antibiotic-resistant bacteria, and the reduction in 
the output of new antibiotics. Antibiotic treatments are only administered for a limited 
duration, making them less profitable than drugs used to treat chronic illness/ disease.4 
This project investigates nisin, a naturally-occurring peptide produced by Lactococcus 
lactis used as a defence strategy against Gram-positive bacteria. Nisin is of interest 
due to its very high activity, in the nanomolar range, against Gram-positive bacteria 
including some antibiotic-resistant bacteria such as MRSA and VRE.5 Although nisin 
displays high activity, it suffers from stability and solubility issues at physiological 
pH, limiting its use as a therapeutic agent. The generation of novel nisin tail analogues 
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was undertaken to investigate the breakdown of the nisin tail at physiological pH, 
while hopefully preserving its bioactivity at such pH’s. 
1.1. Bacterial Cells  
Bacterial cells are unicellular prokaryotic microorganisms which differ from 
eukaryotic cells as they do not have a membrane-enclosed nucleus.6 Bacteria have the 
ability to live and survive on surfaces through attachment mechanisms using their pili 
and flagella (Figure 1).7 
 
Figure 1: Bacterial Cell Structure7,8 
1.2. Bacterial cell walls  
The bacterial cell wall is one of the main components of all bacterial species, with a 
number of critical functions apart from giving the cell its shape and structure.9 It is 
also involved in cellular functions which are crucial for its survival, including 
reproduction, cell division, protection of the bacterial cellular contents and it is the 
main barrier for bacteria against the external environment, preventing cell rupture and 
osmotic shock.10 Bacteria are categorised into two bacterial types, Gram-positive and 
Gram-negative, with this differentiation being based on the bacterial cell wall 
composition and its response to Gram-staining procedures utilised in microbiology. 
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Gram-positive cells stain dark purple and Gram-negative cells stain red/pink when 
under Gram staining.11 
1.2.1 Gram-positive bacterial cell wall 
The cell wall of Gram-positive bacteria contains a multitude of peptidoglycan layers 
(Figure 2) creating a thick layer of peptidoglycan. Woven into the porous 
peptidoglycan matrix are teichoic acids, which are polymers of sugar alcohol 
phosphate, only found in Gram-positive bacteria.12 Teichoic acids, and similar 
molecules, constitute around 50% of the Gram-positive cell wall, with some teichoic 
acids having a lipid attached (lipoteichoic acid or LTA).13 These acids play a role in 
the innate immune system and also stabilize and strengthen the cell wall.14 They are 
anionic in nature and scavenge metals which are required for bacterial growth.15 Also 
present in the Gram-positive bacterial cells is Lipid II, which is a precursor of bacterial 
cell wall synthesis and a target in the mechanism of action of various antibiotics.16 
 
Figure 2: Cell wall composition of Gram-positive bacteria17 
 
1.2.2 Gram-negative bacterial cell wall 
The cell wall of Gram-negative bacterial cells differs greatly from that of their Gram-
positive counterparts. The cell wall can be broken into three main structural 
components, i) the outer membrane, ii) thin layer of peptidoglycan (periplasm in 
Figure 3) and iii) an inner membrane.17 Gram-negative bacteria contain a unique 
component in the outer membrane, the lipopolysaccharide layer (LPS), which is 
composed of a hydrophobic domain known as lipid A (endotoxin), a “nonrepeating 
core” and a distal polysaccharide.18,19 The main structural difference between Gram-
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positive and Gram-negative cells is that Gram-negative contains a thin peptidoglycan 
layer situated in the periplasm of the cell, situated between the outer membrane and 
the cytoplasmic membrane. The outer membrane of Gram-negative cells also contains 
lipopolysaccharide (LPS) components protruding from the cell (Figure 3).20 
 
Figure 3: Cell wall composition of Gram-negative bacteria20 
1.3. Cytoplasmic membrane of bacterial cells 
The cytoplasmic membrane has a key structural role in both prokaryotic and 
eukaryotic cells.21 It is composed of proteins and lipids, with the most abundant being 
the phospholipid component, forming a lipid bilayer.22 The main role and function of 
the cytoplasmic membrane is to act as a selective barrier to the cell, regulating the 
entry and exit of molecules. An important property of the lipid membrane is that it 
behaves like a two-dimensional fluid where the individual molecules are free to rotate 
and move within the bilayer (Figure 4).23  
 




1.3.1 Lipid bilayer structure 
The lipid bilayer of bacterial cells is composed mainly of phospholipids, which 
contains two main components. The first is a hydrophilic phosphate head group and 
the second is a hydrophobic fatty acid tail or lipid, which align to form two layers 
(Figure 5).24  
 
Figure 5: The phospholipid bilayer25 
 
The self-assembly of the double layer phospholipid shell known as the lipid bilayer16 
is driven by the propensity of the hydrophobic tails to interact and is entropically 
driven by water in the aqueous environment.25,26 The bilayer membrane is involved in 
the transport of molecules within the cell, including small peptides, ions and proteins, 
which can either diffuse through the membrane in some instances, or by way of ion 
channels.27 The lipid is very important for the mechanism of action of some 
antibacterial peptides which create pores within the bilayer, disrupting its cellular 









1.3.2 Lipid II 
Lipid II is a membrane-anchored precursor molecule associated with the biosynthesis 
of the rapidly growing bacterial cell wall. It consists of one N-acetylglucosamine-N-
acetylmuramic acid (GlcNAc-MurNAc)-pentapeptide subunit linked by a 
pyrophosphate group to a polyisoprenoid anchor (Figure 6).28,29 After translocation to 
the periplasmic side of the membrane, the penicillin-binding protein (PBP) catalyses 
the polymerisation of the sugar subunits, using lipid II as a substrate, in the synthesis 















































Figure 6: Structure of the lipid II precursor for bacterial cell wall synthesis, 
highlighting the different binding sites of nisin and vancomycin31 
 
A number of natural antimicrobial agents have been shown to target the lipid II, 
allowing for one of the bacterial defences to be turned into an offensive strategy and 
an antibiotic target to treat bacterial infections.32 The pentapeptide subunit of the lipid 
II has been altered by bacteria, where changing one of the D-alanine amino acids (AAs) 
gives rise to resistance to vancomycin. The pyrophosphate linker moiety has remained 
evolutionarily unchanged, which could be a reason that little resistance has been 
reported for antimicrobial agents which target the pyrophosphate.24 Lipid II has been 
described as the “Achilles’ heel of bacteria”, with a wide variety of bioactive 
compounds targeting this cell wall precursor.33 
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1.4. Antibiotics  
Antibiotics are synthetic or natural compounds which are used to treat and combat 
bacterial infections.  They are compounds which usually target either the biosynthesis 
of the bacterial cell wall, or DNA replication, or they can cause bacterial cell death.34 
1.4.1 Antimicrobial Resistance 
Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi 
and parasites change in ways that render the medications used to cure the infections 
that they cause ineffective.35 While antibiotic resistance is more commonly known, it 
is a subset of antimicrobial resistance relating only to bacterial species. 
Antibiotic resistance is when the bacterial target is altered in such a way that the 
antibiotic’s efficacy is reduced or becomes less effective against the bacterial 
pathogen. The alteration of the bacterial target inhibits the antibiotic’s mechanism of 
action.36 
Antibiotics have been used since the 1940s to treat bacterial infections worldwide; 
they have hugely reduced the deaths related to many bacterial infections.37 However, 
years of misuse and over-prescribing has led to resistant bacteria rendering 
conventional antibiotics less effective, and in some cases having no effect against the 
bacteria. There are three fundamental mechanisms of antimicrobial resistance; i) 
enzymatic degradation of the antibiotic compound, ii) alteration of the antibiotic 
targets, and iii) changes to the membrane permeability of the cell and using efflux 
pumps to eliminate the antibiotic compounds from the cell. These mechanisms have 
been associated with the development of multi-drug resistance (MDR).38’39 
Each year in the United States there are over 2 million cases of patients with a bacterial 
infection which is antibiotic-resistant, and at least 23,000 people die each year as a 
direct result of these antibiotic-resistant bacterial infections,40 creating a human health 
issue. It has been recently predicted that by 2050 worldwide 10 million lives will be 
lost per year, with an economic cost of 100 trillion USD to treat these drug-resistant 
bacterial infections, highlighting the need for novel antibacterial therapies to be 
developed as a matter of extreme urgency.41  
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The causes of the antibiotic resistance crisis include the overuse and inappropriate use 
of conventional antibiotics driving the evolution of resistant bacteria, and the acquiring 
of resistance from bacteria that possess resistance genes. The take up of plasmids 
allows for the transfer of genes between bacteria, or through spontaneous mutation. 
Antibiotics eliminate drug-sensitive bacteria, while leaving the resistant bacteria 
behind to reproduce, as a result of natural selection. 
It is estimated that over 80% of antibiotics sold in the United States are used 
prophylactically in agriculture, primarily for animals, to stimulate growth and prevent 
infections, as treating livestock with antibiotics is said to improve the health of the 
animals and produce a greater yield of product.38 The antibiotics used to treat livestock 
remain in the product and can then be ingested by humans, transferring resistant 
bacteria to humans from farm livestock. This was first reported over 35 years ago, 
where a high level of resistant bacteria where found in the gut flora of livestock and 
farmers in the United states.42 
A lack of novel antibiotics has led to resistance against conventional antibiotics, e.g. 
penicillins. The “Golden Age” of antibiotics began in 1928, with the majority of the 
modern antibiotic classes being discovered between 1940-1980.43 The increase in 
antibiotic-resistant infections highlights the need for investment and the creation of  
new antibiotic therapies.  
1.4.2 Prevention of antimicrobial-resistant infections 
To stop the rise of antimicrobial-resistant organisms, there is firstly a supply and 
demand issue which needs to be resolved. Currently the supply of new antibiotic 
therapies is insufficient to keep up with the increase in drug resistance. The demand 
for these drugs is badly managed on a global scale, and huge quantities of 
antibacterials are wasted on both patients and animals that do not need the treatment. 
Antibiotics are being used prophylactically rather than as a treatment and so microbes 
evolve to resist the antibiotics’ mechanisms of action.44 
“Antimicrobial stewardship” refers to co-ordinated interventions and a fundamental 
change in the way antibiotics are prescribed and consumed globally, to preserve the 
efficacy of existing antibiotic drugs, increase their lifetime and reduce the urgency of 




Bacteriocins are defined as extracellular substances, usually peptides/proteins 
produced by one bacterial strain, as a method of defence against another bacterial 
strain. These bacteriocins are ribosomally synthesised peptides which can either act as 
a bactericidal or bacteriostatic agent46; they could be described as antibiotics but are 
not defined entirely in this class, due to the fact that bacteriocins have a narrow 
spectrum of activity.47  
A large number of both Gram-positive and Gram-negative bacteria produce 
bacteriocins, with the bulk of characterised bacteriocins being identified in Gram-
positive bacterial species.47 During their growth they produce either proteins or 
polypeptides which possess antimicrobial properties,48 which are usually restricted to 
bacteria of the same strain.49  
1.4.4 Antimicrobial Peptides (AMPs) 
Antimicrobial Peptides (AMPs) are isolated from a variety of natural sources, and are 
also referred to as Host defence peptides (HDPs).50 These peptides are associated with 
the innate immune system and are found in both eukaryotic and prokaryotic cell types 
including bacteria, insects, plants and mammals. AMPs are, for the most part, small 
molecular weight peptides with a broad spectrum of activity against bacteria, fungi, 
viruses and in some cases they have shown activity against cancerous cells.51 AMPs 
are usually the first line of defence, for a multitude of organisms, including bacteria. 
Production of AMPs is associated with the innate immune system where smaller 
antimicrobial peptides usually act by disrupting the structure and function of cellular 
membranes.52 
The rapid development of increasing resistance towards conventional antibiotics 
suggests that we are en route to a “post-antibiotic era”, meaning that current antibiotic 
therapies will no longer be relevant.52 Thus, peptide antibiotics may have future 






1.5. Lanthipeptides (Lanthionine-containing peptides) 
Lanthipeptides are ribosomally synthesised peptides which are then post-
translationally modified to contain a lanthionine within the polypeptide structure. The 
common feature of the lanthionine moiety (Ala-S-Ala)  is two “alanine” residues 
which are cross-linked via their β-carbons by a thioether linkage, as a monosulfide 
analogue of cystine.54 Also, the polypeptide may contain the β-methyllanthionine 
(Abu-S-Ala) which is similar to lanthionine but the cross-link is of “alanine” and 2-
aminobutyric acid.55 (Figure 7). Both the lanthionine and β-methyllanthionine 
moieties are formed via a dehydration reaction of serine (lanthionine) or threonine (β-
methyllanthionine). The dehydrated AA then acts as a Michael-acceptor in the 






















Figure 7: Chemical Structures of Dehydroalanine (Dha), Dehydrobutyrine 
(Dhb), Lanthionine and β-Methyllanthionine 
 
Other common structural features of many lanthipeptides include the unusual AA 
residues of dehydroalanine (Dha) and dehydrobutryine (Dhb) shown in Figure 7, 
which are achiral α,β-unsaturated amino acids.56 The “alanine” residues within the 
lanthionine contain two stereocentres (S,R), as the meso structure, while the β-
methyllanthionine possess three stereocentres (S,S,R), due to the methyl group on the 
β-carbon of the lanthionine moiety.  These have been studied extensively by the Van 
Der Donk group, who have highlighted the critical importance of the stereochemistry 
of the lanthionine and β-methyllanthionine moieties for biological activity.57 
12 
 
A subset of the lanthipeptides are the lantibiotic peptides (peptide antibiotics 
containing a lanthionine residue), which contain between two and five lanthionine or 
β-methyllanthionine moieties; thus, they contain a number of small ring structures 
within their overall linear structure. Lantibiotics can be sub-divided into two 
categories, Type A or Type B.55 Since the discovery of the first lantibiotic nisin, in the 
1920s, well over fifty different lantibiotics have been identified and characterised.29 
1.5.1 Classification of Lanthipeptides 
Lanthipeptides are divided into four classes, with the most recent classification being: 
Class I-IV. Lantibiotic peptides are divided into each classification or sub-division 
based on their physiochemical properties, mode of action, biosynthetic production 
pathway and the enzymes involved in lanthionine synthesis.58 The most recent method 
of classifying lanthipeptides is based on the enzymes used in the dehydration and 
cyclisation steps forming the lanthionine and β-methyllanthionine residues. 
1.5.2 Class I Lanthipeptides 
Class I lantibiotics are cationic AMPs produced by bacilli, staphylococci and 
lactococci bacterial species. Structurally they are composed of elongated, flexible and 
amphipathic peptides with masses usually exceeding 2100 Da.59 All class I lantibiotics 
contain between two and five lanthionine and/or β-methyllanthionine ring motifs 
within their structures. The lanthionine and β-methyllanthionine moieties contained in 
all class I peptides are formed from two distinct enzymes, a dehydratase (LanB) and a 
cyclase (LanC).60 The cationic peptides within the class I group are generally pore-
forming bacteriocins, which interact with, and alter the electrical potential of the target 
cellular membranes. This pore-formation and change in the electric potential of the 
membrane causes leakage of the cellular components and ultimately cell death.10 
Gram-positive bacteria are responsible for the biosynthesis of a significant proportion 
of lantibiotics including nisin, subtilin, and gallidermin (Figure 8).61,62 In 2015, the 
structure and activity of pinensin A and B was described as the first naturally occurring 
Gram-negatively produced lantibiotics, produced by Chitinophaga pinensis and they 


























































Figure 8: Primary amino acid structure of gallidermin and subtilin64 
 
Gallidermin, as shown in Figure 8, is a tetracyclic 21 AA peptide produced by 
Staphylococcus gallinarum,65,66 while subtilin is a pentacyclic 32 AA peptide 
produced by Lactococcus subtilis.67 Similar to other class I lantibiotics, subtilin is a 
pore-forming antibacterial peptide. It is of note that the B-ring is a conserved sequence 
in class I lantibiotics, as depicted in Figure 8 (red circles).68 The C-terminal tail, which 
is essential for nisin pore formation, is absent from Gallidermin. Rather, its C terminus 
is compact due to a double-ring system involving an aminovinyl cysteine residue 
resulting from oxidative decarboxylation of the terminal ring, similar cyclisation is 
also present in mersacidin a class II Lanthipeptide (Figure 9). Another example of a 
class I lantibiotic is nisin which will be discussed in greater detail in Section 1.6. 
1.5.3 Class II Lanthipeptides 
Class II lanthipeptides are globular and are more rigid molecules than class I 
lanthipeptides, which inhibit enzymatic functions through the interaction with specific 
substrates, usually the lipid II in the cell wall. The globular nature of class II 
lantibiotics is due to their interlocking thioether rings (lanthionine and β-
methyllanthionine moieties).69 When compared to class I lanthipeptides, although both 
bind to lipid II, class II lanthipeptides can bind without forming pores in the 
membrane. In class II, there is a multifunctional lanthionine synthetase (LanMs) 
enzyme which carries out both the dehydration and cyclisation steps forming the 
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lanthionine residues.70 Examples of class II lanthipeptides include mersacidin and 















































Figure 9: Structure of class II lantibiotics Mersacidin and Actagardine71 
 
1.5.4 Class III Lanthipeptides 
Class III lanthipeptides, unlike their class I and II counterparts, lack antimicrobial 
activity. Instead, these peptides have morphogenetic and signalling functions in vivo.72 
Similarly to the class II lanthipeptides, the post-translational modifications of the 
lanthionine and β-methyllanthionine motifs occur via a multifunctional synthase 
LanKC. They are also one of the smallest classification groupings; examples of class 
III lanthipeptides include SapB and the labyrinthopeptins, shown in Figure 10.73 
Labyrinthopeptins contain a Labionine (Lab) bridge, in which the cross-linking is 
composed of a methylene group within the peptide structure instead of lanthionine; 
these moieties consist of a carbacyclic side-chain linkage, with a methylene group 
crosslinked between the α-carbons of two AAs within the structure. These highly 




















































Figure 10: Structure of Class III lantibiotics Labyrinthopeptin A2 and SapB73 
 
1.5.5 Class IV Lanthipeptides 
The final class of lanthipeptides is class IV which are similar to class III, in that both 
biosynthetic pathways use a multifunctional lanthionine synthase. The lanthionine 
synthase used during both the dehydration and cyclisation of the lanthionine moiety is 
LanL.75 This class has been recently assigned through the discovery of the 
lanthipeptide venezuelin, which is produced by Streptomyces venezuelae.76 The major 
difference between class III and IV lanthipeptides is that in class IV the LanL contains 
a zinc-binding motif in the cyclisation domain of the enzyme. This motif is thought to 
activate the thiol side-chain of Cys, promoting the nucleophilic attack on the Dha/Dhb, 
where the dehydrated AA acts as a Michael-acceptor in the presence of cysteine, 
forming the thioether crosslink.43,77 An example of a class IV lanthipeptide is 


























Figure 11: Structure of Class IV Lanthipeptide, Streptocollin77 
1.6. Nisin 
Nisin is a 34 amino acid polycyclic lantibiotic which belongs to the class I 
lanthipeptide family, exhibiting high antimicrobial activity against Gram-positive 
bacterial species.78 It has been extensively studied, with over 4,000 peer-reviewed 
publications to date, making it the most comprehensively studied lantibiotic. Nisin has 
been used a food preservative (E234) for over 50 years, without the development of 
significant antimicrobial resistance.79 
It is used as a food preservative in over 50 countries mainly in the meat and dairy 
industry.80 Importantly, it is active against a wide variety of Gram-positive bacteria 
which include some resistant bacterial strains, such as Streptococcus pneumoniae and 
vancomycin-resistant Enterococcus faecium.81,82 It is ribosomally synthesised, 
followed by a series of sequence-specific dehydrations of serine and threonine 
residues to form Dha and Dhb residues, respectively. The lanthionine moieties are 
formed via stereoselective thioether formation by intramolecular Michael addition 
reactions of the thiolates of cysteine residues to the dehydrated AAs (Dha and Dhb) 
forming the lanthionine (A ring) and the β-methyllanthionine links (B-E rings), shown 












































Figure 12: Primary amino acid structure of nisin A and Z 
 
The formation of the lanthionine and β-methyllanthionine follows a general 
mechanism for all lanthionine-containing peptides described in section 1.5 and is not 
specific to nisin alone. 
1.6.1 Structure of nisin 
Nisin A and nisin Z are the two most common natural forms of the bacteriocin, being 
almost identical in structure apart from a single AA substitution at position 27; nisin 
A contains a histidine (His) residue whereas in nisin Z it is an asparagine (Asn). Nisin 
contains a number of distinct and unusual structural features; the polypeptide contains 
five intra-chain thioether crosslinks, with a lanthionine crosslink in the A ring and β-
methyllanthionines (Figure 12) in the B-E rings. Also contained within the structure 
are three dehydrated AA residues, with a Dha at positions 5 and 33, and a Dhb at 
position 2. The presence of these unusual residues in a number of lantibiotic peptides 
suggests that they play a significant role in the antimicrobial mode of action.84 Also, 
unusually nisin does not contain any aromatic residues such as Phe, Tyr or Trp. In 
addition, of the 34 residues in the nisin structure, 13 of them are unusual residues, a 
very high proportion. Nisin is very hydrophobic with only 3 Lys residues (+ charged) 
and 2 His residues (nisin Z only 1), so both display low water solubility at 
physiological pH. Interestingly there are no negatively charged residues (aspartic or 
glutamic acids), with only the C-terminus COOH being present, which is also highly 
unusual.   
The A ring of nisin contains five AAs and is the only lanthionine thioether ring 
containing a dehydrated residue (Dha 5). The B ring of nisin contains four residues 
joined by a β-methyllanthionine; this ring system is interesting as a large number of 
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lantibiotics, from a variety of disparate sources, share an identical B ring (e.g. subtilin, 
gallidermin and epidermin).85 Both the A and B rings of nisin are involved in the 
binding of nisin to lipid II (see section 1.6.2).86 The portion of nisin between the C and 
D rings is known as the hinge region, consisting of a three AA sequence (Asn20-
Met21-Lys22). The hinge region is highly flexible and hydrophilic, and has been 
associated with pore formation within bacterial cell membranes.87 The complex 
interlocking D and E rings of nisin also play a role in pore formation, with the chemical 
synthesis of these interlocking D and E rings being particularly difficult.88 
1.6.1.1 Dehydroamino acid residues 
Dehydroamino acids (dhAAs) are non-coded AAs that are present in a range of natural 
products, including bioactive peptides.89 Nisin contains three dhAAs, two at the N-
terminal end of the peptide and one present in the tail region. Although dhAAs are not 
included in the 20 proteinogenic AAs, they are abundant in nature. This simple 
functionality can greatly impact the structure and function of the biomolecules that 
contain dhAAs.90 Structurally they assume a roughly planar geometry with their main 
structural feature being the carbon-carbon double bond between the α and β-carbon 
atoms (Figure 13).91 The planar geometry at the α,β-carbons has a significant effect 
on the structure of peptides which contain dehydrated AAs. They are also electrophilic 
in nature acting as Michael acceptors,92 since the introduction of the double bond leads 
to a conjugated system, and significantly affects the conformation of the peptide 
backbone.93 Due to the unsaturated alkene function within dehydrated AAs, they do 
not contain a stereocentre at the α-position like the saturated AAs do, (with the 
exception of glycine). The overall preferred trans-orientation of β-substituted dhAAs 
promotes conformations within peptides and proteins which are not allowed with 












1.6.2 Nisin’s Mechanism of Action 
Class I lanthipeptides, such as nisin, carry a net positive charge at physiological pH, 
which is due to the number of lysine and/or arginine residues in the polypeptide 
structure.95 Due to the cationic nature of the peptide, nisin is attracted to the surface of 
Gram-positive bacteria which contain a high concentration of negatively charged 
teichoic acid residues in their cell walls96 (i.e. teichoic acids in carboxylate form). 
Nisin displays a dual mode of action against Gram-positive bacteria. Initiation of its 
mechanism involves nisin binding to the pyrophosphate moiety of the lipid II 
component (Figure 14) present in the bacterial cell wall and, following binding, it then 
inserts into the membrane, creating a pore.97 
 
Figure 14: Nisin-Lipid II pyrophosphate cage98 
 
Binding of nisin to lipid II via 5 hydrogen bonds forms a complex known as the 
“pyrophosphate cage”,98 with the A and B rings being involved in its formation. As 
shown in Figure 14, in yellow are the intermolecular hydrogen bonds involving the 
amide N-Hs within the nisin backbone to the oxygens of the pyrophosphate.99 As a 
result of nisin binding to the lipid II molecule, which as stated before is a precursor of 
bacterial cell wall synthesis, nisin-lipid II complex formation inhibits the synthesis of 




Figure 15: Binding and pore formation of nisin101 
 
After formation of the pyrophosphate cage the peptide folds, using the hinge region, 
into the bacterial cell leading to rapid membrane depolarisation and cell death (Figure 
15);102 once anchored the C-terminus is parallel to the cell membrane and is then 
inserted into the membrane, forming pores.103 The pore is thought to cause rapid 
dissipation of the transmembrane electrostatic potential.104 Eight individual nisin 
peptide molecules and four lipid II molecules are involved in the formation of a stable 
pore, with a diameter of between 2.0 and 2.5 nm.105 The formation of the membrane 
pore causes detrimental effects, resulting in an efflux of ions, AAs, ATP (adenosine 
triphosphate) and collapse of the proton motive-force.106 It is thought that the slow 






Figure 16: ''Hot Spots'' within nisin determined using 1 and 2D NMR 
experiments33 
 
Recently Breukink used solid state NMR techniques to investigate the nisin-lipid II 
pore complex and described a number of pharmaceutical “Hot Spots” within the nisin 
structure (Figure 16).107 These hot spots lie in the hinge region and the lysine linker 
between the B and C thioether rings. Both regions are flexible and aid in pore 
formation and nisin’s ability to adapt to complex cell membranes. Also highlighted is 
the Ser29 residue located in the tail region of nisin, which also seems to anchor the 
peptide and interact with the bacterial cell wall. Mutations within these regions have 
been shown to modulate the bioactivity of nisin in a strain-specific manner.108  
1.6.3 Aqueous Solubility and Stability of nisin 
The solubility of nisin in aqueous solution is highly pH dependent; as the pH of the 
aqueous solution increases the solubility of nisin decreases dramatically, as shown in 
Figure 17.109 Nisin is a highly hydrophobic peptide which affects its aqueous 
solubility. At pH 2 it has a solubility of 57 mg/ml, but when the pH is increased to pH 
6 its solubility decreases to only 1.5 mg/ml.110 The common natural forms nisin A and 
Z also display differences in solubility, with nisin Z having greater aqueous solubility, 




Figure 17: Aqueous solubility of nisin A as a function of increasing pH109 
 
Nisin is quite stable between pH 2 and 3 but suffers a 90% loss in activity at pH 6.8, 
so at elevated pH both the solubility and stability of nisin are compromised after 18 
days.112 It has been long known that nisin becomes unstable in alkaline pH systems. 
The Dha residue at position 33 is most susceptible to hydrolytic attack above pH 6, 
leading to the cleavage of residues 33 and 34, generating nisin1-32.84 In highly basic 
conditions, e.g. above pH 12, both the Ser29 hydroxyl group and ammonium 
containing side-chains, i.e. lysines, are deprotonated which can then cause 



















Figure 18: Intramolecular nucleophilic attack on Dha 33 of nisin at high pH84 
 
The stability issues of nisin at physiological pH limits its use as a human or veterinary 
therapeutic, so the development of nisin analogues with increased stability at 
physiological pH could allow for its medicinal application as an antibiotic in order to 
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help to address the global AMR crisis. Achieving higher solubility through such 
modifications would also facilitate access to effective therapeutic concentrations.  
1.7. Incorporation of Dha into peptides 
In order to study the stabilisation of the Dha33 moiety located in the tail region of 
nisin A and Z, it is necessary to be able to synthesise efficiently the Dha moiety within 
the peptide structure. Several methods have been employed for the insertion of a Dha 
residue into desired peptide targets. Access to dehydroamino acids in nature is 
predominantly via dehydration reactions of serine and threonine residues, with both 
being demonstrated as intermediates en route to Dha and Dhb formation.113 The 
coupling of a Dha residue directly into peptides is difficult as it suffers from a stability 
issue caused by the reactive α,β-unsaturated centre, which can act as a Michael-
acceptor under a variety of reaction conditions. This reactivity causes the residue to 
be prone to decomposition during peptide synthesis, so the late-stage conversion of 
standard AAs has been utilised to generate the Dha, via a β-elimination reaction.114 
1.7.1 Synthesis of Dha from phenylselenocysteine by oxidative elimination  
Van der Donk and co-workers developed a synthesis of the Dha residue via the 
oxidative elimination of the Fmoc-Se-phenylselenocysteine moiety (Scheme 1). The 
required Fmoc-Se-phenylselenocysteine 4 was prepared, i) by treating Fmoc-serine 
allyl ester 1 with tosyl chloride in pyridine forming the tosylate intermediate 2; ii) this 
intermediate was treated with phenyl selenol and 1 mole equivalent of NaOH, to form 
the fully protected Fmoc-Se-phenylselenocysteine allyl ester 3; iii) the removal of the 
allyl protecting group was performed with palladium tetrakis(triphenylphosphine) 
[Pd(PPh3)4], which gave 4 as a free carboxylic acid ready for used in solid-phase 




























i) p-Tosyl chloride, pyridine 0
oC; ii) Phenylselenol, NaOH (1M), acetone, DMF, rt;
iii) Pd(PPh3)4, morpholine, THF, rt  
Scheme 1: Synthesis of Fmoc-phenylselenocysteine 4, from protected serine 1115 
After the Fmoc-Se-phenylselenocysteine 4 was incorporated into a peptide sequence 
using SPPS, the product was cleaved from the resin after coupling. This peptide was 
then treated with either sodium periodate or hydrogen peroxide, oxidising the Se-
phenylselenocysteine to the selenoxide and prompting its spontaneous β-elimination, 
forming Dha 6, within the peptide structure (Scheme 2).116  

























Scheme 2: Synthesis of Dha 6 by the oxidative elimination of the selenide 5116 
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1.7.2 Synthesis of a Dha via the Hofmann elimination reaction 
Shiba and co-workers employed a Hofmann elimination in their total synthesis of nisin 
to incorporate the Dha into both the A ring and tail region.117 The A ring was 
synthesized with 2,3-diaminopropionic acid (A2pr) 7 in place of the Dha at position 5. 
The β-amino group of the side-chain was then dimethylated by reductive amination, 
using formaldehyde and sodium cyanoborohydride in methanol, to give 8 (Scheme 3). 
The dimethylated residue was then quaternerised by treatment with methyl iodide and 



















1.7.3 Synthesis of a Dha via an Asparagine residue 
α,β-Unsaturated AAs, as described above, are usually derived from both serine and 
threonine amino acid residues. In 1994, Blettner described the incorporation of a 
masked Dha during peptide synthesis, in the form of an asparagine residue.119 It was 
converted to the Dha via a series of Hoffmann-type degradation reactions (Scheme 4). 
(i), (ii), (iii)
(i) 1.5 eq. PhI(O2CCF3)2, DMF/THF/H2O (1:1:1), Pyridine
(ii) MeI (10 eq.), KHCO3
 (10 eq.), MeOH















Scheme 4: Formation of Dha via a masked asparagine residue119 
 
The method involves 1.5 equivalents of PhI(OCCF3)2[bis(trifluoxacetoxy) 
iodobenzene] being added for each asparagine residue present within the peptide to 
facilitate a Hoffmann rearrangement,120 followed by a Hoffmann-type elimination to 
afford the Dha residue on the Merrifield resin solid support. This method allows for 





1.7.4 Synthesis of a Dha via β-elimination of a sulfonate intermediate  
In 1963 Photaki and co-workers reported on the formation of Dha 9 via tosylation of 
serine 12 and subsequent β-elimination of the tosylate 13, on treatment with 












i) p-Tosyl chloride, pyridine, 0
oC, ii) diethylamine, 0oC
12 13 9
 
Scheme 5: Formation of Dha 9 from serine 12121 
The method developed by Photaki was later adapted in 2007 by the Vederas group, 
for the incorporation of Dha and Dhb residues into peptides.122 For the synthesis of 
lactocin S, dipeptide 14 was treated with mesyl chloride, forming the di-mesylated 
peptide 15. The mesyl groups where then eliminated using DBU in dichloroethane 
(DCE) to produce the dehydrodipeptide 16, with both Dha and Dhb residues present 
(Scheme 6).123,124 
i) Mesyl chloride, Et3N, DCM; 

































1.7.5 Synthesis of Dha via oxidative elimination of cysteine thioethers 
The preparation of a Dha through the oxidative elimination of cysteine thioethers was 
reported in 2008 by Bernardes and co-workers. S-Ethyl cysteine 17 was converted to 
Boc-Dha-OMe 18, after treatment with O-mesitylenesulfonyl-hydroxylamine (MSH-
induced oxidative elimination), Scheme 7. Peptides, which contained a thioether, were 











i) MSH (4 mole eq.), DMF/H2O/K2CO3, 10 min, rt
17 18
 
Scheme 7: Oxidative elimination of thioether 17 to generate Dha 18125 
 
The Davis group has used this method for the effective conversion of a free cysteine 
to a Dha in 98% yield, allowing for the conversion of a cysteine, on the surface of 
peptides and proteins, to a Dha moiety.125 Nucleophilic and radical additions to the 
Dha then lead to peptide and protein derivatives in excellent yields. The oxidative 
elimination of cysteine is a perfect example of a site-specific functionalisation within 
peptides and proteins. Post-translational modification of proteins is prevalent 
throughout nature, which contributes to the increasing diversity of protein structure 
and function by two orders of magnitude.126 It has been stated that the ability to modify 
a particular AA or site, among a sea of reactive functional groups (amides, carboxylic 
acids, amines and alcohols) has the potential to “herald new modes of Biology and 
Medicine”.126,127 These protein modifications are often utilised to study both the 





1.7.6 Synthesis of a Dha moiety within peptides via cysteine bis-alkyl 
elimination. 
In 2015 Morrison and co-workers reported a strategy for the conversion of a cysteine 
to a dehydroalanine residue via a bis-alkylation/elimination reaction, using methyl-
2,5-dibromovalerate 20 (Scheme 8). A cyclic sulfonium intermediate 22 is formed 
through the double alkylation of the cysteine thiol 19, where the cyclic intermediate 












































Scheme 8: Bis-alkylation/elimination of a cysteine by reaction with 2,5-
dibromovalerate129 
1.8 Solution-phase peptide synthesis 
In the early twentieth century Curtius and Fischer separately began investigating the 
synthesis of small peptides, as until then the synthesis of peptides had been a challenge 
to chemists for over 100 years.130 The strategy for peptide synthesis in solution 
involves the use of orthogonally protected AAs, and coupling reagents to form the 
activated acid to aid the formation of the amide bond. Similar to SPPS (see section 
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1.9), peptide coupling in solution is a repetitive process of deprotection and coupling 
steps to control the addition of the next protected AA to form the desired peptide 
sequence. The steps involved in solution-phase synthesis are shown in Figure 19. 
Firstly, the protected amino group of AA2 is deprotected, followed by coupling to the 
activated carboxylic acid group of AA1. This pre-activation is achieved using coupling 
agents.   
Z = -COOH protecting group
X = Temporary amino group
Y = Orthogonal side-chain protecting group       (if required)















































Figure 19: The process and steps involved in solution-phase peptide synthesis 
 
A drawback of solution-phase peptide synthesis is that it is labour intensive. After each 
coupling step rigorous purification is required before continuing to the next stage of 
the synthesis. There are also issues associated with the solubility of fully protected 
AAs in the solvents used in solution-phase synthesis (acetonitrile and DCM), since 
DMF is difficult to remove after the coupling step.131  
31 
 
1.9 Solid-phase peptide synthesis (SPPS) 
In the early 1960s solid-phase peptide synthesis (SPPS) was developed by Bruce 
Merrifield, and it is the most widely employed method for the chemical synthesis of 
peptides, for which Merrifield won the Nobel Prize in 1984. The synthesis of the 
desired linear peptide makes use of a solid support (resin), where the peptide is 
elongated in a step-wise manner by the sequential addition of protected AAs, from the 
C-terminus to the N-terminus.132,133 Attached to the resin is a linker bridging the 
peptide to the solid support; the type of linker employed during the synthesis dictates 
the cleavage conditions to recover the synthesised peptide, with the most common 
cleavage method being acidic treatment with TFA.134 The advantages of the SPPS 
technique over classical solution phase is the speed and simplicity of execution. Prior 
to the development of SPPS, peptide synthesis was not only difficult but also labour 
intensive. However, using a solid-support resin has allowed for the automation of 
peptide synthesis of in some cases very complex peptides.135 The swelling of SPPS 
resins is critical as 99% of the coupling sites are within the resin matrix, so swelling 
is essential for optimal permeation of activated N-protected AAs and reagents.136 The 
steps involved in removal of the temporary protected α-amino group, acid activation 
and coupling, are shown in Figure 20.137  
X = Temporary amino protecting group; Y = Orthogonal side-chain protecting group; 

















































2) Cleavage    from resin
 




In peptide synthesis there are two main AA protecting-group strategies used, namely 
the acid-labile Boc (tert-butoxycarbonyl) and the base-labile Fmoc 
(fluorenylmethyloxycarbonyl) chemistries, with the Fmoc protection strategy being 
employed in this project. The Fmoc strategy is the most common because this method 
does not require specialised reaction equipment [e.g. using hydrofluoric acid (HF) for 
Boc chemistries require stainless steel reaction vessels]. 
1.9.1 2-Chlorotrityl Chloride Solid Support Resin (2-CTC) 
One of the most widely used solid supports in the SPPS of biomolecules, like peptides 
and proteins, is the polystyrene-based 2-chlorotrityl chloride (2-CTC) resin, composed 
of a polystyrene core and a 2-chlorotrityl linker.139 The 2-CTC resin is acid labile, 
which is very compatible with the base-labile Fmoc SPPS strategy (Section 1.9.3). 
The loading of the first AA is via an esterification reaction between the free carboxylic 
acid group and the reactive trityl group on the solid support resin, in the presence of 
base, DIPEA (N,N-diisopropylethylamine) shown in Scheme 9.140 



















Scheme 9: Loading of Fmoc-protected amino acid onto the 2-CTC resin 
Some of the advantages of using 2-CTC resins during SPPS include (i) the fast 
attachment of the first amino acid, (ii) prevention of diketopiperazine (DKP) formation 
during the synthesis; and (iii) the cleavage of peptide from the resin can be achieved 
using mildly acidic conditions to afford a free carboxylic acid.141 The mild acidic 
cleavage is also one of the main limitations of the 2-CTC resin, as premature cleavage 
of fully protected peptides can be observed if only a small amount of acid is present; 
as low as 1% TFA has been reported to cleave peptides from the resin.142 Another 
disadvantage of the 2-chlorotrityl resin is that it is prone to hydrolytic cleavage when 
compared to other resins. 
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1.9.2 Wang Solid Support Resin 
Another commonly used resin is the Wang resin, which again consists of a polystyrene 
core but with a Wang linker composed of a p-alkoxy benzyl alcohol (Scheme 10).143 
Similarly to the 2-CTC resin, cleavage using TFA generates a free carboxylic acid. 
The liberation of peptides from the Wang resin requires a minimum of 50% TFA 











Scheme 10: Loading of Fmoc Amino acid onto Wang resin144 
Although the Wang resin is commonly used in SPPS there are two main disadvantages 
to its use: 1) the esterification step of loading the Fmoc-amino acid can be 
accompanied by significant racemisation, and 2) loss of the C-terminal dipeptide via 
diketopiperazine formation.145 
1.9.3 Fmoc SPPS strategy  
The 1970s saw the development of Fmoc chemistry by Eric Atherton and Bob 
Sheppard, who introduced the Fmoc group as a temporary protecting group on the N-
terminus of a growing peptide.146 The Fmoc group is a base-labile protecting group 
often removed using piperidine. This allows for milder removal conditions to be used 
in comparison to Boc chemistry (which requires HF) for both the deprotection 





































Figure 21: Mechanism of deprotection of the Fmoc group using piperidine148 
 
The Fmoc group is readily removed when treated with secondary amines, e.g. 
piperidine, which abstracts the relatively acidic proton from the fluorenyl ring system 
(Figure 21). This deprotonation leads to a β-elimination to form CO2 (rendering the 
reaction irreversible), dibenzofulvene (DBF) and the free amine.149 The piperidine has 
a dual role during the deprotection step, acting as both a base for the removal of the 
Fmoc group, and also as a scavenger to trap the liberated DBF. The use of a large 
excess of piperidine (20% solution) prevents reaction of the free amine product with 




1.9.4 Estimation of Resin Loading 
The removal of the Fmoc protecting group is also used for measuring resin loading, as 
the accurate determination of resin loading dictates the yield of the final peptide 
product.  The base-labile Fmoc group is quantitatively removed using 20% piperidine 
in DMF, forming a dibenzofulvene-piperidine adduct (Figure 22).151 This adduct 
exhibits UV absorbance maxima at two distinct wavelengths, at λ = 301.0 and 289.8 
nm. The absorbance measured at either of the wavelengths, in conjunction with the 
respective molar absorptivity/ extinction coefficient (mL.mmol-1.cm-1),  allows for 




dibenzofulvene adduct in 
supernatant  
Figure 22: Dibenzofulvene-piperidine adduct equilibrium154 
 
Due to the distinct UV absorbance of the dibenzofulvene-adduct, approximately 10-
20 mg of dried resin is sufficient for the estimation of resin substitution. The resin is 
swollen in DMF and treated with 20% piperidine, the supernatant is then measured at 
either distinctive wavelength, with the 290 nm wavelength being reported to be more 
reilable.151 To determine the resin loading the mass of resin (m), UV cell path length 
(cm) and dilution factor of the supernatant (D) must be taken into account, as well as 
the molar absorptivity (ε) also known as extinction coefficient at the specified 
wavelength and an equation (Figure 23) derived from the Beer-Lambert law (A = ε.c.∧, 
where c = molar concentration) is employed.155,156 
 
 
Figure 23: Equation for estimation of resin loading155 
A = absorbance  
ε = molar absorptivity at wavelength λ (mL.mmol-1.cm-1   
or L.mol-1.cm-1) 
V = volume (mL) 
D = dilution factor  
Λ = path length (cm)  




1.9.5 Cleavage of peptides from solid support resins 
The cleavage of synthesised peptides from the solid support resin is achieved using a 
cleavage cocktail. Due to the prevalence of the Fmoc peptide synthesis strategy 
(Section 1.9.3), the most commonly used cleavage method is an acid treatment (Figure 
24). The TFA-based cleavage cocktails are composed of TFA and scavengers like 
water, anisole and triisopropylsilane (TIPS). Cleavage is one of the most critical steps 
during peptide synthesis and the treatment of a peptide resin is not one simple step, 
but a series of competing reactions. Therefore, the choice and selection of suitable 















Figure 24: Cleavage mechanism of Wang resin using TFA 
 
Scavengers like TIPS are used in cleavage mixtures in a concentration between 1-5% 
and are used to suppress side reactions attributed to removal of side-chain protecting 
groups and the reactive Wang linker during the global deprotection of the peptide 
during cleavage.157 They scavenge cations like t-butyl and trityl which could possibly 
react irreversibly with amine functionality within the peptide.158 For post-acidic 
cleavage, in some cases, peptides can be precipitated from cold ethers, for example 
diethyl ether (Et2O) or methyl tert-butyl ether (MTBE), before being purified, usually 
by preparative HPLC.159,160 
1.10  Coupling reagents utilised during peptide synthesis 
In biological systems, peptide and protein syntheses are extremely complex and 
facilitated by the ribosomes.161 Synthetically, the amide bonds are typically prepared 
from the reaction between a carboxylic acid derivative and an amine (amidation). 
However, on its own these chemicals would produce a salt and so does not happen 
spontaneously.162 Usually, without the use of a coupling reagent, the conditions 
employed for amide bond formations are harsh and require high temperatures to drive 













Figure 25: Activation of a free carboxylic acid and amide bond formation 
 
In synthesis the first step involves activation of the free carboxylic acid of one AA and 
the second step involves nucleophilic attack by the free amino group of another AA 
(Figure 25). The carboxylic is converted to an activated species, creating a “hyper” 
leaving group, thus accelerating the formation of the amide bond. 
 
1.10.1 Carbodiimide coupling reagents 
The use of carbodiimide coupling reagents, such as dicyclohexylcarbodiimide (DCC, 
Figure 26), is the traditional method employed for the formation of peptide bonds. 
Carbodiimides contain two nitrogen atoms and are weakly basic; this is enough to 
initiate the reaction forming the activated ester, which is reactive and readily 
undergoes aminolysis, when in the presence of a free amine, to return the desired 
peptide.163 One issue with using DCC is the difficultly in removing the dicyclohexyl 













Figure 26: Structure of DCC (24) and EDC (25) coupling reagents164, 165  
 
In response to solubility issues during purification, a number of other carbodiimides 
have been developed with their corresponding urea by-product having greater water 
solubility, and these include EDC (25). EDC has proven to be a popular alternative to 
the conventional DCC coupling reagent, as the by-product is easily removed by an 




A common problem in the use of carbodiimides as coupling reagents is the 
epimerisation of the α-proton, via intramolecular reactions at the site of acid activation. 
The most common mechanism of epimerisation involves the formation of azlactones 
(Figure 27).166 The formation of the azlactone ring lowers the pKa of the α-proton, 
which facilitates deprotonation, caused by the now more acidic proton. The re-
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Figure 27: Peptide epimerisation of azlactones by intramolecular attack at the 
activated acid167,168 
In attempts to overcome the epimerisation issues, coupling reagents and additives have 
been developed which are used to increase the reactivity of the activated carboxylic 
acid, while suppressing the epimerisation at the α-position during peptide coupling.169 
 
1.10.2  Additives and reagents used in peptide coupling reactions. 
The most common additive used in peptide coupling is 1-hydroxybenzotriazole 
(HOBt, 24), which is either used in combination with carbodiimide coupling reagents 
or designed into stand-alone coupling reagents. The use of HOBt alongside 
carbodiimide reagents increases the reactivity of the activated ester, inhibiting the 















Figure 28: Chemical structures of HOBt (26) and HOAt (27) additives 
 
Although HOBt has been extensively used for over twenty years, it is explosive in its 
anhydrous form and is now difficult to obtain commercially. The benzotriazole 
coupling reagents including HOBt and HOAt (1-hydroxy-7-aza-benzotriazole)  are 
very reactive, accelerating peptide coupling, but have been restricted in their use 
(usefulness) due to their explosive nature.171 
After extensive study, in 1973, Castro and co-workers reported the applicability and 
efficient replacements for HOBt based coupling reagents, benzotriazol-1-
yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP 28) and (1H-
Benzotriazol-1-yloxy)tri-1-pyrrolidinylphosphonium hexafluorophosphate (PyBOP 
29) to be used as alternative peptide coupling reagents.172 These phosphonium-based 
coupling reagents had the advantage of not forming guanidinium by-products 
associated with aminium/uronium coupling reagents (see below). However, BOP 
generates Hexamethylphosphoramide (HMPA 30) as a by-product which has been 


































Another family of coupling reagents are the uronium-type (urea form) based salts, 
many of which are salts of HOBt like the 2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU 31) and the HOAt salt like                  
1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium3-oxide-hexa-
fluorophosphate (HATU 32). The true form of these coupling reagents depends on the 
solvent, isolation and also the counter-ion used.175 HBTU, HATU and other 
aminium/uronium based coupling reagents exist predominantly in the N-form 
(guanidinium), which is less reactive than the corresponding O-form (uronium), but 
both isomers are very effective coupling reagents, with little epimerisation, due to their 












































Figure 30: Structures of aminium/uronium type coupling reagents175 
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1.11  Project Aims and Objectives 
One of the main project aims was the synthesis of analogues of the nisin tail region 
residues 29-34, in order to study the effect of the surrounding AAs on the stability of 
the Dha33 moiety. Due to the reactive properties of the Dha33 in nisin it can undergo 






































Figure 31: Currently accepted mechanism for the decomposition of nisin.79 
 
As shown in Figure 31, the currently accepted literature mechanism for the cleavage 
of Dha33, by acid-catalysed Markovnikov hydration in the physiological pH range, is 
not consistent with the fact that nisin shows its maximum stability at the more acidic 
pH values of 3-4. Therefore, the synthesis of the native nisin tail, and of analogues, to 
study the stability of the Dha33 may shed light on the mechanism and ways to slow it 
down considerably. It was proposed that the synthesis of peptide fragments, by either 
SPPS or solution-phase peptide synthesis would be employed for the synthesis of the 
tail of nisin (residues 29-34). Furthermore, intermediates during the synthesis would 
contain either the Dha or its cyclopropyl AA replacement (AC3C, Figure 32) as a 
structural mimic for the Dha, which would not undergo hydrolysis and therefore could 















Figure 32: Structure of Dha and its cyclopropyl amino acid replacement 
 
Replacement of Dha33 with the AC3C AA makes use of the commercially available 
Fmoc-protected 1-aminocyclopropane-1-carboxylic acid (AC3C), which has been 
used previously to develop metabolically stable, conformationally constrained 
peptides.177 This may allow it to be a structural mimic for the dehydrated amino acid 
as it would not be involved in acid-catalysed Markovnikov hydration. Structurally 
AC3C is a possible replacement for the Dha as the bond angle at the α-carbon lies 
between 115-118o while the Dha has ~120o bond angle,178 possibly maintaining the 
conformational properties, but increasing the stability. For each of the peptide 
fragments synthesised (Figure 33), both their conformation and stability in aqueous 
solutions between pH 2-7.5 could be examined, using a range of spectroscopic 
techniques including NMR, HPLC, LC-MS/MS, circular dichroism (CD) 
















Figure 33: Structures of the nisin tail and tail analogue targets 
 
As seen previously, nisin suffers a dramatic loss in activity and aqueous solubility as 
the pH increases from acidic to physiological pH. From reported CD studies, the 
conformation of nisin is also thought to change at a pH of ~6, which may be 
responsible for the reduction in its activity.179 The imidazole side-chain of histidine 
has a pKa value at around this pH,180 and so this could have an effect on the 
conformational change when the side-chain becomes deprotonated. The 
conformational change, along with overall charge reduction, may lower its solubility 
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and in turn its activity. The effect of the histidine on the stability and solubility of nisin 
at physiological pH could be examined using HPLC, NMR and CD analysis. 
These conformational changes could be studied in detail using both NMR and CD 
analysis, to examine if there are any interactions which may stabilise or destabilise the 
Dha moieties at physiological pH. Understanding the possible effects of the flanking 
AAs on the stability of the dehydrated AAs in nisin may aid in the design and 
development of novel nisin analogues with greater stability at physiological pH. For 
example, replacing the terminal lysine residue with controls such as glycine, alanine 
or phenylalanine. This would allow for the investigation of possible interactions of the 
lysine ammonium side-chain, with the Dha33 residue. The lysine side-chain could be 
involved in the protection of the Dha from hydrolysis, in acidic environments via a 
cation-π interaction.181 Studying the presence of such interactions may increase the 





















2.0  Introduction  
This chapter describes the synthetic efforts employed toward the synthesis of the 
native nisin tail, and its analogues, as proposed in section 1.10, which include the 
incorporation of a Dha residue into the target peptide. The methodologies used, as well 
as the synthesis and characterisation of described target peptides are outlined. 
 Synthesis of the Dha precursor Fmoc-phenylselenocysteine-O-Allyl 
As described in section 1.7.1, the incorporation of a Dha into target peptides using 
Fmoc-Se-phenylselenocysteine was reported by Van Der Donk, as a route to Dha 
formation by oxidative elimination of the selenide, post peptide synthesis.115 This 
method involves replacement of the O-H of serine by a phenylseleno functional group, 
which can then be oxidised, using either hydrogen peroxide or sodium periodate, 
followed by β-elimination to form the desired Dha residue within the synthesised 







































i) Na2CO3, Aliquat 336 (Oct3NMe
+Cl
-
), allyl bromide, DCM; ii) p-Tosyl chloride, pyridine, 0 
oC; 




Scheme 11: Synthesis of Fmoc-phenylselenocysteine-OH 4115 
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The first intermediate required in the synthesis of Fmoc-Se-phenylselenocysteine-OH 
was Fmoc-Ser-O-Allyl 1, which was formed in a biphasic solvent system of DCM and 
water (1:1 ratio) from Fmoc-Serine-OH, using Aliquat 336 (methyltrioctylammonium 
chloride), a phase transfer catalyst, and allyl bromide, giving compound 1 in 94% 
yield. NMR spectroscopy and mass spectrometry confirmed the formation of 1. After 
successful synthesis of 1, the -OH of the Fmoc-Ser-O-Allyl was reacted with p-tosyl 
chloride in pyridine giving 2 in a low yield of 31% (literature yield between 85-
95%).115 
After reaction of tosylate 2 with phenylselenoxide, as per the reported method, to form 
3, no product was identified by either HRMS or 1H NMR analysis, as it may have 
eliminated to form the Dha during purification. Coupling reactions involving the 
COOH of Dha residues are known to be problematic giving low yields and by-
products. The Dha was seen by HRMS analysis with the observed mass [M+H]+ of 
350.1381, compared to the calculated m/z of 350.1387. Many attempts were made to 
perform and optimise this reaction but unfortunately in our hands without success. 
  Synthesis of N-acetyl-Dha methyl amide 
The synthesis of N-acetyl-Dha-methyl amide (38, Scheme 12) was attempted to study 
the reactivity and stability of an isolated Dha moiety which is not within a peptide, 
since the flanking AAs could protect the Dha from reaction in acidic pH environments. 
Therefore, 38 would give a “baseline value” of Dha stability. Nisin contains three 
dehydrated AA residues and it could be thought that in acidic environments these 
residues should be hydrolysed, but this is not consistent with experimental findings, 
so a comparative study of reactivity of the Dha would be performed to determine the 









































Scheme 12: Synthesis of N-acetyl-Dha-methyl amide 
 
The synthesis of 38 was attempted starting from L-serine methyl ester 35 which was 
treated with methylamine to form amide 36. The formation of 36 was confirmed by 
HRMS, with the observed mass [M+H]+ of 119.0821, compared to the calculated m/z 
of 119.0820. Compound 36 proved very difficult to purify by column chromatography, 
so the crude product was carried forward without purification and reacted with acetic 
anhydride in pyridine, for acetylation of the free amino group to produce 37, but this 
product was never detected post synthesis. Instead the presence of Dha 38 was 
observed indicating that elimination of the alcohol had occurred. The formation of 38 
was confirmed by HRMS with the observed mass [M+H]+ of 145.0970, compared to 
the calculated m/z of 145.0972.  
Compound 38 was formed during the acetylation step, and so the dehydration of the 
alcohol using EDC and copper(II) chloride, as shown in Scheme 12, was not required. 
It is most likely that Dha 38 formed by β-elimination of the acetoxy derivative 39 due 
to the acetate group being a better leaving group. To date no NMR identification of 
the isolated product 38 has been achieved, as purification by column chromatography 





  Solution-phase peptide synthesis of nisin tail fragments 
The synthesis of fragments of the nisin tail, and their derivatives, was undertaken using 
a dual approach of both solution and solid-phase peptide synthesis. The solution phase 
was initially employed due to the length of peptide sequences and the higher quantity 
of material that could be generated. SPPS was utilised due to the ease of removing 
reagents, along with no requirement for purification of peptide intermediates, until the 
final stage of synthesis. The materials isolated were analysed using UV-Vis, IR, 
HRMS, NMR, and CD spectroscopy. 
 Synthesis of Fmoc-Lys (Boc)-O-Allyl for solution-phase synthesis 
As the amino acid at position 34 of the nisin tail is a lysine residue, the synthesis must 
generate a fully protected lysine. Using the same method as described in section 2.1, 
Fmoc-Lys(Boc)-O-Allyl 41 was obtained in 80% yield using a biphasic solvent system 
of DCM and water (1:1 ratio), from commercially available Fmoc-Lys(Boc)-OH 40, 

















Scheme 13: Synthesis of Fmoc-Lys(Boc)-O-Allyl (41) 
 
Using HRMS analysis the formation of 41 was confirmed (Table 1), while the 
formation the O-allyl functional group was seen at 4.64 ppm, typical for an O-allyl 
rather than an N-allyl, which would be more upfield. The O-allyl is seen as a multiplate 
due to the non-first order coupling within the alkene system. 
Observed Adduct Expected m/z Observed m/z 
[M+H]+ 509.2646 509.2649 
[M+Na]+ 531.2466 531.2473 
[M+K]+ 547.2205 547.2205 
Table 1: HRMS analysis of orthogonally protected lysine 41  
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 Synthesis of the dipeptide Fmoc-Cys(Trt)-Lys(Boc)-O-Allyl 
Having successfully obtained the required precursor 41, it was then used to prepare 
the dipeptide fragment of the nisin tail. Fmoc-Cys(Trt)-OH was used as the Cys 

















1. 20% piperidine, DCM
2. Fmoc-Cys(Trt)-OH,    PyBop, HOBt, 
    Et
3N, ACN
 
Scheme 14: Peptide coupling to synthesise Fmoc-Cys(Trt)-Lys(Boc)-O-Allyl 42 
 
Removal of the Fmoc protecting group was performed using 20% piperidine in DCM 
for 30 minutes with the resulting mixture being washed with 10% aqueous citric 
acid,182 with subsequent coupling of commercially available Fmoc-Cys(Trt)-OH, 
using PyBop and HOBt as the coupling reagents, in the presence of Et3N. After two 
hours there was no indication of the formation of 42 by either TLC or HRMS analysis, 
so a study of the coupling reaction was conducted (Table 2). Fmoc-S-Methyl cysteine 
was also used, as oxidation of the thioether function would allow for the selective 
generation of the Dha moiety in the target peptides. Examples of peptide coupling 
methods which were used in the study are summarised, and were chosen based on 











































HOBt171 DIEA Not observed 
Table 2: Process optimisation of the dipeptide coupling reaction163 
 
For reactions using HOBt and PyBOP, either alone or in combination, no product was 
observed, but the use of di-isopropyl carbodiimide (DIC) or EDC showed a slight 
improvement with an isolated yield of 19% being obtained. The best isolated yield 
was only 24% using COMU (1-cyano-2-ethoxy-2-oxoethylidene)amino]oxy-
morpholin-4-ylmethylidene]-dimethylazanium hexafluorophosphate), an uronium-
type coupling reagent. One possible reason for these low yields could be due to 
incomplete removal of the piperidine and the piperidine-DBF adduct, leading to the 
AAs reacting with by-products due to the large excess of these reagents. 
Coupling reactions using HBTU in acetonitrile (ACN), with Et3N as the base, have 
previously been shown within our research group to be a promising approach to 




 Fmoc deprotection using tris-(2-aminoethyl)amine (TAEA) 
During conventional Fmoc SPPS the deprotection methods use piperidine in DMF, 
but the presence of piperidine and DMF proves extremely difficult to remove in 
solution-phase syntheses. A report by Carpino, using tris-(2-aminoethyl)amine 46 
(TAEA, Figure 34) for the removal of the Fmoc group has been published for use in 
solution phase, as it can be removed by washing with phosphate buffer at pH 5.5. The 
large excess of TAEA also scavenges the liberated DBF. After washing with the 
phosphate buffer the primary amine groups of TAEA and the DBF-TAEA adduct are 






Figure 34: Structure of tris(2-aminoethyl)amine (TAEA)184 
 
 Synthesis of the dipeptide Fmoc-Cys(Me)-Lys(Boc)-O-Allyl 
Due to the issues involved with the removal of the large excess of piperidine and DMF 
normally used for Fmoc group deprotection, TAEA was used according to the methods 
of Carpino and co-workers,184 while using 1.2-1.5 mole equivalents of the Fmoc-


















HBTU, Et3N, ACN 74% yield
 
Scheme 15: Synthesis of Fmoc-Cys(Me)-Lys(Boc)-O-Allyl (47) 
 
It was found in the reaction work-up that washing the deprotected product with 
phosphate buffer pH 5.5 proved very difficult as each time an intractable emulsion 
was formed. Therefore, TAEA was used for the deprotection of the Fmoc group, 
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followed by washing with 10% aqueous ammonium chloride solution (pH 4.5, which 
did not form an emulsion as was seen with the phosphate buffer). The coupling 
reaction was then stirred at 0oC for one hour and at room temperature for a subsequent 
two hours, giving compound 47 in a vastly improved isolated yield of 74%. 1H NMR 
spectroscopy and MS analysis confirmed the formation of dipeptide 47. Using 1H 
NMR, the O-allyl functional group can be seen as a multiplet at 4.61 ppm, while the 
S-methyl is seen as a broad singlet at 2.20 ppm. 
 
 Synthesis of dipeptides as precursors for nisin29-34 analogues 
Having successfully prepared the dipeptide required for the natural nisin tail, attention 
was turned to the preparation of the other analogues, in tandem. Starting from 
commercially available amino ester hydrochloride salts, dipeptides were prepared and  
in each case NMR and MS analysis confirmed their successful preparation (see Table 
3). The replacement of the terminal lysine was to study the effect of the basic side-
chain on the pH stability of the generated Dha residue.  




































78% ✓ ✓ 
Table 3: Synthesised dipeptide precursors for preparation of nisin tail analogues 
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The glycine analogue was chosen to remove the side-chain completely; alanine was 
chosen to have a small hydrophobic residue and the phenylalanine was to introduce an 
aromatic residue. The aromatic side-chain may be able to interact with the Dha moiety 
(e.g. via aryl-vinyl interaction). In each case the t-butyl ester was used as the carboxyl 
protecting group, for ease of removal post-synthesis, to obtain the free carboxylic acid. 
 Synthesis of the tripeptide Fmoc-Val-Cys(Me)-Lys(Boc)-O-Allyl  
Having successfully prepared a series of dipeptides incorporating the Dha moiety 
precursor S-methyl cysteine, the same method was then used for the preparation of the 
tripeptides. In the nisin tail the next AA is valine, so Fmoc-Val-OH (1.2 mole 













2. Fmoc-Val-OH,    HBTU, 













Scheme 16: Synthesis of Fmoc-Val-Cys(Me)-Lys(Boc)-O-Allyl (51) 
Due to solubility issues not seen during the coupling step of the dipeptide syntheses, 
DCM (10%) was added in order to solubilise all of the reactants fully. Although a new 
spot was observed by TLC analysis, along with the absence of starting material, 
unfortunately attempts to purify 51 were unsuccessful, due to the solubility of the 
tripeptide products and their crystallisation on a silica gel column, causing blockage. 
Extractions were attempted using both DCM and EtOAc to recover the product from 
the silica but were not successful. Therefore, significant further development would 
be required for the purification of 51. The crystallisation of the tripeptide products on 
the column indicates that solids are formed, suggesting that it may be possible to use 
crystallisation as a means of purification. However, many attempts at purification by 















































isolated X ✓ 
Table 4: Target tripeptide precursors for preparation of nisin tail analogues 
 
As shown in Table 4, although each of the tripeptides 52-54 were observed by HRMS, 
it was not possible to isolate these compounds using column chromatography. In each 
case, solubility issues were encountered during purification resulting in blocking of 
the silica column. 
Due to the issues encountered during column chromatography no tripeptides were 
isolated for the full NMR characterisation or stability studies required, so an 




  SPPS of nisin tail fragments 
As stated in section 1.9, SPPS involves the synthesis of the desired peptides uses a 
solid support (resin), to which the peptide is bound covalently for the duration of the 
synthesis. SPPS consists of repetitive deprotection and AA coupling cycles to give the 
desired peptide sequence. In this study, the nisin tail and analogues were targeted using 
SPPS due to the high yields and ease of purification of the desired peptides when 
bound to the insoluble matrix (resin). For the SPPS of the cyclopropyl AA-containing 
nisin tail, commercially available Fmoc-L-Lys(Boc)-2CTC resin was used, as it is pre-
loaded with lysine, the required C-terminal AA in the peptide sequence of the native 
nisin tail. This resin type has been successfully used previously for SPPS within the 
Kelleher research group.185 For the synthesis of fragments containing the Dha moiety, 
a Wang resin was used due to its increased stability towards undesired hydrolytic 
cleavage in acidic solutions. 
   Loading of Fmoc AAs to pre-loaded resin 
The loading during SPPS is a critical step and dictates the quantities of reagents 
required during the synthesis and the overall theoretical yield of the final peptide. The 
calculation of resin loading is a vital parameter and there have been several methods 
described to determine the loading, including gravimetric, elemental analytical and 
photometric methods.153 As described in Section 1.9.1, during our SPPS syntheses the 
photometric method was employed, and measured at 290 nm, to quantify the amount 
of Fmoc-amino acid attached to the resin based on generation of the DBF-piperidine 
adduct. The two commercially available pre-loaded Wang resins; i) Fmoc-L-Lys(Boc) 
55 loaded, and ii) Fmoc-L-His(Trt) 56 were used (Figure 35). 
 
Figure 35: Pre-loaded Lysine and Histidine resins 
56 
 
The Fmoc-His(Trt)-Wang 56 resin was used as a precursor, where the C-terminal 
lysine residue is replaced with a histidine residue. Changing the lysine may give some 
insight into why nisin breaks down at physiological pH. The Dha33 in the nisin tail 
region has been reported to degrade first; the replacement of lysine by histidine is to 
study the effect of the side-chain pKa on the stability of the nisin tail region. 
 Loading of Fmoc-Ser(Trt)-OH to Lysine preloaded Wang resin 
The resin was swollen using DCM and Fmoc deprotection was attempted using 40% 
piperidine in DMF for 30 minutes. The first step in the synthesis (Scheme 17) was 
coupling of the commercially available Fmoc-Ser(Trt)-OH AA to the pre-loaded 
lysine (side-chain Boc protected) on the solid support. The concentration of piperidine 
was increased to 40% in an attempt to increase the yield and coupling of the next AA 


















i) 40% piperidine, DMF






Scheme 17: Coupling of Fmoc-Ser(Trt)-OH onto pre-loaded Lysine resin 
 
A coupling solution containing 3 mol. equivalents of Fmoc-Ser(Trt)-OH, COMU, 
Oxyma-Pure and 6 mol. equivalents of Et3N in DMF was added to 55 and stirred for 
1 h to afford 57.186 This step gave a loading of between 0.42-0.46 mmol/g using 
analyses of the piperidine-DBF adduct, compared to the manufacturers capacity of 0.7 
mmol/g; the formation of the dipeptide 57 was confirmed by HRMS analysis (Table 
5). This dipeptide (57) was a common starting material for several tail fragments and 





Observed Adduct Expected m/z Observed m/z 
[M+H] + 456.2129 456.2131 
[M+Na] + 478.1949 478.1944 
[M+K] + 494.1688 494.1684 
Table 5: HRMS analysis confirming dipeptide (57) formation 
 
 Loading of Fmoc-Ser(Trt)-OH to Fmoc-His(Trt)-Wang Resin 
Using the same methodology as described for the formation of 57, Fmoc-Ser(Trt)-OH 
was coupled onto to a Fmoc-His(Trt)-preloaded Wang resin to afford the resin bound 
dipeptide 58 (Scheme 18). The initial step using this particular preloaded resin gave a 
loading of 0.508 mmol/g. As with all SPPS strategies conducted within this research, 
0.5 g of Fmoc-His(Trt)-Wang resin was used for the assembly of the desired peptide 
target, and so based on the determined loading, the theoretical yield of desired peptide 














i) 40% piperidine, DMF







Scheme 18: Coupling of Fmoc-Ser(Trt)-OH onto pre-loaded histidine resin 
 
As seen in Table 6 the successful overall coupling of the desired resin-bound dipeptide 
was shown by HRMS analysis.  
Observed Adduct Expected m/z Observed m/z 
[M+H] + 465.1769 465.1759 
[M+Na] + 487.1588 487.1576 
[M+K] + 503.1327 503.1232 





 Synthesis of tripeptide fragments  
Following on from the successful formation of dipeptide 57, the next step was the 
Fmoc deprotection and subsequent coupling of the next Fmoc protected AA, Fmoc-L-
Val-OH. Using the same methodology as used to prepare 57, the successful formation 
of 59 was confirmed by HRMS analysis. Post coupling of Fmoc-L-Val-OH to the 
resin-bound peptide 59, the Fmoc protecting group was removed using piperidine in 
DMF, and the resulting free amine was acetylated using acetic anhydride in DMF, 
with a catalytic amount of DMAP. The acetylation (capping) of the amine resulted in 
formation of the tripeptide 60. The optimisation of the Dha formation on the resin is a 
key step in the generation of the peptide targets. However, it is likely to be performed 
















i) 40% Piperidine, DMF
ii) Fmoc-Val-OH, COMU, Oxyma Pure, NMM, DMF
















Scheme 19: Synthesis of Ac-Val-Dha-Lys-OH (60) 
 
Compound Expected m/z Observed m/z 
59 555.2813 555.2815 
60 375.2238 375.2242 
Table 7: HRMS analysis of Fmoc-Val-Ser-Lys-OH (59) and Ac-Val-Ser-Lys-OH 
(60) 
 
All HRMS analyses were conducted after acidic cleavage of a small sample of the 
resin; therefore, all of the observed ions are as their free carboxylic acids. HRMS 
59 
 
analysis showed the observed [M+H]+ at 375.2242 m/z when compared to the 
expected [M+H]+ of 375.2238 m/z, confirming the successful overall coupling and 
acetylation reactions to give the desired tripeptide 60. As seen in Scheme 19, peptide 
60 contains a serine residue rather than a Dha moiety, which would require 
dehydration of the serine to form the desired Dha.  
 Formation of a Dha residue on a solid support resin 
During the synthesis of the tail fragments of nisin, there is a requirement to form a 
Dha in a specific position of the AA sequence. The use of Fmoc-Dha-OH is not 
possible due to the formation of an imine following Fmoc deprotection. This reactive 
imine species is prone to hydrolysis and breakdown, forming ammonia and a pyruvate 




















Figure 36: Imine formation and hydrolytic cleavage of Dha residue after Fmoc 
deprotection 
 
In order to overcome this synthetic barrier, and to facilitate formation of the desired 
target peptide products, a masked Dha in the form of a protected serine residue was 
used, to incorporate the unusual AA in the desired position. To selectively dehydrate 
the serine residue several different methodologies were examined, which involved 
conversion of the serine side-chain alcohol (OH) to a better leaving group, for β-
elimination, and formation of the desired Dha on the solid support resin. These include 
acetylation of the free alcohol using acetic anhydride and DMAP in DMF (5 mL), then 
formation of a bromoalanine on the resin was attempted using 2 mol. equivalents of 
triphenylphosphine (PPh3), carbon tetrabromide (CBr4) in dry DCM (5 mL), but the 
presence of Dha was not observed using HRMS analysis. 
After the unsuccessful attempt of Dha formation on the resin via a bromoalanine 
intermediate, its formation was then attempted with the serine being converted to a 




Intermediate for Dha Formation Base used for Elimination 













































Table 8: Attempted formation of Ac-Val-Dha-Lys-COOH on a solid-support 
resin 
It was found that both the acetylation of the serine alcohol 61 and bromination to give 
the bromoalanine 62 did not produce the desired Dha product, as evidenced by HRMS. 
The third method used methanesulfonyl chloride and Et3N to convert the serine -OH 
to a mesylate intermediate, which was confirmed by HRMS analysis (Table 9). 
Observed Adduct Expected m/z Observed m/z 
[M+H] + 453.2014 453.2019 
[M+Na] + 475.1833 475.1840 
[M+K] + 497.1573 479.1579 




As can be seen in Scheme 20, the trityl (Trt) protecting group can be selectively 
removed using 2% TFA solution [TFA (2%): TIPS (2%): DCM (96%)]. After the 
removal of the O-Trt protecting group, the resulting free alcohol was then converted 
to the mesylate intermediate 63. The DBU deprotonates the α-hydrogen of the serine 
mesylate causing the β-elimination to afford the desired Dha 64.  
i) Trityl deprotection: TFA:TIPS:DCM (2:2:96)
ii) Methanesulphonyl chloride, Et3N, DCM
iii) DBU, DCM




























Scheme 20: Formation of Dha containing tripeptides 64 & 65 via a mesylate 
intermediate (63) 
The successful formation of tripeptide 65 was confirmed by HRMS analysis which 
showed [M+H]+ at 357.2142 m/z when compared to the expected [M+H]+ of 357.2130 
m/z. In Figure 37 the observed m/z for peptide 65, as well as its sodium and potassium 
adducts, are shown to be present. In addition to the Dha-containing peptide 65, there 
was also a significant amount of serine-containing peptide 60 observed by LC/MS 
analysis. It is not clear whether the observed serine is i) unreacted starting material; ii) 
the hydrolysis product of the mesylate intermediate; or iii) hydration of the Dha under 
the basic reaction conditions. With both the serine- and Dha-containing peptides being 
present in significant amounts, as shown by LC/MS analysis, their isolation was 




Figure 37: Extracted Mass Spectrum of Ac-Val-Dha-Lys-OH (65) 
 
Although the preparation of 65 was confirmed, the purification of this tripeptide 
fragment proved problematic by semi-preparative chromatography. The tripeptide 65 
is more hydrophobic when compared to the longer peptide fragments, which are 
discussed later. For this reason, precipitation of the compound from cold diethyl ether, 
a widely used peptide purification method, was unsuccessful and an intractable 
mixture was formed. This mixture proved extremely difficult to separate using semi-
preparative HPLC due to co-elution of the tripeptide 65 with DBU. However, due to 
the successful conversion of the serine to the mesylate intermediate and subsequent β-
elimination, this method was used throughout the remainder of the project for the 
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 Synthesis of Ac-Val-Ser-His-OH on a Wang resin 
Using the same method previously described for AA coupling, Fmoc-L-Val-OH was 
coupled to the resin bound dipeptide 58 to generate tripeptide 66 (Scheme 21). The 
replacement of the terminal Lys residue with a His residue was to study the effect of 
the lower side-chain pKa of the imidazole ring, in comparison to the lysine amine. It 
is at physiological pH that the nisin tail is reported to breakdown, which is in the region 
in which the histidine side-chain pKa lies.187 Thus, replacement of the lysine allowed 
for investigation of the impact protonated AA side-chains might have on the stability 













i) 40% Piperidine, DMF








Scheme 21: Coupling of Fmoc-L-Val-OH to resin-bound dipeptide 58 
 
By HRMS analysis peptide 66 was observed with a [M+H]+ of 564.2445 m/z, as well 
as its sodium and potassium adducts (Table 10). As was the case with peptide 65 the 
precipitation from cold diethyl ether was not possible, as the peptide is more 
hydrophobic than its tetra-, penta- and hexa-peptide counterparts. 
Observed Adduct Expected m/z Observed m/z 
[M+H] + 564.2453 564.2445 
[M+Na] + 586.2280 586.2284 
[M+K] + 602.2012 602.1944 
Table 10: HRMS analysis of Fmoc-Val-Ser-His-OH (66) 
This peptide fragment was not isolated, as it is the precursor to the longer peptide tail 





 Synthesis of tetrapeptide tail fragments 
Following on from the successful synthesis of the tripeptide fragments, using the same 
procedure the tetrapeptide fragment of the nisin tail was prepared. The coupling of 
Fmoc-L-His(Trt)-OH to tripeptide 59 was conducted followed by capping, resulting in 
the formation of tetrapeptides 67 and 68 (Table 11). 







































✓ ✓ ✓ 
Table 11: Synthesis of tetrapeptide fragment of the nisin tail, 68, and its 
precursor, 67 
 
A small portion of resin was taken for analysis, confirming the formation of both the 
Ser (67) and Dha (68) tetrapeptides which are shown in Table 11. After confirmation 
using HRMS analysis (Table 12), the tetrapeptide fragments were purified using semi-
preparative HPLC. 
Compound Expected m/z Observed m/z 
67 512.2840 512.2844 
68 494.2722 494.2741 





Following on from purification of both tetrapeptides 67 and 68, their characterisation 
was carried out using both LC-MS/MS and 1H NMR spectroscopy, which was aided 
by Total Correlation Spectroscopy (TOCSY) NMR. The 1H NMR assignment of 
tetrapeptide 68 is presented in Table 13. 
1H 
Residue N-H α β γ δ ε Exchangeable 




Val 8.06 4.19 1.79 1.37    
Dha 9.68  5.66     
Lys 7.93 4.01 2.86 1.70 1.39 3.02 7.54 (NH3+) 
Table 13: 1H NMR characterisation of Dha-containing tetrapeptide 68 
The mass spectrum of the cleaved peptide 68 shows the m/z of 494.2741 for [M+H]+, 
but also a di-charged ion species [M+H]2+, present in greater abundance (Figure 38).  
 
Figure 38: Mass spectrum of Ac-His-Val-Dha-Lys-OH (68) 
Interestingly, the presence of a second charged AA species dramatically changed the 
overall polarity of the molecule and so helped facilitate the precipitation of the peptide 
from cold diethyl ether post acidic cleavage. There was also a significant amount of 
the serine precursor 67 present in the crude precipitate and so, during the purification 
by semi-preparative HPLC both peptides 67 and 68 were isolated in yields of 17.9 mg 
(16.9 %) and 30.8 mg (28.9 %), respectively. The pH stability of these peptides will 
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In order to investigate the effects of the charged AA side-chains on the stability of the 
tail region of nisin, two tetrapeptides were prepared in which the charged side-chains 
were changed. The tetrapeptide 69 was synthesised by removal of the Fmoc protecting 
group and subsequent coupling of Fmoc-L-His(Trt)-OH to resin-bound tripeptide 66. 
This deprotection and coupling cycle afforded tetrapeptide 69, in which the terminal 
Lys residue was replaced by a His residue. Tetrapeptide 70 containing two Lys 
residues (Table 14), prepared by deprotection and coupling of Fmoc-L-Lys(Boc)-OH 
to resin-bound tripeptide 59, gave a Lys residue in place of His. 
Tetrapeptide Fragment HRMS HPLC NMR 
Fmoc-His-Val-Ser-His-COOH 




















✓ X X 
Table 14: Synthesis of Lys-for-His tetrapeptide fragments of the nisin tail, 70, 
and its precursor 69 
The formation of both peptide precursors 69 and 70 were confirmed using HRMS 
analysis as shown in Table 15. These peptides were not isolated but were used in the 
generation of the subsequent pentapeptide fragments.  
Compound Expected m/z Observed m/z 
69 701.3042 701.3055 
70 683.3763 683.3760 






















 Synthesis of pentapeptide tail fragments 
Using the same method for SPPS as previously discussed, a series of pentapeptide 
fragments and analogues of the nisin tail were prepared. As can be seen in Table 16, 
both the Ser (71) and Dha (72) pentapeptides were successfully isolated. 















































✓ 607.3562 607.3428 
Table 16: Synthesis of pentapeptide fragment of the nisin tail, 72, and its 
precursor 71 
During the purification by semi-preparative HPLC, the peptides 71 and 72 were 
isolated in yields of 20.5 mg (14.8%) and 11.6 mg (8.65%), respectively. 
The formation of 71 and 72 was confirmed using HRMS, shown in Table 16, 
observing the molecular ions for both peptide derivatives and their adducts. As well 
as the HRMS analyses, MS/MS fragmentation of the molecular ion was also carried 
out for further confirmation of successful preparation of the pentapeptides 71 and 72. 
By way of example the MS/MS spectrum of the Dha-containing pentapeptide 72 is 




To aid in the characterisation of isolated peptide fragments, the observed [M+H]+ at 
607.3428 was targeted during the MS/MS analysis and provided with a collision cell 
energy of 40 V, causing fragmentation of the peptide sequence between the amide 
bonds. This generated b and y ions to aid in the identification of the target peptide.188 
b ions Residue  y ions 
156.1058 I Not Observed 
293.1650 H 452.2637 
392.2322 V 315.2060 
461.2522 Dha 216.1381 
Not Observed K 147.1165 
Table 17: MS/MS analysis of Ac-Ile-His-Val-Dha-Lys-OH (72) 
Table 17 shows b ions (cleavage from the N-terminus) which can be prominently seen 
in Figure 39, and y ions (cleavage from the C-terminus) which are present but not in 
great abundance which corresponds to the predicted fragmentation pattern for peptide 
72.  
 
Figure 39: MS/MS fragmentation of [M+H]+ ion of peptide 72 
 
MS/MS analysis was carried out on all isolated peptide fragments, with the MS/MS 
fragmentation of the serine analogue, Ac-Ile-His-Val-Ser-Lys-OH, pentapeptide 71 
described in Chapter VII-Experimental Procedures. 
Other pentapeptide fragments prepared include the fragment with replacement of the 
Lys34 residue with a His residue. Using the resin-bound His-containing tetrapeptide 
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✓ 616.3202 616.3203 
Table 18: Synthesis of di-His-containing pentapeptide tail fragments, 74, and its 
precursor 73 
The formation of the di-histidine containing pentapeptides 73 and 74 were confirmed 
by HRMS, LC-MS/MS and also using 1H NMR spectroscopy. The 1H NMR 
assignment of pentapeptide 74, aided by TOSCY NMR, is shown in Table 19, with 
pentapeptide 73 described in Chapter VII-Experimental Procedures. 
1H 
Residue N-H α β γ δ Exchangeable 

















Val 7.88 3.97 1.59 0.65  
Dha 9.53  5.55   





Table 19: 1H NMR assignment of Dha-containing pentapeptide 74 
 
During the purification via preparative HPLC both peptide 73 and 74 were isolated in 




There are notable chemical shift changes observed between the Dha-containing 
tetrapeptide 68 and pentapeptide 72 after the addition of the Ile AA residue, and after 
the incorporation of a second His residue (74). Table 20 shows the observed chemical 
shifts after the addition of the Ile residue to prepare 72, where there are downfield 
shifts of 0.07 ppm and 0.05 ppm for the Dha amide N-H and C-H vinyl protons, 
respectively, in comparison to tetrapeptide 68. The valine amide N-H was more 
deshielded, moving downfield by 0.23 ppm.  









α 4.37 4.42 
β 1.96 3.07 
His 
C2 8.57 8.60 8.46 
C4 7.21 7.33 7.18 
β 2.99 3.25 3.10 
Val 
N-H 8.06 8.29 7.88 
α 4.19 4.16 3.97 
β 1.79 2.16 1.59 
Dha N-H 9.68 9.75 9.53 C-H (vinyl) 5.66 5.71 5.55 
Table 20: 1H NMR chemical shift comparison of tetrapeptide 68 and 
pentapeptides 72 and 74 
There are also notable changes observed after replacement of the Lys residue of 72 
with the His residue, seen in pentapeptide 74. These changes can be seen in Figure 40, 




Figure 40: 2D-TOCSY NMR spectral stack of pentapeptide 72 (blue) and 74 (red) 
 
Shown in Figure 40, is the TOCSY 2D-spectral stack of pentapeptide 72 and 74, with 
the top and side spectra shown corresponding to pentapeptide 72. Interestingly, the 
chemical shifts of AAs in the di-histidine-containing pentapeptide 74 show upfield 
movements, with the amide N-H of Val moving upfield by 0.41 ppm, while the Dha 
amide N-H moved upfield by 0.22 ppm. These changes in the observed chemical shifts 
could indicate that there may be changes in the local environment. The effect of these 
AA changes on the pH stability of each peptide fragment will be studied in Chapter 
III. 
In parallel, pentapeptide fragments with the replacement of the His residue with a Lys 
residue were also prepared. Both the Ser (75) and the Dha (76) derivatives of the di-


















































✓ 598.3910 598.3904 
Table 21: Synthesis of di-Lys-containing pentapeptide tail fragment, 76, and its 
precursor 
 
Both peptides 75 and 76 were precipitated using cold diethyl ether and their formation 
was confirmed using HRMS, as shown in Table 21, as well as using LC-MS/MS 
analysis. The NMR spectra and MS/MS fragmentation pattern (b and y ions observed) 
confirmed the successful formation of 75 and 76, details of which are presented in 
Chapter VII. 
After confirming the successful formation of both 75 and 76, purification was carried 
out using semi-preparative HPLC, with peptides 75 and 76 isolated in yields of 26.6 




Figure 41: HPLC chromatogram of 76 using a DAD detector at 214 nm 
After purification of pentapeptide 76 by semi-preparative HPLC using a reverse phase 
C18 column, each purified peptide fragment was analysed by analytical HPLC using a 
diode array detector (DAD) at 214 nm. The HPLC trace of pentapeptide 76 is shown 
in Figure 41, with the peptide eluting from the column at 7.84 minutes, while the Ser-
containing pentapeptide 75 eluted from the column at 5.57 minutes. 
 
 Synthesis of hexapeptide tail fragments 
The native nisin tail next contains a serine residue at position 29 (see Figure 12), so 
requires a slightly different approach, as addition of the second serine, prior to the 
formation of the mesylate intermediate would result in the β-elimination of both serine 
residues, affording two Dha residues within the peptide structure, when only one (at 
position 33) is required. 
In order to overcome this issue, Dha formation was carried out prior to coupling of the 
final OTrt-protected Ser residue (Ser). After β-elimination of the mesylate leading to 
Dha formation, the resin-bound peptide was then Fmoc deprotected and the final serine 
residue was coupled to the resulting free amine. The synthesised hexapeptides 76 (Ser) 



























































✓ 694.3883 694.3868 
Table 22: Hexapeptide fragment of the nisin tail, 78, and its precursor 77 
 
The successful formation of the hexapeptide fragments 77 and 78 were confirmed by 
HRMS and LC-MS/MS. Following precipitation of the hexapeptide from the TFA 
solution, using cold diethyl ether, the crude peptide mixture was purified by semi-
preparative HPLC. The hexapeptide 77 was isolated in a yield of 33.1 mg (20.7%), 
while hexapeptide 78 was isolated in a crude yield of 4.0 mg (2.6%), which is 
extremely low in comparison to other peptide fragments discussed previously. 
Although HRMS confirmed the formation of hexapeptide 78, the material isolated 
unfortunately was not pure by analytical HPLC, displaying a purity of 32% after 
purification by semi-preparative HPLC.  It appears that the presence of the second 
serine residue decreases the stability of the native tail fragment, so the compound may 
have decomposed prior to analysis by analytical HPLC.  
The LC/MS trace of the di-serine hexapeptide 77 is shown in Figure 42, and it eluted 
from the C18 column at 4.54 minutes. Although hexapeptide 77 was not fully purified 





Figure 42: LC/MS chromatogram of hexapeptide 77 
 
The peak present at 3.912 minutes is interesting, as the ions observed are similar to 
the observed ions seen during the MS/MS fragmentation of hexapeptide 77, with the 
ion in highest abundance being 470.2740 m/z. This ion corresponds to the y ion after 
cleavage at the amide bond between the His and Ile residues, which is possibly another 
indication that the incorporation of an additional Ser residue may impact or diminish 
the stability of the tail fragment. 
 Synthesis of an AC3C-containing analogue of the nisin tail fragment  
So far, the SPPS synthesis has focussed on the effect of the flanking AAs on the Dha 
moiety and the possible stability of the tail region. Therefore, replacement of the Dha 
moiety was investigated by incorporation of a 1-aminocyclopropane-1-carboxylic acid 
(AC3C) residue, which contains a cyclopropyl group as its side-chain (as stated in 
Section 1.11 in Chapter I). 
Using similar methodology to that previously described, commercially available 
Fmoc-AC3C-OH was coupled onto the preloaded H-Lys(Boc)-chlorotrityl resin; no 
deprotection step is required as this resin contains a free amine. The synthesis of the 
AC3C-containing fragment was conducted using 0.501 g of resin, with the loading of 
Fmoc-AC3C-OH being determined to be 0.397 mmol/g. The synthesis of the full 




















i) Deprotection - 40% piperidine/ DMF
ii) Coupling - Fmoc-AA-COOH, PyBOP, HOBt, NMM, DMF, 2 h








































Scheme 22: SPPS synthesis of nisin29-34 with replacement of Dha 33 with an AC3C 
residue  
 
After each coupling cycle a small amount of the resin was treated with the cleavage 
cocktail and analysed by HRMS, confirming the formation of each peptide fragment 
81-85, as shown in Scheme 22 and Table 23. 
Peptide Intermediate Expected m/z Observed m/z 
 81  452.2184 452.2167 
82 551.2869 551.2853 
83 688.3458 688.3456 
84 801.4299 801.4278 
85 708.4045 708.4054 




Following precipitation from TFA, using cold diethyl ether, the peptide mixture was 
purified by semi-preparative HPLC, with the hexapeptide 85 being isolated in a yield 
of 70.2 mg (50%). This significantly higher yield than the Ser- or Dha-containing 
analogues was possibly due to the overall increase in the stability of the AC3C-
containing peptide fragments. 
In addition to LC-MS/MS, the characterisation of each peptide fragment was aided by 
TOCSY NMR spectroscopy. The use of TOCSY NMR allows for the assignment of 
protons located in crowded regions of the NMR spectrum. The 2D TOCSY spectrum 
of hexapeptide 85 is shown in Figure 43. The NMR spectra were collected in 10% 
D2O: 90% H2O, at 25oC with the solution pH measured as 3.0. 
 
Figure 43: The downfield region (N-Hs) of the TOCSY NMR spectrum of             
Ac-Ser-Ile-His-Val-AC3C-Lys-OH (85) 
 
Each AA in the peptide sequence behaves as an isolated spin system, and so there is 
no coupling between neighbouring residues. As can be seen in Figure 43, each vertical 
grouping of signals corresponds to a separate AA residue. The TOCSY coupling can 
be from the N-H proton all the way along the side-chain protons. This allows for the 




Residue N-H α β γ δ ε Exchangeable 
C-terminus        8.85 (COOH) 
Ser 8.15 4.29 3.68    Not Observed 
Ile 7.94 4.04 1.65 1.17 0.69   






Val 8.03 3.81 1.91 0.74    
AC3C 7.78  2.85 + 2.70 
    
Lys 7.53 4.20 2.83 1.74 1.54 1.22 7.353 (NH3+) 
Table 24: 1H NMR characterisation of AC3C-containing hexapeptide fragment 
85 
 
The 1H NMR assignment of hexapeptide 85 is presented in Table 24, with all the 
resonance signals assigned with the exception of the serine O-H.  
The AC3C N-H signal is a singlet (at 7.78 ppm), because of the absence of an α-proton, 
while the β-protons of the cyclopropyl side-chain of AC3C can be seen as two peaks 
at 2.85 and 2.70 ppm. The N-H of the His residue is seen overlapping with the His C2 
proton; using the C2 proton signal at 8.47 ppm, the α (4.60 ppm), β (3.00 ppm) and C4 




For comparison, and in the absence of the native nisin tail fragment, the 1H NMR 
spectral stack of the Ser33-(77) and AC3C33-containing (85) hexapeptide fragments 
are shown in Figure 44, conducted in 10% D2O: 90% H2O, pH 3.0 at 25oC. 
 
Figure 44: 1H NMR spectral stack of the N-H region of the Ser (77, top) and AC3C 
(85, bottom) hexapeptide fragments 
It can be seen clearly that there are noticeable differences in both appearance and 
chemical shift of the AA residues, showing that the replacement of only one AA 
residue has a dramatic affect on the observed 1H NMR chemical shifts.  
For 85 the resonance signals of the N-Hs are resolved from one another completely, 
while for 77 the N-H region is crowded, with some of the amide N-Hs overlapping. 
This indicates that the overall solution conformation of the hexapeptides changes 
significantly due to the replacement of only one AA residue.  
This might have significant implications for the conformation of the full nisin 
molecule and any possible AA residue changes in the tail region, with a knock-on 




 Chapter Conclusions 
In Chapter II the synthetic strategies for the synthesis of the native nisin tail and 
analogues are detailed. During the optimisation studies of the solution phase synthesis 
it was found that the removal of piperidine, used in the Fmoc deprotection step, proved 
difficult and so a change in the base was undertaken, using a water-soluble amine base 
(TAEA). This allowed for not only the removal of the Fmoc protecting group, but this 
base could also be easily removed using an aqueous ammonium chloride (page 52) 
washing step prior to the coupling of the next AA residue. The optimisation of the 
deprotection and coupling reactions for the dipeptides in the solution-phase proved 
successful, as yields of these reactions were increased from 24% up to 79%. Although 
the synthesis of dipeptides 47-50 was successful and they were isolated in good yields, 
unfortunately no tripeptides have been isolated, due to the issues encountered during 
their purification by column chromatography. Alternative solvent systems, as well as 
purification by crystallisation, were used in many attempts to purify the tripeptide 
compounds. Although this presented a major draw-back, each tripeptide was present 
(as indicated by HRMS), showing the formation of the desired target after synthesis. 
Solution phase peptide synthesis proved not to be the appropriate approach for the 
synthesis of the nisin peptide tail fragments.  
Following on from this SPPS was employed as an alternative approach which proved 
to be very successful for the generation of a number of nisin tail fragments and 
derivatives in varying isolated yields. The SPPS method also eliminated the need for 
purification after each intermediate coupling step, as the compound is bound to a resin. 
Using a double deprotection and coupling strategy, each of the desired peptide targets 
were successfully prepared and their formation confirmed using HRMS. 
The formation of the Dha residue, as discussed in Section 2.4.2.1, proved to be 
challenging on the Wang solid support resin. Its formation from a serine AA was 
optimised using three different methods: i) acetylation of the Ser -OH; ii) formation 
of a bromoalanine and iii) mesylate formation. This optimisation study showed the use 
of a mesylate intermediate facilitated the successful conversion of the serine to the 
desired Dha residue, by β-elimination of the mesylate. Even though the Dha moiety 
was formed while on the solid support resin, a significant amount of the serine-
containing peptide analogue was isolated in all cases.  
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Following on from the successful purification of tail fragments by semi-preparative 
HPLC, all of these peptides were used for the stability studies which are described in 
Chapter III. 
 Possible future synthetic work 
The coupling procedure used for solution-phase synthesis was adequate for generating 
peptide targets but generated a limited amount of material in some cases. So, 
optimisation and scale-up of the described methodologies is desirable to assess these 
compounds using a wider variety of analytical techniques including circular dichrosim 
(CD) and more in-depth NMR analysis. This would help to fully elucidate the 
structural changes, if any, based on altering one AA within the sequence. The use of 
preparative LC could be an option to overcome the issues associated with silica 
purification but would involve PLC purification after each coupling step. 
There has been success in the SPPS of a variety of peptide fragments of the nisin tail, 
but optimisation is still required for the formation of the Dha moiety on the resin. The 
formation and β-elimination of a mesylate derivative to form a Dha has been found 
not to fully convert the serine to the desired Dha residue (Figure 45). This could be 
due to restricted access to the serine β-hydroxyl group by methanesulfonyl chloride, 
due to the incomplete swelling of the solid support resin and an alternative solvent 
may increase conversion due to a better swelling profile of the SPPS resin. Further 
studies of the mesylate formation is also required, to ascertain whether the serine 
observed post Dha formation is a result of hydrolysis of the mesylate or by base-











Figure 45: Hydration of the Dha moiety to a serine residue under basic conditions 
Another possible reason for the incomplete formation of the Dha could be the 
inefficient removal of the trityl protecting group from the serine, so this step may 
require a slightly higher TFA concentration, to ensure complete side-chain 
deprotection. However, removal of the other acid-labile protecting groups and 
cleavage from the resin must be avoided. 
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In addition to the tail fragments shown in Chapter II, an examination of the length of 
the lysine side-chain could be undertaken by preparing the shorter Dap, Dab and 
ornithine analogues. This could help the study of the importance of this chain length 
on Dha stability in aqueous solution, as the side-chains would still be protonated at 
physiological pH.    
In order to fully examine the stability of the Dha residue, other similar lantibiotic tails 
should be targeted. For example, the tail region of subtilin and nisin F both contain a 































Stability Studies of Synthesised Peptide 
Fragments using LC/MS 
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3.0  Introduction  
The synthesised peptide fragments of the nisin tail which are described in Chapter II, 
were used to examine the effect of changing the flanking AAs on the stability of the 
Dha residue, following their purification by preparative HPLC. As previously 
outlined, Dha33 in the tail region of both nisin A and Z is not stable at physiological 
pH, so establishing the relative stability of the nisin tail region at different pH values 
is required in understanding its breakdown. This region of the nisin tail is involved in 
the formation of pores and so is critical in its mechanism of action.191 
The pH stability studies of the various nisin tail derivatives and analogues were 
conducted using an Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS 
equipped with an electrospray ionisation source. The use of LC/MS in the study of 
peptide stability is common, especially for nisin due to the lack of a chromophore.192 
The use of a mass spectrometry detector is extremely useful as it allows not only for 
observation of the molecular ion of the target peptide, but also further characterisation 
using MS/MS fragmentation.193 The analysis can also be quantitative, which allows 
for its utilisation in the stability studies of synthesised peptide fragments and has 
become an established platform for protein quantification.194  
For the stability studies, in all cases the samples were prepared in deionised water with 
a peptide concentration of 0.5 mg/mL. Each peptide was studied in three different pH 
environments (pH 3, 5 and 7), in the absence of any buffers with pH adjustment carried 
out using HCl and NaOH (0.1 M) prior to injection. For the duration of the stability 
trials all samples were stored away from light at 25oC, to avoid any photolytic 
degradation. The pH of each solution was checked on a weekly basis with very little 
pH changes observed throughout the duration of the stability experiments, this could 
be due to self-buffering on the solutions by the protonated side-chains contained 







 Stability of tetrapeptide fragments of the nisin tail 
For the Ac-His-Val-Dha-Lys-OH (68) tetrapeptide fragment of the nisin tail, the 
stability profile data is plotted, tracking the percentage of tetrapeptide 68 remaining, 
based on the relative % peak area using LC/MS due to the lack of a chromophore in 
the synthesised peptide fragments. The Dha-containing tetrapeptide is shown in Figure 
47, examining and tracking the parent peak at 4.07 minutes.  
 
Figure 47: Stability Profile of Ac-His-Val-Dha-Lys-OH (68) at pH 5 and 7 
 
Interestingly, the peptide sample prepared at pH 3 appeared to break down instantly, 
as the peak at 4.07 minutes was absent. The breakdown of the peptide resulted in a 
molecular ion which corresponds to the m/z of the serine derivative, with a retention 
time of 3.77 minutes, very similar to the serine-containing tetrapeptide 67. It cannot 
be determined from the stability experiments what the exact position of substitution 
of the alcohol (O-H’s), i.e. be it an α-hydroxy-alanine (α-OH-Ala) or a β-hydroxy-









































From studies of nisin degradation products, it is known that Dha residues can undergo 
an acid-catalysed Markovnikov addition of a water molecule to the double bond, 
resulting in the formation of an α-OH-Ala residue.195 However, this compound was 
only formed at neutral pH and cleaved to give two fragments. 
As displayed in Figure 47, the stability data is plotted for both the pH 5 and 7 sample 
for the tetrapeptide (68). The trend in the plotted data indicates that there is a decline 
in the tetrapeptide peak at 4.07 minutes (retention time), with the pH 7 sample 
decreasing after 8 days while the pH 5 is slightly more stable until day 15. Overall, 
both peaks decreased significantly. The pH 5 and 7 samples seem to behave in a very 
similar fashion and based on our observations, comparing the breakdown ions 
observed for the pH 5 and pH 7 samples shows they are very similar with 446.1815, 
384.1648 and 297.1571 m/z present in both samples. The largest breakdown product 
observed again has the ion at 512 m/z, at 3.77 minutes which may correspond to the 
“serine” derivative, 67 due to the similar observed retention time. With only slight 
differences observed in the stability of the peptide in changing the pH of the aqueous 
solution from pH 5 to 7, further study is required using NMR spectroscopy to identify 
the resulting peptide species observed for all pH solutions and isolate the breakdown 




In a similar fashion to the stability study carried out for tetrapeptide 68, its Ser-
containing AA analogue 67 was also purified and studied in the pH 3, 5 and 7 
environments. The stability profile date for the Ac-His-Val-Ser-Lys-OH 67 
tetrapeptide is presented in Figure 49, tracking the parent peak at 3.72 minutes. 
 
Figure 49: Stability Profile of Ac-His-Val-Ser-Lys-OH (67) at pH 3, 5 and 7 
 
Interestingly, tetrapeptide 67 displays a higher stability than 68 across the pH range of 
the study. It is not until day 25 that there is a significant decline in the % of peptide 
remaining, with the fastest decline seen at pH 3, in comparison to 68 which was not 
observed at pH 3. Again, the breakdown ions are very similar in each pH sample with 
the most abundant ions being 406.1963, 354.7050, 296.1716, 217.1178 and 145.1351 
m/z. The similar breakdown ions could be due to the same mechanism of degradation, 
while the change in the solution pH may affect the rate of degradation in solution. 
 
 Stability Study of pentapeptide fragments of the nisin tail 
Following the study of the tetrapeptide fragments of the nisin tail, several synthesised 
pentapeptide fragments were also included. The study of these peptides would not only 
investigate the stability of the peptide itself, but also allow for an examination of the 
effect of adding a hydrophobic AA (Ile) on the overall stability of the peptide 






















 Stability Study of Ac-Ile-His-Val-Dha-Lys-OH (72) 
The first pentapeptide sequence studied was the Ac-Ile-His-Val-Dha-Lys-OH 
pentapeptide (72), which included an N-terminal isoleucine residue. The stability 
profile at pH 3, 5 and 7 is shown in Figure 50. 
 
Figure 50: Stability Profile of Ac-Ile-His-Val-Dha-Lys-OH (72) at pH 3, 5 and 7 
As the stability trial progresses, in each pH system the peptide behaves in a similar 
fashion, with the pH 3 sample displaying slightly lower stability than the samples at 
pH 5 and pH 7, but it is not significantly different. Interestingly the presence of the 
isoleucine residue almost completely protects the Dha-containing pentapeptide from 
breaking down in the studied pH range. In contrast to the Ac-His-Val-Dha-Lys-OH 
tetrapeptide 68 presented earlier, the pH 3 sample of the pentapeptide (72) is present 
at T∅, and at each timepoint of the prolonged stability examination, with 72 also more 
stable at pH 5 and 7, when compared to tetrapeptide 68. While it is expected there 
would be some noise observed in the stability data, is not inherently clear for the 
increase observed at 10 days which may be due to the peptide solubility. Although the 























 Stability Study of Ac-Ile-His-Val-Ser-Lys-OH (71) 
The stability study was also carried out for the Ser-containing pentapeptide analogue 
71. The stability profile data for the Ac-Ile-His-Val-Ser-Lys-OH 71 pentapeptide is 
presented in Figure 51, tracking the parent peak at 4.22 minutes. 
 
Figure 51: Stability Profile of Ac-Ile-His-Val-Ser-Lys-OH (71) at pH 3, 5 and 7 
 
There are significant differences observed in the stability of 71 in all the studied pH 
values, with the serine-containing pentapeptide degrading rapidly in comparison to 
Dha-containing analogue 72, which was stable throughout the duration of the study. 
There is no notable difference observed between the pH 5 and 7 samples, both of 
which decline rapidly between days 1-10. The pH 3 sample also behaved in a similar 
fashion until day 32, by which point the peak at 4.22 minutes was absent.  
There were no significant changes in the stability of pentapeptide 71 as a function of 
the changing solution pH, with the most abundant breakdown ions being 455.1983 and 
228.1532 m/z in all cases, with a number of smaller ions also observed. So, the 
replacement of the Dha moiety with a Ser AA may not be preferred due to the lower 
stability in aqueous solution. There is a significant contrast between the stability of 67 
and 68, where 68 (Dha-containing) was much less stable than 67 (Ser-containing), 























 Stability Study of Ac-Ile-His-Val-Dha-His-OH pentapeptide (74) 
In a similar fashion the pentapeptide Ac-Ile-His-Val-Dha-His-OH (74) was also 
studied. This pentapeptide was synthesised with the C-terminal lysine replaced by a 
histidine residue, which has a lower side-chain pKa. The stability profile data are 
presented in Figure 52 for the peak eluting at 5.20 minutes. 
 
Figure 52: Stability profile of Ac-Ile-His-Val-Dha-His-OH (74) at pH 3, 5 and 7 
There are two different trends emerging within Figure 52, for both the pH 3 and pH 5 
samples the stability profiles are almost identical to one another, whereas the pH 7 
sample shows a more rapid decline in the peak area. As there is only been one AA 
change between 72 and 74, the observed differences are likely due to the presence of 
the second histidine residue. The histidine side-chain pKa is significantly lower than 
that of lysine ranging between 6-7,196 compared to 9-10 for the Lys side-chain being 
described as “perpetually charged”.197 So, both histidine side-chains are likely to be in 
their deprotonated neutral forms at pH 7. The decline in the stability may stem from 
this change in the charge state of the peptide, probably initiating a conformational 
change. However, these interactions and phenomena would require significant further 























 Stability Study of pentapeptide Ac-Ile-His-Val-Ser-His-OH (73) 
Also isolated during the preparative HPLC purification of the di-histidine containing 
peptide 74 was the peptide 73, with a serine in the position of the Dha residue. The 
stability profile for 73 is shown in Figure 53, tracking the peak at 4.88 minutes. 
 
Figure 53: Stability profile of Ac-Ile-His-Val-Ser-His-OH (73) at pH 3, 5 and 7 
 
The stability data displayed in Figure 53 shows some distinct differences in 
comparison to its Dha analogue. Firstly, the sample prepared at pH 3 seems to start 
degrading from 10 days whereas the pH 3 sample of the Dha-containing peptide 74 
was very stable throughout the experiment. The second interesting observation is that 
when a serine residue is present, as opposed to a Dha residue, the pH 5 and pH 7 
sample profiles are now almost identical, with the breakdown ions observed also very 
similar. Interestingly, there is some evidence of dehydration of the Ser AA with 
formation of a 616.3198 m/z ion after 18 days in the pH 3 sample and 25 days at pH 
5 and 7. Also in all samples there are similar ions of 461.2206 and 145.1344 m/z 
present. By replacing the supposedly more reactive Dha residue, with a more stable 
serine residue there has been a significant change in the stability profile of the peptide, 
as it is more susceptible and degrades faster in the acidic pH range. Unfortunately, 
there is no indication as to why the serine derivative breaks down faster at pH 3, but it 
does highlight that even one amino acid substitution can hugely alter the chemical 






















 Stability Study of pentapeptide Ac-Ile-Lys-Val-Dha-Lys-OH (76) 
Following on from the stability trial of the di-histidine Dha-containing pentapeptide 
74, which displayed interesting results in terms of its stability at pH 7, the pentapeptide 
in which both histidine residues were replaced with lysine residues (76) was studied, 
again in order to assess the impact of the side-chain pKa on peptide stability. At 
physiological pH the amino group of the lysine side-chain will usually always remain 
charged. This begs the question as to whether this retention of a charged species would 
increase peptide stability at pH 7. 
 
Figure 54: Stability Profile of Ac-Ile-Lys-Val-Dha-Lys-OH (76) at pH 3, 5 and 7 
 
The stability profile data for the di-lysine-containing pentapeptide analogue 76 at pH 
3, 5 and 7 are shown in Figure 54. Again, the switching of the charged AAs in this 
case has a significant effect on the peptide stability. The samples prepared at pH 5 and 
7 behave in a near identical fashion, showing full stability at all timepoints. Possibly 
the higher pKa of the lysine side-chain, retaining the charged species helping increase 
its stability. However, the sample at pH 3 showed a dramatic decline in its stability 
after 25 days, with evidence of hydration of the Dha due to the presence of the 
616.4011 m/z ion. It would seem that, with the incorporation of a second lysine 
residue, the peptide seems to be susceptible to acidic breakdown. It is not inherently 
clear as to why at pH 3 the di-lysine pentapeptide (76) breaks down, but possibly could 
be due to the loss of an aromatic side-chain, i.e. the imidazole of the histidine 























or a cation-π interaction, thus protecting the Dha from acidic cleavage. But further 
expanded studies, including NMR, LC-MS/MS at a wide range of pH values might 
elucidate why this peptide is more susceptible to breakdown at pH 3. 
 Stability Study of pentapeptide Ac-Ile-Lys-Val-Ser-Lys-OH (75) 
Again, also isolated during preparative HPLC purification of the di-lysine containing 
peptide 76 was the analogue containing a serine residue (75), and the stability profile 
data is presented in Figure 55. 
 
Figure 55: Stability Profile of Ac-Ile-Lys-Val-Ser-Lys-OH (75) at pH 3, 5 and 7 
 
The presence of a serine residue in place of a Dha moiety changes the stability profile 
of the peptide when compared to its Dha counterpart (see Figure 55). The pH 5 and 7 
samples are behaving differently when compared to the Dha-containing 76, with the 
peptide’s stability being lower when a Ser residue is present. However, for the sample 
at pH 3, although there is a steady decline in terms of the quantity of peptide present 
in solution, after 39 days there is still a significant amount (41%) of the pentapeptide 
75 remaining. For the Dha-containing analogue, pentapeptide 76, although it is more 
stable at pH 5 and pH 7, at pH 3 it is fully degraded at this timepoint. The lower 
stability of the Ser-containing pentapeptide 75 may be an indication that replacement 
of the Dha moiety in nisin with a serine would not be preferred, as the trend and rate 























 Stability Study of Hexapeptide fragments of the nisin tail 
In the following section the stability profile studies of the synthesised hexapeptide 
fragments are presented, with replacement of the Dha moiety, to assess their stability 
and potential as more stable structural analogues of the native nisin tail. The SPPS 
synthesis of the native nisin tail fragment Ac-Ser-Ile-His-Val-Dha-Lys-OH (78) was 
conducted and the purification of this fragment was successful based on initial 
analytical HPLC (Figure 56). 
 
Figure 56: Analytical HPLC of hexapeptide Ac-Ser-Ile-His-Val-Dha-Lys-OH 
(78), following semi-preparative HPLC 
 
The hexapeptide fragment (78), was isolated in a very low yield of 4.0 mg (2.6%), 
post purification, analysis by analytical HPLC shows the hexapeptide was pure 
directly after semi-preparative LC purification, as can be seen in Figure 56 where it 
elutes at 4.37 minutes. However, prior to full characterisation it had degraded, showing 
it to be very unstable even when stored at a fridge temperature of ~ 4oC, the same 
conditions used for all other purified fragments. 
Unfortunately, unlike the other peptides discussed in this chapter, hexapeptide 78 was 
not present at T∅ of the stability trial. The elongation of pentapeptide 74 with a Ser 
residue seems to have completely changed its stability in aqueous solution, with the 
peptide 78 breaking down relatively easily. Therefore, it was not possible to conduct 






 Stability Study of hexapeptide Ac-Ser-Ile-His-Val-Ser-Lys-OH 77 
The isolated Ser-containing hexapeptide (77), 80% purity (crude yield) was used to 
study the stability of the nisin tail, with replacement of the Dha residue with a serine-
residue. The serine containing hexapeptide which eluted from the C18 LC column at 
4.60 minutes was used to generate the stability profile data shown in Figure 57. 
 
Figure 57: Stability Profile of Ac-Ser-Ile-His-Val-Ser-Lys-OH (77) at pH 3, 5 
and 7 
The data shows a steady decline in the peptide in all three pH solutions. When 
compared to the Dha-containing hexapeptide, the serine analogue is more stable as the 
native nisin tail fragment 78 degraded prior to its stability study. Indeed, for the sample 
prepared at pH 3, the peak at 4.60 minutes, corresponding to the serine analogue, was 
completely absent in the sample after 25 days, the incorporation of the second Ser 
residue, hexapeptide 77 behaves in a similar to pentapeptide 71 which was also 
unstable at each pH value (see Figure 51).  Although further isolation and purification 
studies are required to characterise the resulting degradation products, based on our 
observations, there are similar breakdown ions present, but they are not identical, as 























Figure 58: TIC of the breakdown ions of Ac-Ser-Ile-His-Val-Ser-Lys-OH (77) at 
pH 3 and 7 
The ions present after the breakdown of the Ser-containing hexapeptide 77 in each pH 
solution are similar, for example the breakdown peaks contain the 398.2050 m/z and 
the 420.1842 m/z ions present in greatest abundance at pH 3. Other ions in the 
spectrum also vary depending upon the pH value. The isolation and characterisation 
of these breakdown products would be required to study the degradation mechanism 
of the peptide fragment. 
There is a common trend emerging for most of the peptide fragments which contain a 
Ser residue in the place of the Dha residue, showing lower stability in aqueous solution 
with exception of hexapeptide 77. This might indicate that the replacement of the Dha 
residue with a serine residue may not be preferred in terms of increasing the overall 
stability of the nisin tail region. It would be of real interest to see how the stability of 





 Stability Study of Ac-Ser-Ile-His-Val-AC3C-Lys-OH 
Since the Dha33 moiety of the nisin peptide structure is implicated in the breakdown 
of nisin at physiological pH,198 in an attempt to overcome the stability issues, an 
alternative to the reactive Dha moiety was sought. As described in Chapter II the 
structural mimic for the Dha moiety, 1-aminocyclopropane-1-carboxylic acid (AC3C), 
was used. Interestingly this unusual amino acid has a cyclopropane as its side-chain 
and so although the α-carbon of the AC3C amino acid is sp3 hybridised, its constrained 
system gives rise to a bond angle between 115-118o, close to the Dha angle of 
approximately 120o.178  
As before, solutions of 0.5 mg/mL of the AC3C-containing hexapeptide were prepared 
at pH 3, 5 and 7. The AC3C-containing hexapeptide eluted from the column at 4.72 
minutes in 10% acetonitrile in water, containing 0.1% formic acid.  
 
Figure 59: Stability profile of Ac-Ser-Ile-His-Val-AC3C-Lys-OH (85) at pH 3, 5 
and 7 
 
Figure 59 shows the stability profile for the nisin tail analogue 85. At the three pH 
values studied the peptide appears to be stable, with very little difference seen between 
each pH for the full duration of the study. This encouraging result, based on the 
stability profile data, may mean that the AC3C amino acid is a suitable replacement 
for the Dha moiety, while also possibly maintaining its geometry. However, 
significant further synthetic studies to prepare all the analogues discussed (tetra-, 






















Unlike the Dha-containing peptide fragments which were presented earlier, the AC3C-
containing tail fragment was not only stable but also behaves in a similar fashion 
across the whole pH range studied. The observed difference in the appearance on the 
1H NMR spectra of Ser-containing hexapeptide 77 and 85 could indicate they display 
different solution conformations. The different conformations in solution may be 
related to the increased rate of degradation and lower stability of the Ser-containing 
77, in comparison to the AC3C-containing hexapeptide 85. However, further studies 
would be required to confirm this observation. 
 Chapter Conclusions 
The pH stability studies described have revealed some very interesting results and 
possible insights into the stability of the tail region of nisin. There are significant 
differences identified in the stability of the synthesised analogues of the nisin tail. As 
presented earlier the tetrapeptide fragment 68 (Ac-His-Val-Dha-Lys-OH) degraded 
instantly at pH 3, but displayed higher stability at pH 5 and 7. This observation alone 
is not characteristic of the Dha moiety contained in the native nisin tail, which is 
reported to have its maximum stability at pH 3-4.112 As the tail fragment was elongated 
to incorporate an N-terminal isoleucine residue, the stability data showed the 
pentapeptide was now stable across the full pH range studied. The presence of the 
hydrophobic isoleucine residue seemed to increase the stability of the tail fragment at 
pH 3, protecting the peptide from breakdown in acidic pH. 
Substitution of the C-terminal lysine by a histidine residue to give pentapeptide 74 
was most stable at pH 3 and 5, while beginning to breakdown at pH 7. At physiological 
pH the imidazole sidechain of both histidine residues would be in their deprotonated 
neutral form and may lead to an increased susceptibility to breakdown at pH 7 and 
above. These stability studies show the importance of retaining the overall charge of 
the peptide at neutral pH. In order to investigate this, the His31 residue was replaced 
with a lysine residue, as the amino side-chain is described as being perpetually charged 
at physiological pH. This analogue showed greater stability at pH 7, further indicating 
the importance of retaining the charge at physiological pH. However, incorporation of 
a lysine residue in place of the histidine residue compromised the peptide’s stability 
at pH 3, causing its breakdown. Therefore, the presence of a His residue may play a 
significant role in protecting the peptide from degradation in the acidic pH range.  
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Replacement of the Dha33 moiety by a serine residue surprisingly displayed lower 
overall stability compared to the Dha-containing peptides. The serine-containing 
hexapeptide 77 showed a significant decline in stability at pH 3, 5 and 7. It is not 
known yet why the serine-containing peptides seem more prone to degradation, but it 
suggests that a serine is not an appropriate stabilising replacement for a Dha residue 
in the tail region of nisin. For the hexapeptide 78, the native nisin tail fragment seemed 
to be very unstable, as the purified compound degraded quickly prior to an intended 
stability examination.  
In contrast to the diminished stability observed for the serine- and Dha-containing 
peptides, the incorporation of an AC3C amino acid as a structural mimic for the Dha 
showed very promising initial results. The hexapeptide fragment 85 showed good 
stability over the pH range for the full duration of the study, suggesting its potential 
use as a bioisostere in the replacement of the Dha. Therefore, the AC3C residue may 
be a possible candidate to replace the Dha moiety, thus increasing the overall stability 
of the peptide at physiological pH. This increase in the stability at neutral pH observed 
using the AC3C residue may increase the stability of the nisin peptide as its breakdown 
is known to involve the Dha33 in the tail region. The incorporation of an AC3C residue 
into the nisin tail in vivo, would involve engineering the unnatural AA into the nisin 
peptide by, for example, genetic code reprogramming to generate the recombinant 
peptide sequence.199  
From the data presented in Chapter III, the stability studies conducted on several nisin 
tail analogues have shown some potential targets and possibly more insight into the 
stability of the nisin tail. Perhaps changing the His31 amino acid in the nisin tail to a 
lysine residue may increase its stability significantly at physiological pH. The stability 
studies highlight that not only is the charge of the peptide important for maintaining 
stability at physiological pH, but also maintaining the geometry of the AA in place of 




 Future Work  
The stability studies of the fragments and analogues of the nisin tail showed some 
interesting insights into its stability. However, significant further studies are required 
in order to fully understand the observations; although the nisin tail fragment 78 was 
purified by semi-preparative LC, it degraded prior to the stability examination. 
Therefore, the re-synthesis and detailed pH stability study of the native nisin tail would 
allow for further insights and a direct comparison of the stability compared with the 
AC3C-containing fragment. 
Further studies are required to isolate and purify the many degradation products of the 
synthesised peptide fragments. As some Dha-containing peptides degraded 
(tetrapeptide 68), the m/z ion of their serine equivalent was observed. Characterisation 
of the resulting degradation products by NMR spectroscopy would determine if the 
observed ion corresponds to the formation of a serine residue or an α-hydroxy-alanine. 
This study would aid considerably in the determination of the mechanism of 
degradation of the nisin tail. Also required would be the preparation of the AC3C-
containing tetra- and pentapeptide fragments in sufficient quantities to examine them 
in detail by NMR and LC-MS/MS. These studies could be used to compare the AC3C-
containing peptide fragments to the Dha-containing peptide fragments.  
Detailed NMR studies, including selective 1D NOE experiments at a range of pH 
values should also be conducted, to assess any possible interactions involving the 
histidine, lysine and Dha amino acid side-chains. When the histidine was replaced 
with the non-aromatic lysine residue, the stability of the peptide at pH 3 diminished. 
There could possibly be a protective stabilisation interaction involving the His residue 
in the acidic pH region. These studies could elucidate the observed contradictory 
stability of the Dha moiety of nisin at pH 3-4 and its behaviour at physiological pH 
values. 
Although the stability profile data was favourable for the AC3C-containing tail 
fragment, the increased stability does not account for any possible changes or loss in 
the antimicrobial activity of the peptide due to the absence of the Dha moiety. Further 
study is required to assess the impact of replacing the Dha on the biological activity 
of nisin. Incorporation of the AC3C into nisin at position 33 and subsequent activity 
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testing in partnership with our collaborators in UCC would show the effect of AC3C 
on both nisin’s stability and also its antimicrobial activity. 
There remains an important question as the studies so far have been solely focussed 
on the tail region of nisin. Would the presence of the remainder of the nisin peptide 
change its overall solubility and stability at physiological pH? One possible method to 
explore this would be to study the stability of the nisin22-34 fragment, as this fragment 












































Figure 60: Cleavage of nisin at position 22 using cyanogen bromide (CNBr) 
 
As described by Rijkers and co-workers,150 nisin in the presence of cyanogen bromide 
(CNBr) initiates cleavage of the peptide between Met21 and Lys22. So, following a 
CNBr digestion of the nisin peptide to afford nisin22-34, this study could be done for 
both nisin A and Z, which would allow investigation of the importance of the second 
His residue in nisin A (His27) in the overall stability of the peptide. The stability data 
for this nisin fragment could also be compared to the unstable native nisin tail fragment 
78.200  
As the stability studies have shown some interesting insights, the tail fragments could 
also be synthesised using a Rink amide resin to incorporate a C-terminal amide 
functional group. This would allow investigation of the effect of a C-terminal 






These studies could also be expanded to include different tail mutants which contain 
the Dha moiety, to further investigate the effect of the flanking AAs on the stability of 
the tail fragments. Recent publications have shown a number of synthetic tail 
analogues which contain a Dha and are similar to the nisin tail (Figure 61).201,202 These 
modifications may aid in the design of more stable nisin derivatives and aid in the 






























Figure 61: Naturally occurring Dha-containing tail analogues of the nisin 
tail201,202 
 
The stability studies of different tail mutants could allow for targeted design of a new 
nisin analogue which could be studied with our APC Microbiome Ireland 
collaborators in UCC. These could be assessed for bioactivity, pH stability and by 
















Spectroscopic Solution Studies of Nisin 





4.0  Introduction 
The majority of journal and food reports detailing the use of nisin A or Z, is as a 2.5% 
w/w suspension in a high salt concentration of ~80%, with the remainder being milk 
solids. In this chapter preliminary studies on the effect of ionic strength on aqueous 
solution of the peptides were investigated. One question is whether such high salt 
concentrations affect its stability and/or conformation in solution. There are some 
literature reports which mention nisin and ionic strength, but only with NaCl.203  
The purpose of this study is to examine the possible effect that different salts can have 
on the aqueous solution properties of nisin. There is a significant number of 
publications dealing with nisin (A and/or Z) and its use as a food preservative. 
However, there are no standardised protocols for its use, with reports using different 
concentrations, different solution pH values, and different buffers, while sometimes 
not even mentioning which form of nisin (A or Z) is being used. It is known that nisin 
A and Z only target Gram-positive bacterial species, but a recent report has indicated 
that highly purified nisin Z can attack Gram-negative species (i.e. E.coli), but that high 
NaCl concentrations can inhibit its activity.191  
In this chapter NMR and CD (Circular Dichroism) spectroscopies have been utilised 
to study possible interactions between nisin (A and Z) and a number of different salts. 
This is to investigate the impact of both ionic strength, and the additives themselves, 
on the properties of nisin in aqueous solution, using highly purified samples of nisin 
A and Z. 
 
 NMR studies of nisin A and Z 
Both the nisin A and Z samples (Figure 62) used during the ionic strength studies were 
commercially available as highly purified powders with ≥ 95% purity, with the 
remainder being mainly water. The 1H NMR spectra of both nisin A (Figure 63) and 
of nisin Z (Figure 64) were obtained in 10% D2O/90% H2O at 25 oC using a 3 mM 
concentration, with 640 scans being acquired for each 1H NMR experiment, using a 
BBFO (broadband fluorine observed) NMR probe (unless otherwise stated), as these 











































Figure 62: Structure of nisin A and Z 
 
The NMR spectra of nisin (A and Z) contain a number of distinct features which are 
labelled. In both cases the 1H spectra show two peaks at 5.44 and 5.55 ppm, 
corresponding to the two vinyl protons of the Dha residue at position 5, with the 
corresponding N-H of this residue being at 9.84 ppm for nisin A. Surprisingly, both 
vinyl protons of Dha33 appear as a broadened single peak at 5.72 ppm, and its N-H is 
observed at 9.66 ppm. This shows that the two Dha residues, though identical in 
chemical structure, have quite different local conformations and/ or local 
environments.  
Other spectral features which are shared by both nisin A and Z include the Dhb 
(dehydrobutryine) vinyl proton, as a quartet at 6.61 ppm, with the N-H of Dhb not 
observed within the sweep width of the 1H NMR spectrum.205 Nisin A and Z also 
contain a histidine residue at position 31, as shown in Figure 63 and Figure 64. The 
C4-H of the imidazole of His27 is seen at 7.30 ppm, and is absent in the 1H NMR 
spectra of nisin Z (Figure 64), as this residue is replaced with an asparagine residue.206 
The published chemical shift assignments for nisin A and Z in 10% D2O/H2O were 










Figure 64: The N-H region of the 1H NMR spectrum of nisin Z (3 mM) in 10% D2O:H2O at 25oC (DSS internal reference)207 
108 
 
 Ionic strength titration studies 
All of the following NMR titration studies were conducted at a 3 mM concentration of 
nisin A or Z, unless otherwise stated. Figure 65 shows an NMR titration study of nisin A 
with an increasing concentration of NaCl being added. At the bottom of the spectral stack 
is shown the N-H region of pure nisin A (wine), up to the top spectrum with 300 mM 
NaCl (purple). As the ionic strength is increased there are a number of small spectral 
changes observed, with the majority of these changes being in the N-H region of the 
spectra. The increasing ionic strength, in most cases, causes the chemical shifts of the N-
Hs of the amide backbone of the peptide to move upfield or become less deshielded, with 
the N-H of Dha5 moving upfield by 0.13 ppm. The two vinyl protons of Dha5 also show 
changes, with the C-H at 5.54 ppm becoming deshielded slightly, moving downfield by 
0.02 ppm. For Dha33, which was a broad single peak at 5.72 ppm at zero ionic strength, 
as the ionic strength is increased the peak is seen to separate into two distinct peaks, for 
each of the C-H protons, at 300 mM NaCl, becoming more chemically non-equivalent. 
 
Figure 65: The N-H region of the 1H NMR spectrum of nisin A (3 mM) with 
increasing NaCl concentrations, in 10% D2O/90% H2O, at 25oC 
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Also, on the addition of NaCl, the N-H amide protons of Leu6 and Abu8 show changes 
in their observed chemical shift. The Leu6 N-H peak at 8.93 ppm becomes more shielded 
or less deshielded, moving upfield by 0.054 ppm, while the amide N-H of Abu8 moves 
slightly upfield when compared to its observed chemical shift at zero ionic strength.  
Figure 66 shows the NMR titration study of nisin Z with an increasing concentration of 
NaCl being added. At the bottom of the spectral stack is shown the N-H region of pure 
nisin A (wine), up to the top spectrum with 300 mM NaCl (purple). Similar to nisin A, 
there is a change in the chemical shift of only one of the vinyl protons of Dha5, with the 
peak at 5.56 ppm becoming more deshielded moving downfield by 0.04 ppm, while its 
N-H proton at 9.85 ppm becomes more shielded moving upfield by 0.114 ppm. For the 
Dha33 residue contained in the tail region of nisin Z, its appearance changes from a broad 
single peak into two separate peaks, with no observed change in chemical shift for the 
amide N-H of Dha33.  
The Leu6 amide N-H also shows an upfield movement of 0.042 ppm, becoming slightly 
less deshielded. For the zero ionic strength spectrum of nisin Z, the amide N-Hs of Leu6 
and Abu8 were observed as two separate peaks, but in the presence of 300 mM of NaCl 
both N-H resonance signals are overlapping. This is due to the upfield shift of the Leu6 
N-H and the slight deshielding of the N-H of Abu8. 
In each case, for both nisin A and Z, there are also AA residues not affected by the 
addition of NaCl. For example, there was no change observed for the resonance signals 









As the NaCl concentration was increased for nisin Z it was seen that the overall spectral 
changes are different when compared to nisin A. Sometimes the N-H protons, which 
became more shielded in nisin A become more deshielded in nisin Z, for example 
methionine at position 22. 
 
Figure 67: Changes in the chemical shift of the N-H protons of nisin A and Z in 300 
mM NaCl, when compared to each peptide alone. 
 
Figure 67 shows the comparative N-H proton shift graphs presented for nisin A and Z in 
300 mM NaCl, against their chemical shifts in the absence of NaCl. Overall, nisin A 
shows larger chemical shift changes in the region corresponding to the A and B rings 
(residues 1-11), becoming less deshielded, with the biggest effect shown for Dha5. Nisin 
Z also shows distinct changes with the largest change also seen being for the N-H of the 
Dha 5. Although there is only one AA change between nisin A and Z, overall there are 
definite differences observed spectroscopically. The biggest chemical shift changes in 
both cases are associated with the residues present in the A and B ring region of the 
peptide, the same region that is implicated in the binding to the pyrophosphate moiety of 
lipid II.102 
These results highlight that nisin A and Z may be interacting differently with NaCl in 
solution. Of course it is not known if the changes are due to different interactions of nisin 
A or Z with the Na+ and Cl- ions themselves, or whether the differences are due to the 
impact on the hydration shells around the peptides (different for nisin A and Z).208 The 





One possible reason that only one of the vinyl protons of Dha5 moves downfield may be 
due to a conformational change within the Dha residue itself, bringing one of the vinyl 
C-Hs closer to the adjacent carbonyl of the amide bond (shown in Figure 68). This 











Interaction with carbonyl oxygen
 
Figure 68: Dha moiety Φ dihedral rotation causing closer alignment of one vinyl 
proton with the adjacent amide carbonyl oxygen 
Interactions forming 6-membered ring like structures are reported in both peptide and 
protein chemistry. These interactions can act as a stabilisation force and form via the 
resonance-assisted intramolecular H-bond closing and formation of the flat six-member 


















Figure 69: Formation of six-membered interaction via resonance-assisted 
rearrangement211 
 
The amide N-H of the Dha5 also shows some significant shielding on the addition of 
NaCl. This may be a further result of possible conformational changes in which the 
adjacent carbonyl is brought out of the plane of the N-H and therefore becomes more 
shielded due to a weaker interaction, if any, with the carbonyl oxygen.  
It is possible that rotation of the Dha moiety through the Ψ dihedral angle causes a 
conformational change (Figure 70), showing the formation of a C5-interaction.190 This is 
a weak interaction between the amide N-H and the lone pairs of the carbonyl oxygen 
which are within the same residue: its formation is favoured when the dihedral angles 
Rotation around the Φ dihedral 
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mirror each other (adjacent).212 So the planar geometry of the Dha moiety may favour the 
formation of such an interaction. In the literature “the C5” is described as a H-bond, but 
with the presence of the partially polarised N-H and carbonyl functional groups, this 
could also be a dipole-dipole interaction, with both possibilities shown in Figure 70; 
further conformational studies would be required to identify this interaction.213 
 
Figure 70: Rotation of the Ψ dihedral angle, bringing the carbonyl out of the plane 
shielding the Dha N-H proton212, 213 
As the concentration of salt is increased, the N-H amide proton of the Dha5 becomes 
more shielded: this may be due to a local conformational change of the Dha moiety, 
resulting in the carbonyl being brought out of the plane of the amide N-H. This 
conformational change could weaken the interaction between the N-H and the oxygen of 
the carbonyl, with it ultimately becoming more shielded.   
In the literature there are differences in the stability of the Dha5 and Dha33 residues, with 
the Dha33 being the least stable and is broken-down first by hydrolysis.214 It is most 
probable that the Φ and ψ dihedrals are quite different in Dha5 and Dha33, as Dha5 is 
conformationally constrained within the peptide’s A-ring, whereas Dha33 is in the 
flexible tail region. As indicated by the 1H NMR analysis of nisin, it would seem that 
although identical in chemical structure, they behave quite differently in NMR analysis.  
It was next decided to study whether this was an effect of NaCl specifically or whether it 
was a general ionic strength effect. Therefore, the experiments were repeated using a 
range of different ionic salts, and Table 25 lists the salts which were included in the study. 
These salts were chosen so that not only could the ionic strength effect be studied, but 
also the effect/interaction that the presence of different species of anions and cations may 
have on the chemical shifts of the residues within nisin A and Z. 
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Shown in Table 25 is a full list of salt which were included in the NMR studies of nisin 
A and Z and are available in the appendices. The NMR spectra in the presence of fluoride 
salts are not included due to the poor quality of the NMR spectra and complete absence 
of the N-H amide region. 
Salts included in study 
Appendix of 1H NMR spectra 
Nisin A Nisin Z 
KCl Appendix 13 Appendix 14 
LiCl Appendix 16 Appendix 17 
MgCl2 Appendix 19 Appendix 20 
NaBr Appendix 22 Appendix 23 
KBr Appendix 25 Appendix 26 
LiBr Appendix 28 Appendix 29 
Tetrabutylammonium bromide Appendix 31 Appendix 32 
NaI Appendix 34 Appendix 35 
KI Appendix 37 Appendix 38 
NaF Not Included Not Included 
KF Not Included Not Included 
LiF Not Included Not Included 
Tetrabutylammonium Fluoride Not Included Not Included 
Tetrabutylammonium Iodide Appendix 40 Appendix 41 
Tetraethylammonium perchlorate Appendix 43 Appendix 44 
Tetrabutylammonium 
tetrafluoroborate Appendix 46 Appendix 47 
Tetrabutylammonium 
hexafluorophosphate Appendix 49 Appendix 50 
Table 25: Organic and inorganic salts included in the ionic strength NMR study of 
nisin A and nisin Z 
For example, using tetrabutylammonium chloride (TBAC) the increased ionic strength 
causes changes in the N-H region of the nisin A proton spectrum (Figure 71), with the N-
H of Dha5 shifting upfield by 0.23 ppm, as it becomes more shielded, or less deshielded. 
The vinyl protons of Dha 5 also show changes as the C-H at 5.54 ppm becomes more 
deshielded moving downfield by 0.10 ppm. The vinyl C-Hs of Dha33, which was a broad 
peak at zero ionic strength, shows little or no change as a result of the increasing 
concentration of TBAC. The spectrum of Nisin Z (Figure 72) demonstrates how the N-H 
of Dha5 exhibits an even larger movement upfield of 0.27 ppm, while one of the vinyl C-
H protons of Dha5 moves downfield by 0.10 ppm. The peak at 5.71 ppm for the vinyl C-
Hs of Dha33 moves slightly upfield by 0.02 ppm, while its amide N-H is also less 
deshielded, moving upfield by 0.03 ppm. This suggests that again this salt is interacting 




Figure 71: The N-H region of the 1H NMR spectra with increasing tetrabutylammonium chloride (TBAC) concentrations, for 




Figure 72: The N-H region of the 1H NMR spectra with increasing tetrabutylammonium chloride (TBAC) concentrations, for 
nisin Z (3 mM) in 10% D2O/90% H2O at 25oC 
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As the cation was changed from the Na+ ion to the Bu4N+ ion there were spectral changes 
observed, not only between nisin A and Z, but also differences depending on the identity 
of the cation added to each particular nisin isomer. The Bu4N+ cation is significantly 
larger than the sodium ion. For example, the TBAC showed significantly more 
deshielding of one of the vinyl protons of Dha5, when compared to NaCl. In Figure 73 
the comparative N-H proton shift bar graphs are presented for the N-H protons of nisin 
A and Z in 300 mM TBAC. Although both nisin A and Z were tested using the same 
conditions, again their response to a different salt is not identical, regardless of the fact 
that ionic strength remained constant.  
 
 
Figure 73: Changes in chemical shift of the -NH protons of nisin A and Z in 300 mM 
tetrabutylammonium chloride, when compared to each peptide alone 
Again, the amide N-H of the Dha5 showed significant shielding on addition of Bu4N+, 
with the resonance signals for Dha33 remaining unchanged. The effects do not seem to 
be dependent on ionic strength of the solution, but rather the salt composition. In 
comparison to Figure 67 in the presence of NaCl, the changes are significantly larger in 
the presence of TBAC, especially for the N-H amide of Dha5. This proton moves upfield 
by 0.231 ppm compared to 0.115 ppm in NaCl-containing solution. For nisin Z in the 
presence of NaCl, there are several resonances which become more deshielded moving 
slightly downfield, including Ala3 and 7, Gly10 and His31. Interestingly, these amide 
resonances all show a slight upfield movement in the presence of TBAC which highlights 




 Examination of the impact on nisin A and Z in solution of the presence of 
a range of different salts 
After seeing the observed differences for both nisin A and Z in the presence of Na+Cl- 
and Bu4N+Cl-, the study was expanded to include other salts, varying the anion and cation 
present in solution. This was to further investigate whether the observed changes are 
indeed dependant on the ionic strength or due to the identity of the salt. The effect of the 
addition of a variety of different salts is presented in Table 26, showing the change in the 
1H NMR chemical shift of N-Hs of Dha5, Leu6 and the vinyl protons of Dha 5 and Dha33 
















 Nisin A 9.852 8.933 57.3 0.0 






 LiCl +0.128 +0.054 9.1 11.5 
NaCl +0.115 +0.042 10.4 11.4 
KCl +0.137 +0.065 9.8 9.8 





s LiF N.O. +0.008 2.1 7.5 
NaF N.O. N.O. 1.0 20.9 
KF N.O. N.O. 1.2 22.0 






 LiBr +0.182 +0.081 13.6 11.4 
NaBr +0.186 +0.084 13.4 10.1 
KBr +0.216 +0.106 14.6 11.6 




s NaI +0.240 +0.120 19.1 10.7 
KI +0.267 +0.134 20.0 10.8 





TBA PF6 -0.013 -0.004 -1.0 0.0 
TBA BF4 +0.048 +0.018 5.3 0.0 





For the fluoride salts, some of the peaks for the Dha5 and Leu6 N-Hs were not visible, 
which may be due to the solubility of the nisin A, as the solutions were cloudy, and shown 
as not observed (N.O.) in Table 26. However, the chemical shift changes show that it is 
not purely an overall ionic strength effect,but depends greatly on the specific ionic 
composition of the salt. The changes observed after the addition of each salt vary 
significantly with the biggest change in chemical shift being for TBABr, in which the 
Dha5 N-H showed an upfield movement of +0.253 ppm. There was also an upfield shift 
of one of the vinyl C-Hs of Dha5, as shown in the +53.88 Hz change in the spacing 
between the vinyl proton signals. This indicates a significant change in the local chemical 
















 Nisin Z 9.845 8.932 58.6 3.1 






 LiCl  +0.136  +0.058  8.6 8.9 
NaCl  +0.114 +0.042   8.6 8.8 
KCl  +0.153  +0.068  8.6 8.1 





s LiF +0.506 +0.003 0.6 6.5 
NaF N.O. N.O. 1.3 23.6 
KF N.O. N.O. -0.4 29.7 






 LiBr +0.179 +0.080 12.4 9.0 
NaBr +0.198 +0.098 13.0 8.9 
KBr +0.204 +0.103 13.1 8.9 




s NaI +0.241 +0.128 18.3 8.8 
KI +0.256 +0.137 19.6 8.4 





TBA PF6 +0.003 -0.003 1.0 0 
TBA BF4 +0.060 +0.026 6.3 0.6 





Interestingly, for both the TBA PF6 (tetrabutylammonium hexafluorophosphate) and 
TBA BF4 (tetrabutylammonium tetrafluoroborate) solutions, which are described as non-
coordinating anions,215 although the ionic strength remains constant there were negligible 
changes to the chemical shift of these protons in comparison to other added salts. 
A similar examination was conducted for nisin Z, with the changes in chemical shifts for 
Dha5, Leu6 and Dha33 displayed in Table 27. There are again differences depending on 
the identity of the salt, but also differences observed between nisin A and nisin Z. For 
example, the largest spectral change for Dha5 in nisin Z was in the presence of TBABr 
(+0.325 ppm), while in comparison nisin A showed a smaller upfield movement of 
+0.253 ppm. In fact, the largest change seen in the nisin A spectra was in the presence of 
KI, with the amide N-H of Dha5 becoming more shielded and moving upfield by +0.267 
ppm (0.256 ppm for nisin A). Again, for the fluoride salts some of the peaks are not 
observed due to solution being cloudy, but there are differences observed between nisin 
A and Z. In the case of potassium fluoride (KF) the effect on the spacing of the two vinyl 
protons of Dha5 is interesting, as nisin Z shows a smaller change (-0.35 Hz), while nisin 
A the spacing is increased by 1.19 Hz. Once again this shows that nisin A and Z do not 
behave in an identical manner and it not only depends on the salt type but also on the 




 The effect of increasing salt concentration on the pH of nisin-containing 
solutions 
As it is known that the ionic strength can alter the pH of a solution,216 the pH was 
measured for all solutions, of both the nisin A and Z with 300 mM of each salt. They 
were compared to the pH of pure nisin A (pH 4.08) and nisin Z (pH 3.26) solutions alone, 
in zero ionic strength (Table 28). It is interesting that the response to the addition of salts 
is different for both nisin A and Z. For example, it can be seen that for NaCl the changes 
in the pH show an opposite response, with the solution pH of nisin A decreasing by 0.15, 
while the nisin Z solution increased by the same value. 
300 mM 
Δ pH Δ pH 
Nisin A Nisin Z 
NaCl -0.15 0.15 
KCl -0.07 0.07 
LiCl -0.12 0.01 
MgCl2 0.03 0.04 
Tetrabutylammonium chloride -0.11 -0.06 
LiBr -0.06 0 
NaBr -0.09 0.09 
KBr -0.14 0.16 
Tetrabutylammonium bromide -0.21 -0.06 
NaI -0.11 0.07 
KI -0.08 -0.02 
Tetrabutylammonium iodide -0.28 -0.03 
Tetraethylammonium perchlorate -0.12 -0.03 
Tetrabutylammonium 
tetrafluoroborate -0.15 -0.16 
Tetrabutylammonium 
hexafluorophosphate -0.08 0 
Table 28: pH changes observed in aqueous solution as result of the addition of 300 
mM salt, to both nisin A and Z 
Table 28 shows the change in solution pH after the addition of each salt, since large pH 
variations may also contribute to changes in the proton chemical shifts of either nisin A 
or Z (see Chapter V). At the highest concentration of salt added (300 mM), the pH 
changes were +0.15 to -0.28, with the highest value of -0.28 for the tetra-butylammonium 
iodide. The majority of the pH changes ranged between 0-0.15 pH units, with no dramatic 
changes being observed and all values still being in the pH range at which nisin is known 
to have maximum stability (pH 3-4).195 Therefore, the NMR spectral changes which have 
been observed are due to the addition of each salt, rather than any large changes in the 
pH of the solution. 
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 Investigation of H-bonding by 1H NMR spectroscopy 
From the results shown in sections 4.2 and 4.3, which demonstrate significant changes in 
the amide N-H chemical shifts of the polypeptide backbone, the deshielding of these 
protons could be due to the disruption of hydrogen bonds (H-bonds). The increase in 
temperature has been shown to affect and/or disrupt hydrogen bonding causing an upfield 
movement of donor X-H signals.217 So, to examine the extent of H-bonding present in 
aqueous solutions of both nisin A and Z, variable temperature (VT) 1H NMR studies were 
conducted. 
 Variable temperature (VT) 1H NMR studies   
The changes in the chemical shift of the amide N-H of Dha5 as a function of temperature 
are shown in Figure 76. Both nisin A (Figure 74) and nisin Z (Figure 75) were studied 
using VT NMR over a temperature range of 20 to 45oC. These chemical shift changes in 
response to the increasing temperature can be attributed to the N-H proton becoming 
more shielded, possibly due to disruption of H-bonding associated with nisin.218 
 
Figure 74: Variable temperature 1H NMR spectrum of pure nisin A (3 mM), 










Figure 76: Dha5 amide N-H proton chemical shifts as a function of temperature 
for nisin A and Z 
 
As shown in Figure 74 (Nisin A), Figure 75 (Nisin Z) and Figure 76, for the N-H of 
Dha33, as the temperature is increased there is an upfield shift of the amide N-Hs, 
showing disruption of either intra- or inter-molecular interactions. As with the correlation 
of temperature and changes in the chemical shift described above, Leu6 also showed a 
strong correlation with its N-H amide moving upfield because of the increased 
temperature, as is seen in appendix 42.  
Although the VT 1H NMR studies show the presence of H-bonding, its intermolecular or 
intramolecular nature was not known. A paper published by Raines show that most 
peptides at this concentration are monomeric, so it is unlikely that these interactions are 




 Intermolecular or Intramolecular H-bonding 
To investigate the intermolecular or intramolecular nature of the H-bonding observed 
during the VT NMR experiments, a concentration gradient of 1-5 mM was conducted for 
both nisin A and Z using 1H NMR spectroscopy at 25oC.  
 
Figure 77: Concentration gradient of nisin A (1-5 mM) in 10% D2O: H2O at 25oC 
 
As the concentration of peptide was increased from 1 mM to 5 mM the peak height 
increases were due to the increase in concentration. However, no chemical shift changes 
or peak broadness were observed, for either peptide, (nisin A Figure 77 and nisin Z 







 1H-15N HSQC NMR studies of nisin A and Z  
As shown during the course of the 1H NMR studies of both nisin A and Z, the N-H amide 
region of the spectrum is overcrowded and in some cases the proton resonances are 
overlapping. To try and further examine the changes based on the addition of a specific 
salt, the use of 1H-15N HSQC was employed. The 1H-15N HSQC NMR studies of peptides 
and proteins are usually conducted using 15N-enriched peptides to increase resolution and 
sensitivity.219 However, due to the instability issues with aqueous solutions of nisin A 
and Z, this was not practical. The studies were conducted using a 600 MHz Agilent NMR 
spectrometer equipped with a cryoprobe, to measure the effect on the individual amide 
N-Hs, at the natural abundance of 15N at 0.4%.220 Due to the limitation of the 
commercially available nisin A and Z samples not being 15N-enriched, the cryogenic 
NMR probe allows for significant enhancement and increased sensitivity, to allow for the 
low-abundance of 15N to be observed. However, the drawbacks were that only 150 mM 
of salt additions was possible, with each experiment taking up to 5 hours of instrument 
time. Figure 78 shows the 2D 1H-15N HSQC experiment of nisin A stacked before and 
after the addition of 150 mM of NaCl.   
 
Figure 78: 1H-15N HSQC of 3 mM nisin A (Blue) and after addition of 150 mM NaCl 
(Black) in 10% D2O: H2O at 25oC 
127 
 
The second dimension of the spectrum allows for the separation of the amide N-H 
resonances which overlap in the 1D proton NMR spectra of both nisin A and Z. There 
are differences observed between the nisin A spectrum after the addition of NaCl, 
especially corresponding to the N-H of Dha5 which displays the largest upfield shift, 
while amide N-Hs of Ile4, Leu6, Abu8 and Gly10 also show a upfield movement (see 
Figure 78). These AA residues are in the important A- and B-ring binding regions of both 
nisin A and Z. 
The 1H-15N HSQC experiment is in agreement with the previous NMR studies, showing 
the major effects and/or interactions are associated with the A- and B-rings of nisin, 
which is known to be involved in its binding to lipid II. Such interactions may also impact 
on the antimicrobial activity of nisin as there is a report which shows that purified nisin 
Z displays activity against both Gram-positive and Gram-negative bacteria. However, 
nisin Z, in the presence of a high NaCl concentration, shows a reduction in activity against 
Gram-negative species.221 The 1H-15N HSQC of nisin Z in the absence and in the presence 
of 150 mM NaCl is shown in Figure 79. 
 
Figure 79: 1H-15N HSQC of 3 mM nisin Z (Blue) and after addition of 150 mM NaCl 
(Black) in 10% D2O: H2O at 25oC 
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For nisin Z, the addition of 150 mM of NaCl again shows slight changes to the observed 
chemical shift of the amide N-Hs. Again, the main spectral changes observed are 
associated with the AAs located in the A- and B-rings of nisin, such as Ile4, Leu6 and 
Abu8. Interestingly, Gly10 in nisin A which showed an upfield shift, shows no change in 
its chemical shift in nisin Z.  
Both nisin A and Z were also examined using two other different salts (NaBr and TBAC) 
with the complex overlay of the 1H-15N HSQC spectra shown in Figure 80, at a constant 
ionic strength of 150 mM (NaCl, NaBr and TBAC). The number of salts studied was 
restricted by available NMR time on the 600 MHz instrument. Each of the three different 
salts show some differences depending on the salt, with the TBAC having the greatest 
effect on the Dha5 moiety, showing the N-H in the presence of 150 mM TBAC 
significantly less deshielded, as well as significant movement of the amide N-Hs of Ile4 
and Leu6, in comparison to the other salts.  
It is still not clear whether there is a direct interaction of the cation or anion with nisin or 
whether it is having an impact on the local solvent environment. If there is some kind of 
“binding” interaction of the A- and B-rings with a cation or anion, we would expect to 
see it using the 1H-15N HSQC studies. For example, if the chloride anion (Cl-) is binding, 
then it would be expected that for NaCl and TBAC spectral changes would be similar. 
Likewise, if the Na+ cation is binding, then the NaCl and NaBr spectra would be similar.  
But this is not the case, where each of the different salts seem to interact differently with 








 Biological Buffer Components 
As the largest effect of added salts is shown to be in the A-ring region of nisin, this may 
help to explain the reported reduction of nisin Z bioactivity against Gram-negative 
bacteria. Possibly interactions between the anions, cations or salt and the A-ring region 
of nisin interferes with the binding to the polyoxygenated pyrophosphate moiety (Figure 









Figure 81: Structure of the polyoxygenated pyrophosphate moiety of lipid II 
 
Therefore, the effect of common buffer components, used in a wide range of biological 
research, on both nisin A and Z in aqueous solution was of interest. One example of a 
common buffer used to examine nisin in a range of bioassays is phosphate-buffered saline 
(PBS). This widely used buffer system contains polyoxygenated phosphate Na2HPO4 
(Figure 82) as the main component in excess of 100 mM, as well as 137 mM of NaCl and 
other salts depending on the type of assay being conducted.222 in the context of PBS, there 
are two relevant anions in solution, H2PO4- and HPO42-, in ~ equal concentration. Could 
the presence of a polyoxygenated phosphate species, present in the buffered solution, act 
in a similar way to the pyrophosphate and interact or bind to the A and B rings of either 



























Figure 82: Chemical structures of common biological buffer components 
 
Also shown in Figure 82, are the chemical structures of two common biological buffer 




There is also a possibility that these components could interact and bind to nisin during 
bioassays and assessment of its biological activity, possibly inhibiting its bioactivity. The 
NMR studies were also extended to include perchlorate salts as, although they not used 
commonly in biological buffering systems, they are used commonly used in organic 
chemistry. Both sodium perchlorate and tetraethylammonium perchlorate (TEA 










Sodium Perchlorate TEA Perchlorate
 
Figure 83: Chemical structures of sodium perchlorate and TEA perchlorate, 
polyoxygenated salts 
 
The NMR studies using common biological buffer components and polyoxygenated 
anions such as sodium perchlorate and tetraethylammonium perchlorate (TEA ClO4)  
were examined as before using 3 mM nisin and 300 mM of the respective buffered 
component and the pH was adjusted to the solution pH of nisin in the absence of the 
additive.   
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 Examining the effect of biological buffer components using 1H NMR 
spectroscopy 
The effect of sodium dihydrogen phosphate (NaH2PO4), a very common buffer 
component, was investigated at pH 3.1, shown in Figure 84. The main phosphate species 
in solution at pH 3.1 would be H2PO4-, (~89% from Henderson-Hasselbalch) as only one 
of the acidic protons will be deprotonated, due to the pKa values of H3PO4 being reported 
to be 2.2, 7.2 and 12.3.223  
 
Figure 84: Nisin A (wine) in the presence of 300 mM NaH2PO4 (blue) both at pH 3.1 
in 10% D2O: H2O at 25oC 
 
In the presence of NaH2PO4, nisin A displayed some interesting spectral changes, with 
some of the observed changes not being seen in the presence of other ionic species. As 
can be seen in Figure 84, the C2 and C4 protons of the histidine side-chain imidazole 
showed an upfield shift of 0.03 ppm, which is interesting as the histidine side-chain 
chemical shift did not vary in the study of either nisin A or Z in the presence of different 
salts. The C-H vinyl protons of Dha5 show a slight upfield shift in comparison to nisin A 
alone, while its N-H amide resonance is slightly deshielded, an opposite response to what 
was observed in the presence of other salts. The vinyl proton of the Dhb2 also shifted 
slightly upfield, while the amide N-H of Leu6 and Abu8 moved slightly downfield by 
0.018 ppm and 0.100 ppm respectively, indicating that the interactions in the presence of 
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NaH2PO4 seem to be localised in the A-ring region of nisin. The observed changes to the 
1H spectrum of nisin A could possibly be due to interactions or binding of the phosphate 
to the A-ring, in a similar way that nisin binds the pyrophosphate of the lipid II. 
Each of the other polyoxygenated compounds were also studied, and in each case there 
were significant spectral changes in the observed chemical shift of the amide N-H of the 
AAs located in the A ring of nisin A. Table 29 shows the observed changes in the 
chemical shift of the Dha5, Leu6 and Dha33 residues, in comparison to their chemical 
shift on the absence of additive. 











 Nisin A  9.852 8.933 57.3 0 








 NaH2PO4 3.10 -0.031 +0.018 2.4 7.6 
K2HPO4 3.10 +0.108 +0.051 7.4 9.7 
HEPES 4.30 +0.124 +0.003 16.3 6.0 
CAPS 4.30 +0.109 0.000 22.0 0.0 
NaClO4 4.15 +0.087 +0.057 6.2 5.9 
TEA ClO4 4.15 +0.220 +0.083 24.1 7.1 
Table 29: Effect on selected chemical shifts of nisin A (3 mM), in the presence of 
common polyoxygenated components (300 mM) 
 
There are differences observed depending on the identity of the additive. The two 
phosphates, NaH2PO4 and K2HPO4, showed different spectral changes, the N-H of Dha5 
showed a downfield movement in NaH2PO4 of -0.031 ppm compared to the upfield shift 
of 0.108 ppm in the presence of K2HPO4. The phosphate samples were made using either 
NaH2PO4 or K2HPO4 with the pH of these solutions are the same, the phosphate species 
in solution will be the same, so the contrasting downfield movement of the amide N-H of 
Dha5 in the presence of K2HPO4 may be due to the K+ cation concentration being double 
that of the Na+ in the NaH2PO4 solution. The HEPES component, containing a sulfonic 
acid moiety, shows a large upfield movement for the amide N-H of Dha5 of 0.124 ppm. 
In the presence of CAPS, also containing a sulfonic acid moiety, the amide N-H of Dha5 
also showed upfield shift of +0.109 ppm while there were negligible changes observed 
for the chemical shift of the N-H of Leu6 or for the C-H vinyl proton signal of the Dha33.  
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Nisin A in the presence of the two perchlorate salts also displayed differences, with the 
largest changes being observed for TEA perchlorate. The Dha5 amide N-H became less 
deshielded, moving upfield by 0.220 ppm, overlapping with the N-H amide of Dha33. 
The C-H vinyl protons of Dha5 displayed a change in the measured gap between each 
proton resonance signal, increasing by 24.1 Hz. Interestingly, nisin A in the presence of 
sodium perchlorate did not show big spectral changes in comparison to the other 
polyoxygenated anions except NaH2PO4, again showing that nisin A interacts differently 
depending on the composition of the additive. 
A similar examination was also conducted for nisin Z. The effect on the Dha5, Leu6 and 
Dha33 is shown in Table 30, with the spectral changes again being more prominent in 
the A-ring of nisin Z. 
@500 MHz 










 Nisin Z  9.845 8.932 58.6 3.05 








 NaH2PO4 3.10 +0.021 +0.013 3.0 6.4 
K2HPO4 3.10 +0.142 +0.073 7.7 9.6 
HEPES 3.40 +0.117 +0.034 14.8 4.8 
CAPS 3.40 +0.119 +0.008 21.3 0.0 
NaClO4 3.50 +0.062 +0.045 4.1 3.0 
TEA ClO4 3.50 +0.225 +0.091 25.3 3.3 
Table 30: Effect on selected chemical shifts in nisin Z (3 mM), in the presence of 
common polyoxygenated buffer components (300 mM) 
Similar to nisin A, there are significant spectral changes in the nisin Z spectra depending 
on the buffer component present in aqueous solution. With the addition of the phosphate-
containing buffer components, there are significant differences in the observed spectral 
changes depending on the phosphate species, with the K2HPO4 greatly shielding the 
amide N-H of Dha5, moving upfield by 0.142 ppm in comparison to an upfield movement 
of 0.021 ppm in the presence of NaH2PO4, while in both cases there is a slight upfield 
movement of the N-H amide of Leu6 of 0.073 ppm and 0.013 ppm, respectively. In 
comparison to nisin A in the presence of polyoxygenated buffer components, there is a 
very similar trend for nisin Z. Like nisin A and Z after the addition of common salts there 
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are significant differences observed, with all polyoxygenated species interacting with the 
A-ring AAs in solution. 
Although there have been interesting spectral results observed in the presence of 
polyoxygenated species, one of the limitations of 1H NMR spectroscopy is the complexity 
of the proton spectra due to spectral overlap in both the aliphatic and amide N-H regions. 
In an attempt to overcome this issue, 2D-TOCSY (Total Correlation Spectroscopy) was 
employed, in order to try to resolve the overlapping proton resonance signals by bringing 
them into a second dimension.224 The 2D-TOCSY NMR technique is a useful tool in the 
identification and examination of effects on individual amino acid residues within 
peptides, as described in Section 2.4.10.225,226 
The TOCSY NMR technique was used to examine the effects of K2HPO4 on individual 








In comparison to nisin Z alone (blue), in the presence of the phosphate (red) there are 
slight upfield shifts in the A-ring which could be an indication of possible 
conformational changes as a result of interactions with the phosphate in solution. The 
Dha5 N-H shows the largest change becoming less deshielded, which was also 
observed during the 1H NMR study. An upfield shift movement of the Leu6 N-H 
amide was also seen. However, shown in the TOCSY spectrum (Figure 85) the side-
chain methyl group of the isopropyl also moves upfield becoming more shielded. This 
may be an indication of binding and/or interactions of the phosphate ion with the nisin 
A-ring in solution, which could have an impact on the antimicrobial activity and the 
binding to the pyrophosphate of the lipid II. There are also changes to a number of the 
aliphatic resonance signals, corresponding to the AA side-chains. This could be also 
an indication of changes to the solution conformation of nisin Z; further study is 
required using NMR and CD spectroscopy to assess the conformational changes in the 
presence of polyoxygenated species in solution. 
To further investigate the effect of the sulfonic acid-containing biological buffer 
components, the 2D-TOCSY NMR was also conducted for nisin Z in the presence of 
HEPES buffer shown in Figure 86. 
It can be seen that there are upfield shifts in the N-H region with the largest being for 
Dha5, similar again to what was seen for nisin Z in the presence of K2HPO4.  Based 
on both the 1H and TOCSY NMR spectra of nisin Z there is an indication that the 
HEPES component of biological buffers can bind and interact with nisin.  
From the 1H and TOCSY NMR studies, the nature of how the polyoxygenated species 
interact with both nisin A and Z in solution is not inherently clear. However, it is clear 
for both nisin A and Z, that these species in solution seem to selectively interact with 
the A-ring region, which is associated with binding lipid II.  
If there was a direct interaction between the negative oxygens of the buffer 
components with any of the amide N-Hs, it would be expected that they would display 
a deshielding in the NMR spectra. The deshielding of the amide N-H of Dha5, Abu8 
and Gly10 were observed nisin in the presence of lipid II in DMSO-d6, reported by 
Breukink.98 Further study is required to examine the nature of the interactions, by 1H-








 Circular Dichroism (CD) studies of nisin A and Z 
CD spectroscopy is widely used to study the solution conformations of peptides and 
proteins.227 The studies reported here were undertaken in the Centre for Synthesis and 
Chemical Biology (CSCB) in UCD; the spectra were collected at 190-260 nm allowing 
for examination of any changes in the secondary structure of nisin.227 The CD data 
which is presented has been analysed using the CD Tool software, which was supplied 
by Birkbeck, University of London.228 All CD spectra were converted into molar 
ellipticity (molar delta epsilon), which is the commonly used units of CD 
spectroscopy, and is required for compatibility with the currently published CD 
analyses of nisin.229 
The CD studies include similar ionic strength studies to those conducted using 1H and 
1H-15N HSQC NMR spectroscopy. From the outset, there were significant issues 
acquiring CD spectra, due to solubility of nisin in solution, so the concentration of the 
samples was decreased from 3 mM to 0.3 mM. This method allows for a comparison 
with the NMR experiments described in section 4.2, as changes in the CD spectrum 
of nisin A or Z could be an indication of conformational changes attributed to the ionic 
strength and/or salt composition. Collection of nisin CD spectra is difficult due to the 
lack of aromatic AA residues, i.e. Phe, Trp and Tyr. Figure 87 shows the CD spectrum 




Figure 87: CD spectrum of 0.3 mM nisin A in H2O at 25oC 
 
Also, the CD analysis of nisin Z (Figure 88) showed a peak at 210 nm. It is not known 
why nisin A is negative and nisin Z is positive as all instrument settings were identical 
in both cases. All of the CD spectra for nisin A and Z, with increasing ionic strength 
on addition of salts, were studied for comparison with the pure samples, in order to 




Figure 88: CD spectrum of 0.3 mM nisin Z in H2O at 25oC 
 
Examples of all CD spectra acquired for nisin A and Z, after the addition of 30 mM of 






Figure 89: CD spectrum overlay of nisin A in H2O and after addition of chloride 
salts (30 mM) 
After the addition of a variety of chloride salts, there are noticeable differences in the 
CD spectrum for nisin A (Figure 89). Interestingly, not all of the experiments 
displayed changes: for example, in the presence of the KCl salt the CD spectrum is 
identical to that of the pure nisin A. The largest change in the CD spectra was after the 
addition of TBAC which showed a significant change, in comparison to pure nisin A 
(Figure 89). At short wavelength (λ), there is a very obvious difference in the CD 
spectra between the TBAC and the MgCl2, but it is also notable that the metal ions 
Na+ and Li+ show differently from K+ and Mg2+ above 220 nm. 
The CD spectra, like NMR spectra, also showed that the nisin A spectral changes are 
dependant on the identity of the salt, as there are different spectral changes in the nisin 
A CD spectrum. This again shows that interactions between the salt and nisin may 
cause a change in the overall solution conformation, as indicated by the observed 










differences observed are due to the type of salt, nature of the ions and the nisin form 
present in aqueous solution. 
Following on from the CD analyses of nisin A, a similar study was conducted to assess 
the effect of the presence of the chloride salts on nisin Z in solution, shown in Figure 
90. When compared to nisin A (Figure 89) there are significant differences based on 
the addition of salts. 
 
Figure 90: CD spectrum overlay of nisin Z in H2O and after addition of chloride 
salts (30 mM) 
 
Although the spectra are inverted in comparison to nisin A, the CD spectra of nisin Z 
in the presence of the other chloride salts did not show significant spectral changes. 
The TBAC which showed a significant change in the CD spectrum of nisin A, showed 
little or no change for nisin Z. Again, at λ > 220 nm, Na+/Li+ show differently from 










There were significant issues encountered while collecting the CD data, with the 
absence of the nisin peaks on duplicate samples. So further optimisation is required to 
ensure consistency and reproducibility of all of the studies. All the CD spectra of both 
nisin A and Z in the presence of each salt are available in the Appendices, as detailed 
in Table 31. 
Salts included in study 
Appendix 
Nisin A Nisin Z 
KCl Appendix 55 Appendix 56 
LiCl Appendix 57 Appendix 58 
MgCl2 Appendix 59 Appendix 60 
Tetra-butylammonium chloride Appendix 61 Appendix 62 
NaBr Appendix 63 Appendix 64 
KBr Appendix 65 Appendix 66 
LiBr Appendix 67 Appendix 68 
Tetrabutylammonium bromide Appendix 69 Appendix 70 
NaI Appendix 71 Appendix 72 
Tetraethylammonium  perchlorate Appendix 73 Appendix 74 
Tetrabutylammonium 
tetrafluoroborate Appendix 75 Appendix 76 
Tetrabutylammonium 
hexafluorophosphate Appendix 77 Appendix 78 
Table 31: Organic and inorganic salts included in ionic strength CD study of nisin 
A and nisin Z 
 
 Comparison of 1H NMR and CD spectral changes 
Both 1H NMR and CD spectral analyses have shown that nisin A and Z interact 
differently with salts, depending on their composition. During the 1H NMR studies, 
there were large changes associated with the amide N-H of the Dha5 in both nisin A 
and Z after addition of 300 mM TBAC, but by CD analyses, there is little or no spectral 
change for nisin Z in the presence of TBAC. There is a similar observation for nisin 
Z, in which the largest change in the CD spectrum was in the presence of KCl which 
showed no change in the CD spectrum of nisin A. In both cases the 1H NMR studies 
show the amide N-H of Dha5 moved upfield by +0.137 ppm and +0.153 ppm for nisin 
A and Z, respectively, as well as chemical shift changes involving Leu6 and a change 
in the appearance of the Dha33 C-H vinyl protons. So, it would have been expected 
that there would be CD spectral changes for both nisin A and Z in the presence of KCl 
and TBAC in solution. 
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Similarly, nisin Z showed very little change to the addition of chloride salts while nisin 
A showed significant changes. It is clear from the nisin A studies that each salt 
demonstrated a different effect on nisin A in solution, but the CD studies of nisin Z 
need to be optimised further. 
 Chapter Conclusions 
The NMR spectroscopic studies of both nisin A and Z have shown very interesting 
results as there are spectral differences depending on the identity of the salt used: each 
salt has shown slightly different chemical shift changes for nisin A and Z in the amide 
N-H region of the 1H NMR spectra. It is not purely an overall ionic strength effect, 
since the BF4- and PF6- anions showed no changes in the 1H NMR spectra, for either 
nisin A or nisin Z. It was also determined that nisin does not participate in 
intermolecular H-bonding and so is in its monomeric form within the studied 
concentration range. Therefore, the observed amide N-H chemical shift changes are 
likely due to disruption of intramolecular H-bonding, which may indicate a 
conformational change, the degree of which is dependent on the salt composition (i.e. 
the nature of the cations and anions present in solution) and its concentration. 
Following on from the 1H NMR studies, 1H-15N HSQC was employed to study more 
closely the added salt effects on the amide N-H of individual AAs on both nisin A and 
Z. Although these studies where limited to 150 mM of salt, the amide N-H of Dha5, 
Abu8, Gly10 and Dha33 showed the biggest upfield movement in the presence of the 
added salts. The changes in the observed chemical shifts of some AA side-chains 
indicates a change in their local environment and possible local conformational 
changes in the presence of a particular salt species in solution.  
In the presence of common polyoxygenated buffer components there were some 
chemical shift changes mainly attributed to the A and B-ring region of nisin A and Z, 
which were observed by tracking of the amide N-Hs of the Dha5 and Leu6 residues. 
These buffer components all contain a polyoxygenated functional group, i.e. a 
phosphate, sulfonic acid or perchlorate, which may be the feature interacting with the 
A- and B-rings. In the presence of TEA perchlorate, the amide N-H of Dha5 showed 
significant shielding, moving upfield by 0.220 ppm and 0.225 ppm for nisin A and Z, 
respectively. In all cases there are different changes observed depending on the 
polyoxygenated species present in solution. The interaction of the polyoxygenated 
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species in solution may cause a change in the A-ring conformation, potentially 
affecting its biological activity. As these interactions involve the A-ring at the N-
terminal end of the peptide, the buffer components could compete in binding with the 
pyrophosphate moiety of Lipid II. 
The CD analysis shows that any spectral changes are very dependent on the type of 
salt and ions present in solution, and also shows that nisin A and Z do not show the 
same changes in response to the same environment. The changes appear to be due to 
the salt composition rather than the overall ionic strength of the solution, although in 
the case of nisin Z, only KCl showed any significant effect in CD analysis. For nisin 
A, each of the chloride salts had a different effect, except for KCl which was identical 
to the pure nisin A CD spectrum. 
For salts which showed large changes in the 1H NMR spectra - for example the amide 
N-H of Dha5, Leu6 and Gly10 for nisin A - they also showed changes in the CD 
spectrum. It is interesting that nisin Z in the CD studies showed very little change on 
addition of different salts, especially since there were some significant changes 
observed during the NMR studies. For example, nisin Z in the presence TBAC showed 
changes in the NMR chemical shifts of the amide N-H of Dha5, Leu6 and Gly10 but 
no changes were seen in the CD spectra, except for KCl, but even its spectral change 
was not as pronounced as what was seen for nisin A. Both nisin A and Z showed 
changes in the CD spectrum in the presence of TBABr (Appendix 60 and 61), which 
by 1H NMR also showed significant chemical shift changes in the amide N-H region. 
Further optimisation of the CD acquisition method is required to ensure the spectral 
changes, or lack of change, are correct and reproducible.  
As the two derivatives of nisin (A and Z) interact and behave differently in aqueous 
solution, they cannot be used interchangeably. It matters not only what type of nisin 





 Future NMR and CD studies of nisin A and Z 
Although there are spectral differences found between nisin A and Z in the presence 
of different salts, the nature and significance of these interactions are not known. The 
changes in the amide N-H chemical shift, and also changes in the CD spectra, indicate 
that a change in the solution conformation needs to be investigated. As all of the NMR 
studies conducted within this chapter have been in the pH 3-4 range, the studies should 
be expanded to study the interactions of nisin A and Z in the presence of salts and 
polyoxygenated species at closer to pH 7.0. There are limitations in terms of solubility, 
which lowering the nisin and additive concentration may overcome, but would require 
in longer acquisition times for both NMR and CD spectra. This would allow for 
comparison and investigation of the behaviour of nisin A and Z at physiological pH, 
which would be more applicable to therapeutic applications and biological assays. 
Further studies should be carried out using both 2D-TOCSY and nOesy (nuclear 
Overhauser Enhancement spectroscopy) to investigate in detail the conformational 
changes and the specific interactions involving the AA side-chains. 2D-nOesy NMR 
was used during this research but further optimisation of the NMR method, including 
duration of the pulse and relaxation are required, as these proved difficult due to the 
experiment being conducted in aqueous solution. The use of nOe NMR techniques 
may give further insight into the exact conformational changes, by irradiation of the 
protons in side-chains and observing the through-space coupling and interaction rather 
than through bonds to the closest AA residue. This would allow the use of the 
determined nOe constraints to model the solution conformations of nisin A and Z, in 
the presence of both salts and polyoxygenated species. It would also allow for the 
study of the extent and strength of any binding, possibly helping to determine the 
nature of the observed interactions.230 
In addition, in-depth conformational studies of both nisin A and Z at varying pH 
should be conducted, using 2D-TOCSY, nOe NMR and CD spectroscopy. This would 
allow a study of the conformational stability of both nisin A and Z in aqueous solution, 
which may shed some light on the decline in nisin solubility at physiological pH. Use 
of NMR and analytical HPLC, in the presence of salts or additives, would allow an 
examination of the decrease or increase in the rate of decomposition of either nisin A 
or Z in aqueous solution over time. 
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The lipid II molecule within the bacterial cell wall contains a pyrophosphate moiety 
to which nisin binds (see section 1.3.2.). Using the commercially available diethyl acid 
pyrophosphate (Figure 91) as a model for the lipid II molecule could allow for further 
study in relation to binding the nisin A- and B-ring region. This would involve an 
investigation of possible interactions and also conformational changes of nisin (A and 
Z), as a result of the pyrophosphate of the lipid II binding to either nisin A or Z. For 
both the lipid II and the diethyl acid pyrophosphate (Figure 91), although the exact 
pKa values of the pyrophosphate in lipid II or diethyl acid pyrophosphate are not 
known, it is highly likely that both are fully deprotonated at physiological pH. (The 




























Lipid II Diethyl acid pyrophosphate  
Figure 91: Structure of lipid II highlighting the pyrophosphate moiety and its 
model compound, diethyl acid pyrophosphate 
 
It would also be beneficial to study both nisin A and Z at pH 7 with a reduced 
concentration of lipid II, phosphates (including diethyl acid pyrophosphate) and 
polyoxygenated buffer components, to study their binding affinity to both nisin A and 
Z. This would allow for competitive binding assays to be conducted, to determine if 
the presence of these additives completely inhibits or displaces the lipid II molecule. 
It is extremely important in terms of assessing biological activity, and potential 
interactions of these molecules with nisin, and ultimately assess if these possible 























5.0  Introduction 
In the previous chapter all of the NMR spectroscopic studies were conducted in a pH 
range of 3-4. It is also important to study the effect of a change of pH on nisin, 
especially as nisin as used usually at a pH between 6.5 and 7.5. Therefore, NMR 
spectroscopy was used to study both nisin A and Z at different pH values, due to its 
sensitivity to the changes in the chemical environment. Both 1H and 2D-TOCSY NMR 
techniques were used to study the effect of changing the pH of the aqueous solution, 
in attempt to study the specific effects of pH on individual AA residues with either 
nisin A or Z.  
The following chapter describes the studies of nisin A and Z in different pH 
environments. Firstly, both nisin derivatives were studied in a pH range of ~3.0-7.7, 
to investigate any spectral changes based on the pH of the solution. As previously 
stated, the solubility of both nisin A and Z dramatically drops above pH 6.231 The cause 
of the change in the solubility is of significant interest, especially in the context of 
utilizing nisin as a future therapeutic treatment. An important question is: does any 
change in the solution pH affect the conformation of the nisin peptide? So, studying 
both nisin A and Z in different pH environments, to investigate the effects on specific 
AAs or regions of nisin is paramount, especially as published CD studies have reported 
a conformational change as a result of changing the solution pH,179 possibly due to the 
imidazole side-chain(s) of the His residue(s) going from protonated to neutral. 
 Effect of pH on 1H NMR spectra of nisin A and Z in aqueous solution 
The studies were all carried out in a similar fashion to those described in Chapter III, 
that is in 10% D2O: H2O, with a reference tube containing 1% DSS in D2O external to 
the nisin sample. As the solubility of nisin is reported to significantly diminish at pH 
~6 and above, the concentration of nisin used was lowered, from 3 mM to 0.5 mM, in 
an attempt to prevent the likely precipitation of the peptide and resistant distortion of 
the observed NMR resonances.  The pH values of the 0.5 mM nisin-containing 
solutions were adjusted using HCl or NaOH (0.1 M), to obtain the desired pH for 
analyses. Each NMR experiment was conducted at 25oC, with the residual water 




Figure 92: 1H NMR spectra of nisin A (0.5 mM) in 10% D2O: H2O at pH 7.7 (top), 
6.0 and 2.9 at 25oC 
 
Figure 92 shows the 1H NMR spectrum of nisin A at three different solution pH values 
(7.7, 6.0 and 2.9), and it is immediately obvious that there are significant differences 
between the spectra. Adjusting the pH has prompted a significant change to the local 
chemical environment of the Dha33 at pH 6.0 and above. The resonance signal for the 
two vinyl protons of Dha33 with a small spacing of only 0.01 ppm at pH 2.9, has 
increased significantly to 0.09 ppm at pH 7.7, resembling the spacing seen for signal 
for the Dha5 residue located within the nisin A-ring. All of the amide N-H resonance 
signals also disappear at the higher pH values (Figure 92). Showing that the N-H’s 
may be exchanging rapidly at higher pH, with only the C-H resonance signals visible, 
it is noticeable that the effect is similar to complete exchange with D2O (see Figure 
96, of nisin in 10% D2O versus nisin in 100% D2O). 
This could be due to the solubility of the peptide in aqueous solution at pH 6 and 
above, as solutions at higher pH values were slightly cloudy.  However, due to the 
clear resolution of the proton resonances in Figure 92, it is more likely that the change 




It is reported that at higher pH values, the D (2H) in D2O-containing solutions 
exchanges more rapidly with the N-H amide protons; for example, the amide N-Hs of 
some AAs, where the exchange is ~3 minutes at low pH (pH 3.0), while this is 
significantly decreased to ~6 ms at pH 7.233 This could explain the disappearance of 
the amide N-H protons in the pH 7.7 spectrum. 
Importantly, the C-H protons of the imidazole rings of the histidine residues present 
in nisin A (His27 and His31) show the largest chemical shift changes, with the C2 
protons of His27 and 31 moving upfield (shift) by 0.86 ppm (Figure 92).  This change 
in the chemical shift is likely due to the deprotonation of the imidazolium ion to form 
an imidazole, its conjugate base (Figure 93).  
 
Figure 93: pH-dependant equilibrium of the imidazolium ion to form imidazole 
 
The change in the appearance of the vinyl protons of Dha33 as the pH of the aqueous 
solution increases is very interesting, which may be a result of significant changes in 
the solution conformation of the nisin tail region. Since His27 and His31 are close to 
Dha33, their deprotonation could impact the local conformation of the Dha33 residue, 
which now resembles the appearance of the Dha5 residue in the 1H NMR spectrum.  
Could this change in the local environment of Dha33 be responsible for the reported 
loss in solubility, stability and activity of nisin A and Z at physiological pH? The 
solubility drop of nisin A at physiological pH is most likely due to the overall change/ 
loss in the polarity of the peptide in solution, due to the deprotonation of the two 




Figure 94: 1H NMR spectra of nisin Z (0.5 mM) in different pH environments (pH 9.0, 7.0, 5.0 and 2.0) in 10% D2O/H2O @ 25oC
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A pH titration (pH 2.0-9.0) was also conducted for nisin Z (Figure 94). As was seen 
previously for nisin A there is a similar change in the resonance pattern observed for 
the two vinyl protons of the Dha33 residue, but what is apparent is that this is a gradual 
change. As the pH of the solution increases to physiological pH and beyond, the effect 
and change of the chemical environment is more pronounced. There are negligible 
changes in the chemical shifts, or appearance, of the signals for the vinyl protons of 
Dha5 or Dhb2 residues. The changes seem to be isolated to the C-terminal tail region, 
of both nisin A and Z, with not only a change in appearance of the vinyl protons of 
Dha33 but also a slight deshielding, with an overall movement downfield. 
 Determination of the pKa values of the imidazole side-chains of the 
histidine residues of nisin A and Z 
Following on from the observed changes in the 1H NMR spectra for both nisin A and 
Z as the pH of the solution increases, it is possible that the histidine residues play a 
key role in the changes observed for Dha33. For nisin A this change is seen at pH 6 
and above, and for nisin Z the changes are seen at pH 5 and above. These observations 
further indicate that the two forms of nisin do not act in an identical manner. The 
observed changes reside in the pH range that the pKa of the imidazole side-chains of 
the histidines may lie.187 
Although it has been proposed that the pKa of the histidine side-chain may lie within 
this range, it has never been measured accurately. Therefore, the determination of their 
relevant pKa values may increase the understanding of the sudden decline in solubility 
and stability of nisin at pH 6 and above. The determination of the pKa values could 
also shed some light on the exact nisin state in different pH environments, which is 
very important as nisin is used as a food preservative in a wide variety of different 
food products, including cheeses, canned food, juices and meat products. These food 
types have different pH environments ranging from orange juice at pH 3.3, up to meat 
and dairy products which can be up to pH 7.0.234 Therefore, the pH of the food system 
is likely to have a significant effect on the biological activity and thus the effectiveness 
of nisin as a food preservative, as well any potential application in human and 





The determination of pKa values for side-chain protons, contained within peptides and 
proteins is extremely important, especially for the study of conformational stability 
and potential intramolecular interactions between AA residues.235 This is especially 
true for histidine residues, which are described as one of the most active and versatile 
members that play multiple roles in protein-protein interactions.236 The side-chain 
imidazole can be involved in a variety of different interactions, which include: (i) 
cation-π interactions, in which the imidazole acts as the aromatic π-motif in its neutral 
form, or plays the cationic role in the protonated imidazolium form (Figure 93); (ii) π-
π stacking interactions between histidine and other aromatic amino acids.237,236 
To accurately determine the pKa values of the histidine side-chain, present in both 
nisin A. Using the changes in the chemical shift of both the imidazole C2 and C4 
protons were measured as a function of the pH of the solution (Figure 95), using more 




Figure 95: Nisin A (0.5 mM) 1H NMR pH titration at pH 2.0-8.3 (10% D2O/H2O @ 25oC) 
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Figure 95 shows the pH titration for nisin A between pH 2.0 and 8.3. As expected, 
there is a change in the observed resonance signal corresponding to Dha33. The most 
dramatic change occurs at ~pH 6 when the signal shows baseline resolution. Also, as 
the solution pH is increased the peaks for the C2 and the C4 protons of the imidazole 
rings of His27 and His31 move upfield, due to the deprotonation of the imidazolium 
ion. 
The pH titration above was conducted in 10% D2O/ H2O at 25oC and although there 
are significant pH-dependant chemical shift changes, they proved to be quite difficult 
to track, due to the crowded amide N-H region. So, in order to only observe the desired 
NMR resonance signals the sample was prepared in pure D2O (Figure 96). 
 
Figure 96: 1H NMR spectral comparison of nisin A in pure D2O and 10% D2O/ 
H2O 
The change to pure D2O allows for complete hydrogen to deuterium exchange of the 
amide N-Hs of the peptide backbone to occur, leading to the disappearance of these 
peaks in the 1H NMR spectra (Figure 96). This allowed for convenient tracking and 
observation of changes to the chemical shifts of the relevant imidazole C-H protons, 
which are resolved from each other as seen in Figure 96.239 
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 Deuterium Isotope Effect on pH measurements 
As the examination and determination of the pKa of the histidine side-chain was 
studied in neat D2O solutions, the effect of the deuterium isotope needs to be taken 
into account. The presence of deuterium gives the heavy water slightly different 
properties to its hydrogen counterpart, which impacts on the measurement of pH in 
deuterium oxide solutions.240 The differences in the measured pH in both solutions 
stems from the variation in the auto-ionisation constant (Kw) of H2O and D2O at 25oC, 
in which the deprotonation forms a hydroxide ion due to its amphiprotic nature.241, 242 
Eqn 1         pH + pOH = 14.000 
For H2O, pKwH = 13.995 
For D2O, pKwD = 14.951 
Since pH = ½ pKw 






This gives rise to a separate pD scale when measuring the pH/D of a solution in heavy 
water. For our pKa determinations the Gross–Butler–Purlee theory was used, based on 
the different activities of the H+ and D+ ions. So, if using a pH meter calibrated using 
pH buffers in H2O, there is a simple relationship to correlate pH to pD.243,244 
Eqn 2    pD = meter reading + 0.44 
So, for the pD NMR titrations to determine the pKa of the histidine side-chain, the 
results obtained will take into account the effect of the deuterium isotope, for the 
conversion of pD to pH, i.e. pH = pD – 0.44, in order to correlate the pKa in D2O to 
its H2O counterpart. 
 Effect of Ionic Strength on pKa value 
As the pD NMR titrations of nisin A and Z will be used to determine the specific pKa 
of each imidazole of the histidine side-chains, the ionic strength of the aqueous 
solution is also of paramount importance. Without taking the ionic strength of the 
aqueous solution into account, the results would be reported as a ‘practical’ or 
‘conditional’ pKa, denoted as pKa′.243  This is defined within the Debye-Hückel theory, 
in which solutions that contain ionic solutes do not behave ideally.245 The presence of 
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ionic species in solution can affect the pKa. In the case of acetic acid, the pKa is 
lowered due to the stabilisation of the charged species resulting from the proton 
dissociation. Conversely, for acids such as Et3N+H, pyridinium or imidazolium, the 
protonated nitrogen is favoured and stabilised by the ionic species in solution, and so 
is more difficult to deprotonate, thus increasing the pKa.243,246 The ionic strength can 
be calculated by the summation shown in equation 3, where ci is the concentration of 
each ion type and z is its charge.247  
Eqn 3            I = 1
2
∑(𝑐𝑐𝑖𝑖𝑧𝑧2) 
Taking this summation into account, for simple salts such as NaCl, KCl, etc., their 
molar concentration is equal to the ionic strength of the solution. To account for the 
ionic effect on pKa, a modification of the Debye-Hückel equation is used, which takes 
into account the ionic strength, charge type and temperature of the experiment.248 
Equation 4 does not include temperature explicitly, with the contains value varying 
with temperature (A is a constant at a particular temperature, and is 0.512 at 25oC). 




The pD NMR titrations, which follow in this chapter, were conducted using a 0.5 mM 
solution of compound in pure D2O, with DSS in D2O in a reference tube separate to 
the sample, and in the presence of NaCl (50 mM) in order to keep the ionic strength 
of the solutions constant, at 25oC. Using the described sample preparation, the ionic 
strength correction can be determined to calculate/ convert to the thermodynamic pKa, 













As the ionic strength effect on pyridinium- and imidazolium-type acids is known to 
increase the pKa, the correction of 0.088(4) is subtracted from the pKa′ to obtain the 
thermodynamic pKa at 25oC and zero ionic strength.241 
 1H NMR pD titration of imidazole to determine its pKa 
A validation of the described published methods of utilising NMR spectroscopy to 
determine specific pKa values is desirable, especially for protons contained within 
peptides and proteins can be difficult to determine using conventional titration 
techniques, due to their complex nature. 1H NMR chemical shifts are exquisitely 
sensitive to local ionisation events and serve as excellent reporters in pH titrations, 
and so are widely utilised.249,250 The side-chain of histidine contains an imidazole 
moiety with the chemical shift movements in each case comparable to those of His 
residues in nisin A and Z. So, imidazole itself was studied to validate the use of NMR 
spectroscopy to determine the pKa of the side-chains of the histidine residues of nisin 
A and Z. The acid dissociation constant for the imidazolium ion was determined in 
deuterium oxide (D2O) using a 0.5 mM solution of imidazole, in 50 mM NaCl at 25oC.  
The NMR titration was performed using individual NMR samples for each different 
pD measurement in the experiment, to ensure that a consistent concentration of analyte 
is present among samples throughout the pD titration.  
The 1H NMR spectral stack of imidazole in pure D2O at pD 2.34 and 9.19 is presented 
in Figure 97, highlighting the upfield movement of both the C2 and C4 protons as a 




Figure 97: 1H NMR spectral stack of imidazole pD 9.19 (top) and 2.34 
 
The data obtained from the pD NMR titration of imidazole was used to generate the 
titration curves shown in Figure 98, by plotting the pD of the each NMR tube sample 
versus the 1H chemical shift of both the C2 and C4 protons of the imidazolium/ 
imidazole ring.  
 

































Table 32 shows the pD-dependant NMR chemical shifts of the imidazole C4 proton. 
The ratio of protonated to deprotonated imidazole species in solution are also 
presented as pKa, based on each proton’s chemical shift, in acidic or basic aqueous 
media. The XB and XBH+ are determined by the ratio of the chemical shift of the proton 
in the most acidic solution relative to its chemical shift in base, with the pKa calculated 
using the Henderson-Hasselbalch equation. 
Measured 
pD 
Chemical Shift of 





2.34 7.4733  ~0 ~1 N/A 
2.95 7.4712  0.006 0.994 (5.17) 
3.32 7.4736  0.000 1.000 (5.17) 
3.61 7.4721  0.003 0.997 (6.07) 
3.99 7.4731  0.001 0.999 (7.23) 
4.20 7.4730  0.001 0.999 (7.27) 
4.53 7.4730  0.001 0.999 (7.60) 
4.70 7.4737  0.000 1.000 (7.62) 
5.12 7.4719  0.004 0.996 (7.52) 
5.66 7.4679  0.015 0.985 (7.46) 
5.88 7.4669  0.018 0.982 (7.61) 
6.28 7.4604  0.037 0.963 (7.70) 
6.48 7.4499  0.067 0.933 (7.62) 
6.95 7.4215  0.148 0.852 (7.71) 
7.00 7.4212  0.149 0.851 7.76 
7.51 7.3461  0.364 0.636 7.75 
7.80 7.2836  0.542 0.458 7.73 
8.20 7.1943  0.797 0.203 7.61 
8.39 7.1868  0.819 0.181 7.73 
8.87 7.1464  0.934 0.066 7.72 
9.19 7.1234  ~1 ~0 N/A 
Table 32: 1H NMR pD titration monitoring the C4 proton of imidazole 
 
The change in the observed chemical shift of the C2 proton was also used to determine 
the pKa′ of the imidazolium N-H. The change in the proton chemical shift was used to 
determine the pKa using the Henderson-Hasselbalch equation, shown in equation 5 
(below), where the chemical shift relative to the most acidic and basic solutions were 
used to determine the ratio of protonated and deprotonated species in solution to 




Eqn 5   pKa = 𝑝𝑝𝑝𝑝 + log � 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝𝑝𝑝 𝑠𝑠𝑝𝑝𝑝𝑝𝑠𝑠𝑖𝑖𝑝𝑝𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝𝑝𝑝 𝑠𝑠𝑝𝑝𝑝𝑝𝑠𝑠𝑖𝑖𝑝𝑝𝑠𝑠� 
For example the imidazole solution at pD 6.95, the imidazole pKa can be calculated 
for the solution, using equation 5. At this solution pD is shows that the imidazole is 
mainly in its protonated imidazolium form (~85%). 
pKa = 6.95 + log �0.8520.148� 
pKa = 6.95 + log(5.756) 
pKa = 7.71 
The determined pKa′ in D2O, based on the chemical shift changes of each proton are 
in close agreement. Shown in Table 33 are the pKa′ and pKa values of the imidazolium 
N-H in both D2O and H2O media. These values were obtained using the calculated 
ionic strength and deuterium isotope effect on pH and pKa, as discussed in Section 
5.2.1 and 5.2.2. 
As the experiment was conducted in pure D2O, the determined pKa′ corresponds to the 
conditional pKa′ in NaCl 50 mM. So, for the thermodynamic pKa the ionic strength 
effect needs to be subtracted, i.e. 0.088, to give the pKa of the imidazole at zero ionic 
strength. Also shown on the right in Table 33 are the pKa′ and pKa of the imidazolium 
in H2O, which is determined by subtracting the deuterium isotope effect of 0.44. 





















Table 33: Determined pKa′ and pKa using the C2 and C4 protons of imidazole 
 
Following on from the pKa determination, the average Ka value for the C2 and C4 
protons was taken for each different medium, then converted to determine the both 
pKa′ and the thermodynamic pKa (Table 34). This shows the average pKa′ and pKa of 











e pKa′ D2O (NaCl) 1.90 x10
-8 7.72 
pKa D2O (Thermodynamic) 2.35 x10-8 7.63 
pKa′ H2O (NaCl) 5.25 x10-8 7.28 
pKa H2O (Thermodynamic) 6.46 x10-8 7.19 
Table 34: Average Ka and pKa values for imidazole N-H 
 
 1H NMR pKa determination of imidazole side-chains of His27 and His31 
of nisin A in pure D2O 
In a similar fashion to the pKa determination of imidazole, a pD NMR titration of nisin 
A was conducted to determine the pKa of each imidazolium N-H of the histidine side-
chains. The experiment was conducted using 0.5 mM of nisin A and 50 mM NaCl in 
D2O. Again, each pD data point was prepared as an individual NMR tube sample to 
avoid changes in sample concentration on pH adjustment. The chemical shift of the 
C2 and C4 protons of both His27 and His31, measured at different solution pD values 
were used to construct the titration curves, with the pD titrations conducted in 
triplicate, by performing three independent titrations. The 1H NMR pD titration of 
nisin A is in Figure 99, showing the upfield movement of the C2 and C4 protons of the 
His27 and His31 imidazole rings. The measurement of the pH was conducted using a 
Hamilton-Spintrode pH Electrode, 180 mm x 3 mm. with a required immersion depth 
of 7mm. calibrated in H2O, so conversion of the measured pH to its pD value was done 




Figure 99: Nisin A pD NMR titration in D2O, 50 mM NaCl (pD 2.06-8.30) at 25oC
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There is significant change to the signal for the vinyl protons of Dha33, where the two 
previously overlapping vinyl protons at 5.69 ppm are resolved into two distinct 
resonance signals at higher pH values (between pH 5 and 6). This shows that the 
change in the solution pH has a significant affect on the local chemical environment 
of the Dha33 residue. 
 
Figure 100: 1H NMR pD titration curve of the His31 C4 proton of nisin A 
 
Figure 100 shows the constructed pD titration curve for the His31 residue using the 
imidazole C4 proton. The basic region of the curve in typical titration experiments 
would usually plateau showing the point of full deprotonation. Due to the solubility 
issues associated with nisin in pH/D systems at pH 6 and higher, it proved extremely 
difficult to obtain data above pD 8.7, even after reducing the concentration of the nisin 
used in the NMR titration from 3 mM to 0.5 mM. Regardless of the solubility issues 
encountered during the pD NMR experiments, three independent 1H NMR titrations 











































2.06 7.288  ~0 ~1 N/A 
2.29 7.288  ~0 ~1 N/A 
2.55 7.288  ~0 ~1 N/A 
2.88 7.285  0.009 0.991 (4.91) 
3.09 7.285  0.009 0.991 (5.12) 
3.51 7.280  0.025 0.975 (5.10) 
3.60 7.280  0.025 0.975 (5.19) 
3.93 7.277  0.034 0.966 (5.38) 
4.24 7.276  0.037 0.963 (5.65) 
4.70 7.271  0.053 0.947 (5.95) 
4.94 7.269  0.059 0.941 (6.14) 
5.19 7.259  0.090 0.910 (6.19) 
5.62 7.247  0.127 0.873 (6.46) 
5.94 7.232  0.174 0.826 (6.62) 
6.21 7.213  0.233 0.767 6.73 
6.40 7.204  0.2609 0.739 6.85 
6.61 7.171  0.3634 0.637 6.85 
6.93 7.121  0.5186 0.481 6.90 
7.35 7.088  0.6211 0.379 7.14 
7.56 7.034  0.7888 0.211 6.99 
7.81 7.004  0.8820 0.118 6.94 
8.30 6.966  ~1 ~0 NA 
Table 35: pD NMR titration of imidazole C4 proton of His31 of nisin A (0.5 mM) 
 
Table 35 shows the results of one of the NMR titrations, for the imidazole C4 proton 
of His31, using the change in chemical shift to determine the ratio of protonated to 
deprotonated species in solution. The pD NMR titrations were conducted in triplicate, 
to obtain the average side-chain pKa for both His27 and His31 residues present in nisin 
A.  
These results (Table 35) show the determined pKa′ values for both the C2 and C4 
protons of the imidazole ring. Using the previously discussed deuterium isotope and 
ionic strength effect corrections on the determined pKa, the pKa′ and pKa are reported 













T1 6.96 1.10 x10-7 6.87 1.35 x10-7 6.52 3.02 x10-7 6.43 3.72 x10-7 
T2 6.95 1.12 x10-7 6.86 1.38 x10-7 6.51 3.09 x10-7 6.42 3.80 x10-7 
T3 6.94 1.15 x10-7 6.85 1.41 x10-7 6.50 3.16 x10-7 6.41 3.89 x10-7 
Average 6.95 1.12 x10-7 6.86 1.38 x10-7 6.51 3.09 x10-7 6.42 3.80 x10-7 
His27 
C4 
T1 6.96 1.10 x10-7 6.87 1.35 x10-7 6.52 3.02 x10-7 6.43 3.72 x10-7 
T2 6.94 1.15 x10-7 6.85 1.41 x10-7 6.50 3.16 x10-7 6.41 3.89 x10-7 
T3 6.94 1.15 x10-7 6.85 1.41 x10-7 6.50 3.16 x10-7 6.41 3.89 x10-7 
Average 6.95 1.13 x10-7 6.86 1.39 x10-7 6.51 3.11 x10-7 6.42 3.83 x10-7 
His31 
C2 
T1 6.93 1.17 x10-7 6.84 1.45 x10-7 6.49 3.24 x10-7 6.40 3.98 x10-7 
T2 6.91 1.23 x10-7 6.82 1.51 x10-7 6.47 3.39 x10-7 6.38 4.17 x10-7 
T3 6.89 1.29 x10-7 6.80 1.58 x10-7 6.45 3.55 x10-7 6.36 4.37 x10-7 
Average 6.91 1.23 x10-7 6.82 1.51 x10-7 6.47 3.39 x10-7 6.38 4.17 x10-7 
His31 
C4 
T1 6.90 1.26 x10-7 6.81 1.55 x10-7 6.46 3.47 x10-7 6.37 4.27 x10-7 
T2 6.88 1.32 x10-7 6.79 1.62 x10-7 6.44 3.63 x10-7 6.35 4.47 x10-7 
T3 6.88 1.32 x10-7 6.79 1.62 x10-7 6.44 3.63 x10-7 6.35 4.467 x10-7 
Average 6.89 1.30 x10-7 6.80 1.60 x10-7 6.45 3.58 x10-7 6.36 4.40 x10-7 




Table 36 shows the determined pKa values for His27 and His31 of nisin A. The 
experiments were conducted in triplicate (T1, T2, T3, with the %relative stand 
deviation calculated to be 2.3% RSD) and were found to be reproducible, with the 
resulting pKa values in close agreement. In each case, both the C2 and C4 protons of 
the imidazole ring were used in each pD titration to give the average pKa′ values. The 
determined pKa′ was then converted to a Ka value to ensure that there was not an 
exaggeration of errors due to the logarithmic nature of the pKa values reported. Taking 
into consideration the effect of both ionic strength and deuterium on the measurement 
of pKa′, using the corrections described previously in Section 4.2.1 and 4.2.2, both the 
average conditional pKa′ and thermodynamic pKa values can be reported in both H2O 
and D2O solution environments (Table 37). 
Determined at 25oC Average Ka  





pKa′ in D2O (50 mM NaCl) 1.13 x10-7 6.95 
pKa in D2O (Thermodynamic) 1.39 x10-7 6.86 
pKa′ in H2O (50 mM NaCl) 3.10 x10-7 6.51 
pKa in H2O (Thermodynamic) 3.82 x10-7 6.42 
Histidine 
31  
pKa′ in D2O (50 mM NaCl) 1.26 x10-7 6.90 
pKa in D2O (Thermodynamic) 1.56 x10-7 6.81 
pKa′ in H2O (50 mM NaCl) 3.48 x10-7 6.46 
pKa in H2O (Thermodynamic) 4.29 x10-7 6.37 
Table 37: Imidazolium N-H pKa′ and pKa values of His27 and 31 of nisin A 
determined using their average Ka values at 25oC 
The determined average pKa′ and pKa are displayed in Table 37 and are reported for 
several solution environments at 25oC. Interestingly there is a difference in the 
observed pKa of His27 and His31 with the conditional pKa′ values in H2O determined 
to be 6.51 and 6.46, respectively. The difference in the two pKa values could be due 
to interactions with the flanking AA residues, with the His27 contained in the nisin E-




 Calculation of the side-chain imidazole N-H pKa of both His27 and 
His31 of nisin A at 38oC 
If nisin is to be utilised as a therapeutic agent, it is also important to estimate the pKa 
of these histidine residues near the physiological temperature of 38oC. The effect of 
changing the solution temperature from 25oC to 38oC can be accounted for using a 
temperature correction for the imidazole. For most acids the dissociation process is 
endothermic, so according to Le Châtelier's Principle as heat is applied to an 
endothermic process the equilibrium is shifted to the right. Therefore, at higher 
temperatures the Ka increases, subsequently lowering the pKa.251  
The correction for increasing temperature of an imidazole functional group has been 
stated that “for every 1oC increase in the solution temperature the pKa of an imidazole 
is lowered by 0.020”.243 So a change from 25oC to the physiological temperature of 
38oC, would lower the pKa of each histidine imidazole by 0.26 units (12 x 0.020 = 
0.260).243 
This change in temperature would also alter the effect of ionic strength on the 
determined pKa′ values. The ionic strength correction can be recalculated, changing 









= 0.095(7) − 0.0050 
= -0.090 
The subtraction of the ionic strength effect (-0.090) and the solution temperature effect 
at 38oC (-0.260), gives an overall correction of -0.351 units. Incorporating these 
corrections, the results for the imidazole pKa values of His27 and His31 in nisin A are 
shown in Table 38.  
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T1 6.70 1.20 x10-7 6.61 2.46 x10-7 6.26 5.50 x10-7 6.17 6.76 x10-7 
T2 6.69 2.04 x10-7 6.60 2.51 x10-7 6.25 5.62 x10-7 6.16 6.92 x10-7 
T3 6.68 2.09 x10-7 6.59 2.57 x10-7 6.24 5.75 x10-7 6.15 7.08 x10-7 
Average 6.69 2.04 x10-7 6.60 2.51 x10-7 6.25 5.62 x10-7 6.16 6.92 x10-7 
His27 
C4 
T1 6.70 1.20 x10-7 6.61 2.46 x10-7 6.26 5.50 x10-7 6.17 6.76 x10-7 
T2 6.68 2.09 x10-7 6.59 2.57 x10-7 6.24 5.75 x10-7 6.15 7.08 x10-7 
T3 6.68 2.09 x10-7 6.59 2.57 x10-7 6.24 5.75 x10-7 6.15 7.08 x10-7 
Average 6.69 2.06 x10-7 6.60 2.53 x10-7 6.25 5.67 x10-7 6.16 6.97 x10-7 
His31 
C2 
T1 6.67 2.14 x10-7 6.58 2.63 x10-7 6.23 5.89 x10-7 6.14 7.24 x10-7 
T2 6.65 2.24 x10-7 6.56 2.75 x10-7 6.21 6.15 x10-7 6.12 7.59 x10-7 
T3 6.63 2.34 x10-7 6.54 2.88 x10-7 6.19 6.46 x10-7 6.10 7.94 x10-7 
Average 6.65 2.24 x10-7 6.56 2.76 x10-7 6.21 6.17 x10-7 6.12 7.59 x10-7 
His31 
C4 
T1 6.64 2.29 x10-7 6.55 2.82 x10-7 6.20 6.31 x10-7 6.11 7.76 x10-7 
T2 6.62 2.40 x10-7 6.53 2.95 x10-7 6.18 6.61 x10-7 6.09 8.13 x10-7 
T3 6.62 2.40 x10-7 6.53 2.95 x10-7 6.18 6.61 x10-7 6.09 8.13 x10-7 
Average 6.63 2.36 x10-7 6.54 2.91 x10-7 6.19 6.51 x10-7 6.10 8.00 x10-7 
Table 38: Calculated Ka and pKa values for the imidazolium N-H of His27 and His31 of nisin A at 38oC, with T1-T3 referring to the 
individual titration experiments 
172 
 
Table 39 shows a summary of the extensive data presented for the calculated pKa 
values of nisin A at 38oC. 
Determined at 38oC Average Ka  





D2O (50 mM NaCl) 2.050 x10-7 6.69 
D2O (Thermodynamic) 2.522 x10-7 6.60 
H2O (50 mM NaCl) 5.646 x10-7 6.25 
H2O (Thermodynamic) 6.946 x10-7 6.16 
Histidine 
31  
D2O (50 mM NaCl) 2.302 x10-7 6.64 
D2O (Thermodynamic) 2.832 x10-7 6.55 
H2O (50 mM NaCl) 6.339 x10-7 6.20 
H2O (Thermodynamic) 7.799 x10-7 6.11 
Table 39: Imidazole pKa′ and pKa values of His27 and 31 of nisin A, determined 
using their average Ka at 38oC 
 
It is very important to calculate the pKa of the histidine residues at near physiological 
temperature, if nisin was to be used as a therapeutic agent, as the lowered pKa may 
significantly impact on its stability at this elevated temperature. Table 39 shows the 
calculated imidazolium N-H, pKa′ and pKa values for both His27 and His31, with the 
conditional pKa′ values in H2O determined to be 6.25 and 6.20, respectively.  The 
comparative results of the pKa values at 25oC and 38oC are shown in Table 40.  






pKa′ in D2O (50 mM NaCl) 6.95 6.69 
pKa in D2O (Thermodynamic) 6.86 6.60 
pKa′ in H2O (50 mM NaCl) 6.51 6.25 
pKa in H2O (Thermodynamic) 6.42 6.16 
Histidine 
31  
pKa′ in D2O (50 mM NaCl) 6.90 6.64 
pKa in D2O (Thermodynamic) 6.81 6.55 
pKa′ in H2O (50 mM NaCl) 6.46 6.20 
pKa in H2O (Thermodynamic) 6.37 6.11 
Table 40: Comparison of determined pKa values of the imidazolium N-H of His27 
and His 31 of nisin A at 25oC and 38oC 
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In comparison to the pKa determined at 25oC, at physiological temperature the pKa of 
the histidine side-chain is significantly lower at 38oC. The determined pKa′ lies within 
the pH range in which nisin is known to suffer a significant decrease in aqueous 
solubility, possibly due to the change in the overall polarity of the peptide above the 
histidine side-chain pKa. It can be seen in Table 40 that, at physiological pH (7.4), 
both histidine residues will predominantly be in the neutral form, at both temperatures.  
During the pH titration studies, it was found that it was in this pH range that there is a 
significant change to the signal of the Dha33 (C-H) residue in the 1H NMR spectra. In 
Figure 101, for pH 2-8, the Dha33 amide N-H signal moves slightly upfield and then 
subsequently disappears, while the amide N-H of the Dha5 remains constant over the 
same pH range. The C-H vinyl protons of the Dha33 residue showed the biggest 
change in appearance, moving downfield signifying a change in their local chemical 
environment and probably its conformation. It seems that the pH changes specifically 
affect one region of nisin (the tail region) but is very difficult to see any changes in 
other AAs due to the disappearance of the N-H signals at higher pH values. 
 
Figure 101: 1H NMR spectral stack of nisin A (0.5 mM) in pH range 2-8 in 10% 
D2O/ H2O at 25oC 
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This is the opposite to what was seen on the addition of salts, where the amide N-H of 
Dha5 moved upfield while the Dha33 remained relatively stable. This change in 
conformation could expose the Dha33 moiety and may promote its degradation. This 
implies that the salts affect one region (A- and B-rings), while the change in pH affects 
a different region (the tail region).  
It has been shown that at pH values around the pKa values of the His residues, there 
are significant changes to nisin A, which may compromise its stability. Since nisin is 
mainly used in the food industry and many foods are stored at lower temperatures (e.g. 
fridge at 4-7oC or freezers at -20oC), it is also important to investigate the changes in 
the side-chain imidazolium N-H pKa value. Using the calculated temperature 
correction, the pKa was calculated at a range of lower temperatures from +20 to -20oC, 
and the results are in Table 41. 
























pKa′ in D2O (50 mM NaCl) 6.95 7.05 7.15 7.25 7.35 7.45 7.85 
pKa in D2O (Thermodynamic) 6.86 6.96 7.06 7.16 7.26 7.36 7.76 
pKa′ in H2O (50 mM NaCl) 6.51 6.61 6.71 6.81 6.91 7.01 7.41 









pKa′ in D2O (50 mM NaCl) 6.90 7.00 7.10 7.20 7.30 7.46 7.80 
pKa in D2O (Thermodynamic) 6.81 6.91 7.01 7.11 7.21 7.31 7.71 
pKa′ in H2O (50 mM NaCl) 6.46 6.56 6.66 6.76 6.86 6.96 7.36 
pKa in H2O (Thermodynamic) 6.37 6.47 6.67 6.67 6.77 6.87 7.27 
Table 41: Calculated pKa values of the imidazole N-H side-chain of His27 and 
His31 of nisin A at low temperatures 
 
At lower temperatures the pKa of the imidazole is increased, for example at -20oC the 
pKa′ in H2O of the imidazole of His31 is increased by 0.90 units from 6.46 at 25oC to 
7.36 at -20oC (freezer storage). Quite how this change would impact on nisin A’s food 




 1H NMR pKa determination of His31 of nisin Z in neat D2O 
A similar study was also conducted for nisin Z, which contains only one histidine 
residue, His31 being located within the tail region of the peptide. The chemical shift 
data obtained from each of the individual 1H NMR experiments at each different pD 
value are presented in Table 42. 
Measured 
pD 






2.00 8.615   ~0 ~1 N/A 
2.30 8.613   0.003 0.997 (4.86) 
2.70 8.611   0.005 0.995 (5.04) 
2.80 8.610   0.005 0.995 (5.10) 
3.10 8.612   0.004 0.996 (5.54) 
3.48 8.609   0.006 0.994 (5.69) 
3.60 8.607   0.008 0.992 (5.67) 
3.90 8.606   0.009 0.991 (5.93) 
4.30 8.598   0.019 0.981 (6.02) 
4.64 8.598   0.019 0.981 (6.36) 
5.10 8.589   0.028 0.972 (6.64) 
5.30 8.577   0.040 0.960 (6.68) 
5.44 8.584   0.033 0.967 (6.91) 
5.90 8.505   0.117 0.883 6.78 
6.10 8.483   0.140 0.860 6.89 
6.50 8.439   0.187 0.813 7.14 
6.60 8.483   0.140 0.860 7.39 
7.07 8.175   0.466 0.534 7.13 
7.40 8.058   0.589 0.410 7.24 
7.69 7.005   0.773 0.227 7.16 
7.8 7.005   0.773 0.226 7.27 
8.30 6.966   0.894 0.106 7.37 
8.70 6.928   ~1 ~0 N/A 














T1 7.13 7.413 x10-8 7.04 9.120 x10-8 6.69 2.042 x10-7 6.60 2.512 x10-7 
T2 7.09 8.128 x10-8 7.00 0.0000001 6.65 2.239 x10-7 6.56 2.754 x10-7 
T3 6.97 1.072 x10-7 6.88 1.318 x10-7 6.53 2.951 x10-7 6.44 3.631 x10-7 
Average 7.06 8.752 x10-8 6.97 1.077 x10-7 6.62 2.411 x10-7 6.53 2.966 x10-7 
His31 
C4 
T1 7.08 8.318 x10-8 6.99 1.023 x10-7 6.64 2.291 x10-7 6.55 2.818 x10-7 
T2 7.10 7.943 x10-8 7.01 9.772 x10-8 6.66 2.188 x10-7 6.57 2.692 x10-7 
T3 6.95 1.122 x10-7 6.86 1.380 x10-7 6.51 3.090 x10-7 6.42 3.802 x10-7 
Average 7.04 9.160 x10-8 6.95 1.127 x10-7 6.60 2.523 x10-7 6.51 3.104 x10-7 
pKa at 38oC  
His31 
C2 
T1 6.87 1.349 x10-7 6.78 1.660 x10-7 6.43 3.715 x10-7 6.34 4.571 x10-7 
T2 6.83 1.479 x10-7 6.74 1.820 x10-7 6.39 4.074 x10-7 6.30 5.012 x10-7 
T3 6.71 1.950 x10-7 6.62 2.398 x10-7 6.27 5.370 x10-7 6.18 6.607 x10-7 
Average 6.80 1.593 x10-7 6.71 1.959 x10-7 6.36 4.386 x10-7 6.27 5.397 x10-7 
His31 
C4 
T1 6.82 1.514 x10-7 6.73 1.862 x10-7 6.38 4.167 x10-7 6.29 5.129 x10-7 
T2 6.84 1.445 x10-7 6.75 1.778 x10-7 6.40 3.981 x10-7 6.31 4.898 x10-7 
T3 6.69 2.042 x10-7 6.60 2.512 x10-7 6.25 5.623 x10-7 6.16 6.918 x10-7 
Average 6.78 1.667 x10-7 6.69 2.051 x10-7 6.34 4.591 x10-7 6.25 5.648 x10-7 




The pD NMR titration of nisin Z is shown in Appendix 79, showing pH/D dependant 
upfield movement of the C2 and C4 for His31, as the solution pD is changed from 2.3 
to 8.7. There is also significant change to the resonance signal associated with the 
vinyl C-H protons of Dha33, similarly to what was seen for nisin A. The two 
previously overlapping vinyl protons at 5.69 ppm are resolved at higher pD, into two 
distinct resonance signals, resembling the appearance of the Dha5. This is a possible 
indication of a conformational change within the tail region of nisin, more than likely 
due to the deprotonation of the imidazolium N-H of the His side-chain, with its pKa′ 
value in H2O determined to be 6.61. Therefore, it will substantially be in its 
deprotonated neutral form at physiological pH, for pH versus 7.4 (physiological) ratio 
would be ~6 B: 1 BH+. 
Determined at 25oC Average Ka  





pKa′ in D2O (50 mM NaCl) 8.956 x10-8 7.05 
pKa in D2O (Thermodynamic) 1.102 x10-7 6.96 
pKa′ in H2O (50 mM NaCl) 2.467 x10-7 6.61 
pKa in H2O (Thermodynamic) 3.035 x10-7 6.52 




pKa′ in D2O (50 mM NaCl) 1.630 x10-7 6.79 
pKa in D2O (Thermodynamic) 2.005 x10-7 6.70 
pKa′ in H2O (50 mM NaCl) 4.489 x10-7 6.35 
pKa in H2O (Thermodynamic) 5.522 x10-7 6.26 
Table 44: Imidazolium pKa′ and pKa value of His31 of nisin Z determined using 
the average Ka at 25oC and 38oC  
 
The determined pKa and Ka values for the His31 side-chain of nisin Z are quoted for 
both 25oC and 38oC. Interestingly, the pKa′ in H2O is higher than that determined for 
the His31 side-chain of nisin A, though it is not immediately clear as to why this is the 






Throughout the NMR studies it is apparent that although nisin A and Z have a very 
similar structure they do not behave in an identical manner. This is further confirmed 
by the differences in the determined pKa values of the His31 residues (Table 45). 
Determined at 25oC Nisin A Nisin Z 
Histidine 
31  
pKa′ in D2O (50 mM NaCl) 6.90 7.05 
pKa in D2O (Thermodynamic) 6.81 6.96 
pKa′ in H2O (50 mM NaCl) 6.46 6.61 
pKa in H2O (Thermodynamic) 6.37 6.52 
Table 45: Comparison of determined pKa values of the imidazole side-chain of 
His31 for both nisin A and Z at 25oC 
 
There is a significant difference in the determined pKa′ in H2O of 6.61 for nisin Z 
compared to 6.46 for nisin A, a difference of 0.15 units. The higher relative pKa of the 
His31 in nisin Z may be responsible for the slightly higher reported solubility of nisin 
Z at physiological pH.56 As for nisin A, the effect of lower temperatures on the 
determined pKa values were also calculated for nisin Z, and are presented as Table 46. 
 
























pKa′ in D2O (50 mM NaCl) 7.05 7.15 7.25 7.35 7.45 7.55 7.95 
pKa in D2O (Thermodynamic) 6.96 7.06 7.16 7.26 7.36 7.46 7.86 
pKa′ in H2O (50 mM NaCl) 6.61 6.71 6.81 6.91 7.01 7.11 7.51 
pKa in H2O (Thermodynamic) 6.52 6.62 6.72 6.82 6.92 7.02 7.42 
Table 46: Calculated pKa values of the imidazole N-H side-chain of His31 of nisin 




 Nisin-Metal Binding in physiological pH systems 
As previously stated, in physiological pH systems, nisin suffers from a dramatic 
decline in solubility and stability. Although its antimicrobial activity has been reported 
to remain the same, the solubility and stability of nisin are pH-dependent.195,252 
Therefore, methods for increasing the solubility of nisin while maintaining its solution 
stability are key, if nisin is to be used in human or veterinary medicine. As determined 
earlier, the pKa′ in H2O of the imidazole side-chain of His27 is 6.51 in nisin A, and 
the His31 is 6.46 and 6.61 for nisin A and nisin Z, respectively. These values lie within 
the region in which the solubility of nisin declines significantly. The deprotonation of 
the imidazolium N-H may play an important role in the conformational stability and 
solubility of nisin.  
There have been reports of nisin binding metals ions such as cobalt, iron and zinc, in 
attempts to increase its stability at physiological pH.253,254 Copper(II) is described as 
a “histidine-binding ion”, and in the presence of nisin A and Z may complex to the 
neutral imidazole side-chain of the histidine residues following deprotonation of the 
imidazolium N-H between pH ~5.5 and 7.0.255  This begs the question, could the 
binding of copper stabilise nisin from any pH-dependant degradation, while also 
incorporating a “bioactive” antibacterial copper ion? 256 
This complexation of the metal ion in solution may increase the solubility of both nisin 




 UV/vis wavelength scan (400-1000 nm) of copper(II) chloride 
A 3 mM solution of copper (II) chloride at pH 6.6 (green solution) was measured using 
a wavelength scan from 400-1000 nm. The green-coloured solution was expected to 
absorb in the visible region of the UV-Vis spectrum, as shown in Figure 102. The free 
copper in solution showed an absorbance for a d-d transition band, which can be seen 
between 800 and 900 nm. To confirm that the UV-Vis band between 800 and 900 nm 
is the Cu(II) ion in solution, the solution was serially diluted and as the concentration 
of Cu(II) is decreased there is a corresponding decrease in the intensity of the d-d 
transition band at 800-900 nm. 
 
Figure 102: UV/Vis wavelength scans of serial dilutions of the 3 mM solution of 
copper(II) chloride at pH 6.6  
 
 Nisin in the presence of copper(II) chloride 
To investigate the ability of both nisin A and Z to bind Cu(II) ions, initially a 3 mM 
solution of nisin A and Cu(II) chloride in a 1:1 molar ratio was prepared in 10 mL of 
water (pH 4.1). The solution was then adjusted to pH 6.6 with 0.1 M NaOH. It was 
noted that as the pH of the copper-containing nisin solution was increased to pH 6.6 
the colour of the solution changed from pale green to light blue. This is a likely 
indication of nisin binding to the Cu(II) ions. To confirm the binding, a UV-vis 
wavelength scan was conducted (Figure 103) which shows a band at 550 nm. This 
band was previously absent for solutions of both nisin A and copper(II) chloride alone, 




Figure 103: UV/Vis wavelength scan of nisin A and copper(II) chloride (1:1 molar 
ratio) at pH 6.6 
 
A serial dilution of the samples was conducted, while maintaining the solution pH 
value at 6.6, to ensure that the band was indeed associated with the prepared solution. 
Overall, Figure 103 shows that as the concentration of nisin and copper in the sample 
increases so too does the intensity of the corresponding absorbance band at 550 nm,  
confirming that it is a new species present in solution, with the nisin A binding the 
Cu(II) ion. The highest concentration possible in the study was a 0.3 mM solution of 
nisin A, as light scattering in the UV-vis spectrometer for higher concentration 








An identical set of experiments was also conducted for nisin Z in the presence of Cu(II) 
ions (Figure 104), which again shows binding of the Cu(II) ions in solution by nisin 
Z. 
 
Figure 104: UV/Vis wavelength scan of Nisin Z and copper(II) chloride (1:1 
molar ratio) at pH 6.6  
 
The 0.3 mM sample of nisin Z in the presence of copper is interesting, as the maximum 
absorbance at 550 nm is more pronounced, when compared to the nisin A copper-




 UV-vis pH Titration of Nisin in the presence of Copper (II) ions 
Both nisin A and Z bind Cu(II) ions at pH 6.6; however, the UV-Vis experiments as 
outlined do not give any insight into the pH-dependant nature of the binding 
interaction. In order to investigate the effect of the solution pH on the binding 
capability of nisin A and Z, a UV-vis pH titration was conducted, in the pH range of 
4.0-7.1. 
 
Figure 105: UV-Vis pH titration (pH 4.0-7.1) of nisin A (0.3 mM) in the presence 
of Cu(II) ions 
 
Figure 105 shows the results, where the absorbance band at 550 nm is absent in the 
spectra for the solutions with pH values below 5 but can be seen at pH 5.4. As the pH 
of the solution is increased to pH 6 and above, the intensity of the absorbance band at 
550 nm also increases. This shows that as the pH approaches the determined pKa 
values of the two histidine residues, there is evidence of copper binding. As the 
solution pH is increased to physiological (pH) the colour of the nisin solution also 
changes from green to blue, another indication of copper binding.  
It was seen previously that for nisin A alone, in solutions above pH 6, it usually 
precipitates out of solution, due to its low solubility. However, in the presence of 
Cu(II) ions in solution, there was no observed precipitate formed between pH 6.0 and 
7.1 for nisin A. It may be the case that the binding of Cu(II) to the neutral imidazole(s) 
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mimics the “polarity” of the imidazolium ion, thus keeping the nisin A in solution at 
pH values close to, and above, the pKa value. 
A similar pH titration for nisin Z was conducted in the pH range of 4.1-7.0 (Figure 
106). 
 
Figure 106: UV-Vis pH titration (pH 4.0-7.1) of nisin Z (0.3 mM) in the presence 
of Cu(II) ions 
 
Figure 106 shows that there is a slight difference with the band at 550 nm present at 
pH 6.1 and above. There are differences observed between the nisin A and nisin Z pH 
titrations, with nisin A binding the Cu(II) ion at pH 5.4, while the solution of nisin Z 
at pH 5.5 showed little noticeable change. Nisin A contains two histidine imidazoles 
to bind the Cu(II), while nisin Z only contains one, so perhaps nisin A can attain a 
geometry in which both of the imidazole side-chains can bind a single Cu(II) ion. This 
may be a stronger binding interaction, promoting the formation of the nisin-copper 
complex. The histidine side-chain pKa values for nisin A are lower in comparison to 
nisin Z, and may aid binding of the Cu(II) ions at lower pH values. Both nisin A and 
nisin Z exhibit Cu(II) binding at pH 7 meaning they would both have copper bound at 
physiological pH. Nisin may also help keep the Cu(II) in solution at higher pH, where 
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OH- can precipitate Cu2+ as Cu(OH)2, i.e. complex mutually solubilises both nisin and 
copper in solution. 
 Stability of the binding of copper(II) by nisin as the pH varies 
The pH value of the nisin A and Cu(II) solution (1:1 ratio of 0.3 mM) was adjusted 
and cycled back and forth between pH 4.0 and 6.9, using HCl and NaOH (0.1 M) to 
assess the stability of the nisin A: Cu(II) interaction, after its formation at pH 6.9. The 
results of this pH cycling experiment are shown in Figure 107. 
 
Figure 107: Nisin A and copper(II), pH cycling between pH 4.0 and 6.9 
 
As the pH of the solution was the adjusted back to pH 4.0 using 0.1 M HCl, the UV-
vis absorbance band at 550 nm disappeared in the spectrum. The process of cycling 
the pH value of the solution between pH 4.0 and 6.9 was repeated. Each time the pH 
of the solution was adjusted to pH 6.9 using 0.1 M NaOH, the absorbance band at 550 
nm was present, but absent at pH 4.0.  
The pH-cycling of the copper-containing nisin A solution not only confirmed again 
the pH-dependant nature of the metal binding, but also that this is a reversible process. 
Nisin A binds the Cu(II) ions in solution at physiological pH, but is not at pH 4.0, 
showing that the presence of acid eliminates complexation. This reversible process 
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could be considered as the Cu2+ and H+ competing for the histidine site(s). The nisin-
H+ binding equilibrium will be fast (diffusion-controlled i.e. essentially 
instantaneous). The nisin-Cu2+ binding equilibrium would also be expected to be fast 
(in both directions), so the overall nisin (Cu2+/H+) equilibria are expected to be rapidly 
established and freely reversible. 
The same pH cycling experiment was also conducted for the copper-containing nisin 
Z solution, again cycling between pH 4.0 and 6.9. Figure 108 shows that nisin Z acts 
in a similar way to nisin A.  
 
Figure 108: Nisin Z and Copper(II), pH cycling between pH 4.0 and 6.9 
 
The observed interaction and binding of the copper (II) ion has been shown not only 
to be pH-dependant, but it also acts as a possible pH-dependant molecular switch.257 
This is indicated by the copper binding displaying pH dependence that can alternate 





The exact mode of binding of copper by both nisin forms is not known from the UV-
vis analysis. However, the effect on the increased solubility visible at physiological 
pH, of both nisin A and Z, by binding to Cu(II) is very interesting and would merit a 
further in-depth investigation.  
Figure 109 shows the effect of the concentration of Cu(II) in solution in relation to a 
constant nisin concentration (0.3 mM) at pH 6.9. The lower Cu(II) concentration of 
0.003 mM at pH 6.9 shows the light being scattered in the UV-vis spectrometer for 
nisin A as it precipitates near physiological pH. However, as the concentration of 
Cu(II) in solution is increased, the UV band at ~550 nm is observed, and the light 
scattering is greatly reduced. A similar result was found for nisin Z (see Appendix 70). 
 
Figure 109: Nisin A (0.3 mM) copper(II) titration at pH 6.9 
 
For the solutions containing a copper concentration of 0.15 mM and above, at pH 6.9 
there is no precipitation observed. This is very encouraging and confirms that after 
binding the Cu(II) ion in solution, there is an apparent increase in the solubility of both 




 Chapter Conclusions 
Based on the pH NMR titrations of both nisin A and Z, there were significant changes 
observed for the peak at 5.6 ppm of the vinyl protons of the Dha33 residue of both 
nisin species A and Z. As the pH of the solution environment was increased, a change 
in appearance of this signal was observed, from an overlapping single peak to two 
distinct peaks at pH ~6 and above. This could be an indication of a change in nisin’s 
conformation in solution, mainly within the tail region of the peptide as few other 
notable changes have been observed as a consequence of changing the pH.  
The two histidine residues in nisin A, and one in nisin Z, were of interest as it was 
thought that their pKa values lie within this pH region (pH 6-7). 1H NMR spectroscopy 
was used to measure the pD-dependant upfield movement of the chemical shifts of 
both the C2 and C4 protons of the histidine residues’ imidazole rings. The relevant 
side-chain pKa′ values in H2O were determined at 25oC in 50 mM NaCl and for His 
27 side-chain pKa′ value of nisin A was determined to be 6.51, while the side-chain 
pKa values of His31was determined to be 6.46 and 6.61 for nisin A and nisin Z, 
respectively. Interestingly the pKa value of the His31 residue in nisin Z is higher that 
its nisin A counterpart.  However, at physiological pH the determined pKa values show 
that histidine residues would be mainly in their neutral deprotonated state.  
As the tail region of nisin is directly involved in its antimicrobial mechanism of action, 
the indication that there is a conformational change in this region could potentially 
affect its activity. Also the deprotonation of the histidine residues is likely to be partly 
responsible for the decline in the aqueous solubility, due to the overall change in the 
number of charged AA residues within the nisin peptide structures, at pH values of 6 
and above. 
Regarding the use of nisin for therapeutic applications, if its application is for internal 
use then nisin would be circulating in the bloodstream at pH ~7.4 and at 38oC, or if 
for an external application the pH and temperature of the environment will differ 
greatly. Therefore, it is important to also study the impact of a change in temperature 
on both nisin species. As presented the pKa′ values of the histidines were determined 
to be significantly lower at higher temperature, with the temperature correction 
determined to be -0.26. The adjusted pKa′ value at 38oC for the His27 in nisin A was 
determined to be 6.25, and for the His31 in both nisin A and Z was determined to be 
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6.20 and 6.35 respectively. So, at body temperature and physiological pH the 
histidines will be even more substantially in their neutral deprotonated form. 
The Dha33 residue is implicated in the degradation of nisin A and Z at physiological 
pH, due to its breakdown and cleavage at pH 7 and above. The Dha33 residue is most 
stable at lower pH values of 3-4. From the pH studies using 1H NMR spectroscopy 
there was a significant change associated with signals for the two vinyl C-H protons 
of Dha33 at higher pH, so its stability at acidic pH values may be as a result of it being 
“protected” in some way. Therefore, at higher pH values, a conformational change 
may cause the Dha33 to become more susceptible to breakdown and cleavage. As was 
observed in Chapter III, Dha-containing peptide fragments, which also contained a 
His AA residue, showed lower stability at pH 7, which may be a result of the change 
in the conformation of the tail fragment of both nisin A and Z. 
Both nisin A and Z have also shown the ability to bind copper(II) ions in solution in 
pH systems above pH 5.5, by UV-vis spectroscopy. This metal-binding ability of nisin 
appears to involve the deprotonated neutral imidazole ring of the histidine residues 
contained within nisin. The binding of the copper(II) ion also increases the solubility 
of nisin at pH 6 and above, as the metal binding overcomes the precipitation of nisin 
A and Z in this pH range. The pH-dependant binding interaction of nisin A and Z to 
Cu(II) is reversible, as shown by pH cycling experiments, by changing the pH from 
4.0 to 6.9, and then back and forth. This may be useful as the binding acts as a pH or 
molecular switch. 
The investigation of both species of nisin A and Z in different pH environments may 
be a starting point in the understanding of the possible changes to their conformations 
in solution. These changes may well be the reason for the decline in the solubility and 
stability in neutral pH systems, as well as aiding the design of nisin analogues with 




 Future Work 
Further study of both nisin A and Z is required to investigate the pH-dependant 
changes in the solution conformation of the peptides. A variety of additional NMR 
spectroscopic techniques including 1D and 2D NOESY should be employed to 
investigate the changes in the solution conformation using through-space coupling 
rather than via atoms directly bonded to one another. These nOe constraints will aid 
in conformational modelling to determine the solution structures, as well as helping 
the study of interactions between amino acids and if there are any interactions 
disrupted as a result of the changing pH. In particular, studies of the interactions 
involving the Dha33 residue are important, as the resonance signal of this residue 
displayed significant changes as the pH/D of the aqueous solution was increased from 
2 to 8.  
Similarly, the study of the ability of nisin to bind metal ions should be further 
expanded to include other metals described as “histidine-binding ions”, which include 
nickel, cobalt, zinc and silver. Also, the exact mode of how nisin binds copper(II) ions 
should be investigated using mass spectrometry, to ascertain whether more than one 
nisin molecule is participating in the metal binding. This will aid in the study of the 
stability/ reactivity and conformations of both nisin A and Z. The isolation of the nisin-
metal complexes would allow for both their structural analysis and for evaluation of 
their biological activities (if any), compared to nisin A and Z alone. As the pH of the 
solution changes, it is also important to determine the exact species of copper ion 
present in each pH system, possibly using pH potentiometry studies to distinguish the 
different metal species that could be involved in binding nisin. This may also provide 
additional insight into the mode of copper binding by both nisin A and Z. 
It would also be interesting to study nisin in the presence of copper and metal ions at 
physiological pH using CD spectroscopy. It is reported that the CD spectrum of nisin 
changes with pH, due to conformational changes. As the solubility of nisin was 
increased at physiological pH in the presence of copper, a key question is whether the 
resulting nisin-metal complexes maintain the charge and conformation of nisin (A and 



















  Synthesis and stability studies of nisin tail fragment analogues 
The use of SPPS allowed for the successful incorporation of a Dha moiety into a target 
peptide, on a Wang resin, using a masked serine by a selective dehydration step, via a 
mesylate intermediate. The formation of the Dha moiety on the resin did not convert 
the serine to a Dha completely, so both the serine and Dha analogues were isolated by 
semi-preparative HPLC. Although the synthesis of several Dha-, Ser- and AC3C-
containing peptides were successful, and the synthesis of the native nisin tail was 
shown to be present by HRMS, its purification nevertheless proved extremely difficult 
resulting in the isolation of only 4 mg of a very impure compound. This degraded 
rapidly prior to characterisation and stability examination (32% purity). 
The series of tetra-, penta- and hexa-peptides described in Chapter II were then used 
to examine the impact of changing the AA residues on the stability of the tail 
fragments. It is quite clear from these stability studies of the peptide tail fragments that 
significant differences were observed. The tetrapeptide 69, which contained a Dha 
moiety, broke down instantly at pH 3, while it was stable at both pH 5 and 7. In 
comparison, for the Dha-containing pentapeptide 71, the elongation of the tail to 
include an isoleucine residue increased the stability at pH 3, showing that the 
isoleucine may play a role in protecting the tail from degradation in acidic pH 
environments.  
Interestingly, there were significant effects on the peptide stability when changing the 
charged AA residues. Pentapeptide 73, which contains a histidine in the place of a Lys 
residue, displayed lower stability at pH 7 compared to pentapeptide 71, while 
maintaining stability at lower pH values. Interestingly, replacement of His with a Lys 
residue showed greater stability at pH 7, but was compromised at pH 3. The stability 
studies highlighted the importance of the side-chain pKa, with the Lys residues’ 
replacement proving to be more stable at physiological pH. The AC3C-containing 
hexapeptide was consistently stable across the full studied pH range. 
From the stability studies, the increased stability at physiological pH of both the di-
Lys-containing (present in Nisin H) and AC3C-containing peptides, may indicate them 
to be possible targets to study their activity with our collaborators in APC Microbiome 
Ireland at UCC.  
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 Effects of salts and polyoxygenated buffer components on nisin A 
and Z  
During the course of the NMR study of both nisin A and Z in the presence of various 
salt species, it became apparent that each nisin form behaves differently, depending 
on the identity of the salt, rather than just on the overall ionic strength of the solution.  
The addition of the salts seemed to alter the solution conformation of both nisin A and 
Z, with the largest effect being observed for the Dha5 residue. The interaction of salt 
at the A-ring of nisin may explain why nisin Z, in the presence of NaCl, is no longer 
active against Gram-negative bacteria.  
Using NMR spectroscopy, the effect of biological buffer components on both nisin A 
and Z was studied. In the presence of these polyoxygenated species, again there were 
chemical shift changes in the A-ring region of the peptides, with the largest change 
being for the amide N-Hs of both Dha5 and Leu6. The interaction, or binding of the 
buffer components, indicates that they may bind to the A-ring, possibly in a similar 
fashion in which nisin binds the pyrophosphate moiety of lipid II. So, the presence of 
these polyoxygenated species in solution may have an impact on the biological activity 
of nisin and also on its ability to bind the pyrophosphate component of lipid II. 
Many of the observed spectral changes are associated with the A- and B-ring regions 
of nisin, which are directly involved in the binding of lipid II. So the presence of 
polyoxygenated species in solution could potentially compete with the pyrophosphate 
in binding with the A and B-rings, possibly affecting its biological activity. This 
highlights that is in important to be conscious of not only the composition of the salts 
in solution, but also the buffers used in the antimicrobial testing of nisin and its 




  pH Studies of nisin A and Z 
Following on from the NMR studies of nisin in the presence of different salts and 
additives, the effect of pH was also studied. Using 1H NMR spectroscopy both nisin 
A and Z were studied in the pH range of 2.0-8.0, and it was found that as the solution 
pH was altered there were significant changes observed in the proton spectra. For the 
pH NMR titrations of both nisin A and Z, there were significant changes observed for 
the vinyl protons of Dha33 at 5.6 ppm. As the solution pH approached physiological 
pH, the vinyl protons which were superimposed at low pH became resolved. The 
significant change in the observed resonance signals for the two vinyl protons could 
be a strong indication of a conformational change in the tail region of both nisin A and 
Z. It is at pH 6, and above, that nisin shows a dramatic loss in its solubility and stability, 
which may stem from this change in solution conformation. 
The His27 side-chain pKa′ value was determined to be 6.42 in nisin A, while for His31 
the pKa′ values were determined in 50 mM NaCl, to be 6.46 and 6.61 for nisin A and 
nisin Z, respectively. As predicted the pKa values lie in the pH region where nisin 
suffers a drop in solubility, most likely due to the change in the overall polarity and 
charge of the peptides. It is interesting that the histidine-containing peptide tail 
fragments also have a lower stability, compared to lysine-containing peptide 
fragments. Based on the stability studies of the nisin tail fragments, retention of the 
charge side-chain at physiological pH may increase the stability of nisin at 
physiological pH, and broaden its possible applications and allow its potential use as 
a therapeutic agent. 
The ability of both nisin A and Z to bind copper(II) ions at pH values near and above 
the determined pKa values of histidine side-chains was very encouraging. The 
resulting nisin-copper complex also increased the solubility of nisin at physiological 
pH. The increase in solubility may be a result of retaining a charge in higher pH 
environments and could possibly enhance the biological activity of nisin, based on the 
metal ion used (copper, silver, iron or zinc). In addition to studying the effect of 
changing AA residues, the use of nisin-metal complexes may also be a method of 
increasing nisin’s potential therapeutic applications by also expanding activity to the 




The addition of salts, and changes to the solution pH, seemed to affect two different 
regions of both nisin A and Z. So, it would be interesting to study if these changes are 
additive. As nisin is used in the food industry, there could be significant changes in 
nisin’s bioactivity or stability as a result of the varying pH and salt content of different 
food types. Nisin is used across a wide variety of foods which are stored at different 
temperatures. From the pH study and the calculated changes to the histidine 
imidazolium N-H pKa values as a function of temperature, the conformational stability 
of nisin may vary depending on the temperature.  
In the literature nisin A and Z are used interchangeably, in the presence of different 
buffers and in different solution environments, but from our results it is clear that based 
on the salt type and buffer composition there are significant changes to both nisin A 
and nisin Z, changing biologically important regions of the peptide. Therefore, it is 
important not only to be conscious about the form of nisin used, but also the multitude 






















7.0  General experimental procedures 
All solvents used during both synthesis and purification, and salts used for NMR 
studies, which were purchased from VWR, Lennox or Sigma Aldrich. Petroleum ether 
40-60o was used for all purifications described, unless otherwise stated. Melting points 
(MP) were determined for solid samples using a Stuart Melting Point SMP30 
apparatus.  
NMR spectroscopy was performed using a Bruker Avance 500 MHz spectrometer, 
with chemical shifts reported in parts per million (ppm, δ). The instrument operated at 
500 MHz (1H NMR with a typical resolution of 0.28 Hz) and at 125 MHz (13C NMR 
with a typical resolution of 0.45 Hz). 1H NMR spectral assignments were aided with 
DEPT 90, DEPT 135, HH-COSY, HMBC and HSQC experiments. Tetramethylsilane 
(TMS) was used as an internal standard for all 1H and 13C NMR experiments unless 
otherwise stated. 
NMR analysis was conducted using, ultra-pure nisin A and Z (95% purity with the 
remainder mainly water) were purchased from Handary, and also in high ionic strength 
solutions, were conducted in 9:1 H2O: D2O (18.2 Mohm.cm H2O, D2O 99%) with all 
spectra acquired at 25oC (+/- 0.1oC), with the exception of VT NMR experiments. 1% 
w/v of DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) in pure D2O was used as a 
reference in an external capillary tube to the nisin solution. 640 scans were acquired 
for each 1H NMR experiment, using a BBFO (broadband fluorine observed) NMR 
probe. 
NMR studies in NUI Galway for the 1H-15N-HQSC spectra were conducted on an 
Agilent DD2 NMR 600 MHz 54mm ASC Spectrometer, triple resonance (TXI) 
equipped with a cryoprobe, using a 3 mM nisin concentration and 150 mM 
concentration of the salt under investigation. All samples were prepared in 10% 
D2O/H2O at 25oC and scanned for a 4-hour period with 1% w/v of DSS in pure D2O 
was used as a reference in an external capillary tube to the nisin solution. 
IR spectra were recorded on a Shimadzu IR Prestige-21 with 4 cm-1 resolution, over a 
frequency range of 600–4000 cm-1, in transmittance mode. Solid samples were 





Liquid Chromatography/ Mass Spectroscopy (LC/MS) were performed using an 
Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS, using the Mass Hunter 
software. Samples were dissolved in HPLC grade acetonitrile, with injection volumes 
between 0.5-2.0 μl, mobile phase of 10% acetonitrile, 70% water and 0.1% formic 
acid, with a flow rate of 0.2 mL/min. 
Semi-Preparative HPLC was conducted in the Department of Chemistry, Maynooth 
University, using a Gilson Semi-preparative HPLC system equipped with a VP-250/21 
Nucleosil 100-5 C18 Column, with a detector wavelength of 214 nm. A gradient flow 
of 5-20 % acetonitrile in water for 3 minutes and then plateaued for 20 minutes as 20% 
acetonitrile in water was used. The water and acetonitrile with 0.1% TFA used for the 
purifications was filtered and sonicated for 5 minutes prior to HPLC injection. The 
peptide-containing fractions were then freeze-dried overnight, affording fluffy-white 
solids. 
Thin Layer chromatography (TLC) was performed using Merck aluminium-backed 
sheets with silica gel 60 F254. Isolation of products using flash chromatography was 
on silica gel (0.040-0.063 mm, 230-400 mesh) purchased from VWR. 
Manual SPPS was conducted in a 25 mL CEM reaction vessel at room temperature. 
All AAs and resins were purchased from Iris Biotech GmbH. The SPPS resin was 
swollen in 5 mL of DCM for 30 minutes. The removal of the Fmoc protecting group 
was performed using 40% piperidine in DMF (double deprotection). The Fmoc 
removal was confirmed using ninhydrin stain to demonstrate the presence of the free 
amine. The coupling of amino acids was performed using 3 molar equivalents of 
COMU, Oxyma-pure and NMM; a one-hour double coupling was done for each step 
of the SPPS synthesis. Capping/ acetylation of the N-terminus was done using 50:50 
Ac2O:DMF, with a catalytic amount of DMAP added to the solution. After each step 
of the manual SPPS, the resin was consecutively washed using 3 x 5 mL portions of 
DMF and DCM. Removal of the trityl protecting group was performed using 
TFA:TIPS:DCM (2:2:96)  for 1 hour. The synthesised peptide was cleaved from the 
resin using TFA:TIPS:DCM (96:2:2) for 1 hour, with the TFA removed in vacuo. The 
peptide was precipitated from cold diethyl ether, with the resulting off-white/yellow 
solid pelleted using a centrifuge at 5000 rpm for 5 minutes. 
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Circular Dichroism (CD) analysis was performed in the Centre for Synthesis and 
Chemical Biology (CSCB) in UCD, using a Jasco J-810 spectropolarimeter with a 
path length of 1 mm, at 25oC. Samples were recorded using 8 scans between 190-250 
nm. CD spectra of each ionic strength solution, in the absence of nisin A and Z, were 
also recorded and subtracted from each sample reading to eliminate background noise. 
All CD spectra were processed using CD Tool software, which was supplied by 
Birkbeck, University of London.228 
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Fmoc-L-serine-OH (6.99 g, 21.4 mmol) and Na2CO3 (1.79 g, 1.6 mmol) were 
dissolved in deionised water (50 mL) and stirred at RT. In a separate RBF, Aliquat 
336 (8.66 g, 21.4 mmol) and allyl bromide (2.03 mL, 23.5 mmol) were dissolved in 
DCM (50 mL) and this solution was added to the Fmoc-serine-OH-containing flask. 
The resulting mixture was stirred vigorously for 72 h at RT. The mixture was extracted 
with DCM (4 x 30 mL) and the combined organic fractions were washed with brine 
(3 x 20 mL), dried over anhydrous MgSO4 and concentrated in vacuo. The resulting 
yellow oil was purified by flash chromatography on silica gel using petroleum ether: 
ethyl acetate (3:1), which gave 1 as a white solid (7.46 g, 94% yield). 
MP: 82-83oC; Rf: 0.66, petroleum ether: ethyl acetate (2:1); 1H NMR: (CDCl3) δ/ 
ppm; 7.82 (d, 2H, J = 7.3 Hz, A), 7.61 (d, 2H, J = 6.2 Hz, B), 7.41 (pseudo t, 2H, J = 
7.3 Hz, C), 7.31 (pseudo t, 2H, J = 7.3 Hz, D), 5.90 (m, 1H, L), 5.70 (d, 1H, J = 5.1 
Hz, G), 5.35-5.27 (m, 2H, M, N), 4.93 (d, 2H, J = 6.1 Hz, K), 4.67-4.44 (m, 3H, E, 
F), 4.12 (pseudo q, 1H, J = 7.2 Hz, H), 3.62 (d, 2H, J = 6.2 Hz, I); 13C NMR: (CDCl3) 
δ/ ppm; 171.3 (C=O, ester), 143.4 (C=O, Fmoc), 142.2 and 141.1 (Cq of Fmoc), 131.1 
(L), 127.8 (B), 127.1 (C), 125.1 (D), 120.0 (A),  118.9 (M, N), 67.0 (I), 66.2 (K), 63.0 
(F), 60.2 (H), 47.0 (E); IR: (KBr)/cm-1; 3435 (O-H, alcohol), 3050 (C-H, alkene), 
1741 (ester C=O), 1676 (C=O, carbamate); HRMS: ES+ for C21H21NO5 calculated 




























Fmoc-L-serine-O-Allyl (2.29 g, 6.23 mmol) and p-toluenesulfonyl chloride (5.94 g, 
31.16 mmol) were placed in a 50 mL RBF and the vessel was then purged with 
nitrogen for 5 min, after which 10 mL of pyridine was added and the solution was 
stirred at 0oC for 18 h. The mixture was added to diethyl ether (100 mL), washed with 
water (50 mL), 10% aqueous KHSO4 solution (4 x 40 mL), brine (3 x 20 mL), dried 
over anhydrous MgSO4 and concentrated in vacuo. The resulting yellow oil was 
purified by flash chromatography on silica gel using petroleum ether: ethyl acetate 
(3:1), which gave 2 as a clear oil (1.003 g, 32% yield). 
Rf: 0.61, petroleum ether: ethyl acetate (2:1); 1H NMR: (CDCl3) δ/ ppm; 7.73-7.33 
(m, 12H, A-D and J-K), 5.85 (m, 1H, N), 5.61 (d, 1H, J = 7.2 Hz, G), 5.34-5.21 (m, 
2H, O, P), 4.75 (d, 2H, J = 5.3 Hz, M), 4.67 (q, 1H, J = 7.2 Hz, H),  4.67-4.59 (m, 3H, 
E,F), 4.03 (q, 2H, J = 6.9 Hz, I), 2.36 (s, 3H, L); 13C NMR: (CDCl3) δ/ ppm; 168.2 
(C=O, ester), 155.8 (C=O, carbamate), 142.4 and 141.3 (Cq of Fmoc), 132.1 (N), 129.9 
(B), 127.9 (C), 125.2 (D), 127.7 (J), 124.6 (K), 120.3 (A),  118.7 (O, P), 69.1 (F), 
66.9 (I), 65.4 (M), 57.0 (H). 47.3 (E), 21.7 (L); IR: (KBr)/cm-1; 3345 (N-H), 3056 (C-
H, alkene), 1741 (C=O, ester), 1674 (C=O, carbamate); 1065 (S=O, sulfonate); 
HRMS: ES+ for C28H27NO7S calculated m/z [M+H]+ of 522.1586, observed m/z 


















In a RBF a solution of commercially available L-serine methyl ester hydrochloride 
(0.25 g, 1.6 mmol) and 33% methylamine solution in ethanol (15.15 mL, 25 mole 
equivalents) was stirred at 30oC for 3 hours. The mixture was purged with nitrogen for 
20 min, and 20 mL (50:50 mixture) of acetic anhydride and pyridine in DCM was 
added and the mixture was stirred at 50oC for 4 h. The DCM mixture was washed with 
10% aqueous citric acid solution (3 x 15 mL), brine (3 x 15 mL), dried over anhydrous 
MgSO4, and removed in vacuo affording an oil. Yield was not determined due to issues 
during purification of the intractable mixture. 
Rf: Not determined; 1H NMR of crude product: (CDCl3) δ/ ppm; 5.97 (dd, 1H, 
geminal alkene, J = 5.2 Hz, C), 5.76 (dd, 1H, geminal alkene, J = 2.3 Hz, C), 2.42 (s, 
3H, A), 2.17 (s, 3H, E); 13C NMR: (CDCl3) δ/ ppm; Carbon NMR spectrum very 
weak, dominated by pyridine; unable to purify for IR analysis; HRMS: ES+ for 
C6H10N2O2 calculated m/z of 145.0972, observed m/z [M+H]+ at 145.0970. 
NMR also contains peaks for pyridine which are very prominent in spectra 






























Compound 46 was prepared using a similar procedure to that used to prepare 1, using 
commercially available Fmoc-L-Lys-(Boc)-OH (6.99 g, 14.1 mmol), Na2CO3 (1.25 g, 
14.1 mmol), Aliquat 336 (6.81 g, 14.9 mmol) and allyl bromide (1.46 mL, 16.4 mmol). 
The resulting yellow solid was purified by flash chromatography on silica gel using 
petroleum ether: ethyl acetate (3:1), which gave 41 as a white solid (6.12 g, 81% yield). 
Tm: 109-111oC; Rf: 0.57, petroleum ether: ethyl acetate (2:1); 1H NMR: (CDCl3) δ/ 
ppm; 7.75 (d, 2H, J = 7.2 Hz, A), 7.61 (d, 2H, J= 6.8 Hz, B), 7.40 (pseudo t, 2H, J = 
6.8 Hz, C), 7.2 (pseudo t, 2H, J = 7.1 Hz, D), 5.91 (m, 1H, O), 5.40 (d, 1H, J = 6.3 
Hz, G), 5.34-5.27 (m, 2H, P, Q), 4.64 (m, 2H, N), 4.41-4.38 (m, 3H, E, F), 4.12 
(pseudo q, 1H, J = 7.2 Hz, H), 3.12 (t, 2H, J = 7.1 Hz, L), 1.62 (m, 2H, I), 1.51 (m, 
2H, K), 1.43 (s, 9H, t-butyl, M), 1.37 (m, 2H, J); 13C NMR: (CDCl3) δ/ ppm; 172.3 
(C=O, ester), 156.1 (C=O, Boc), 155.5 (C=O, Fmoc), 141.3 and 140.1 (Cq of Fmoc), 
131.6 (O), 126.9 (B), 126.7 (C), 125.5 (D), 119.6 (A), 118.2 (P, Q), 79.5 (t-butyl Cq), 
67.1 (F), 66.2 (N), 53.6 (H), 47.3 (E), 40.3 (L), 36.3 (I), 30.1 (K), 28.7 (M), 22.7 (J); 
IR (KBr)/cm-1; 3327 (N-H), 3036 (C-H, aromatic), 2986 (C-H, alkene), 2943 (C-H, 
aliphatic), 1734 (C=O, ester), 1691 (C=O, carbamate); HRMS: ES+ for C29H36N2O6 







































Fmoc-L-Lys-(Boc)-O-Allyl 41 (0.10 g, 0.19 mmol) was placed in a 50 mL RBF, 
treated with 50% tris-(2-aminoethyl)amine (TAEA) in DCM (5mL), and was stirred 
for 30 min at RT. The reaction mixture was taken up in EtOAc (40 mL) and washed 
with a 10% aqueous ammonium chloride solution (2 x 5 mL), brine (2 x 10 mL), dried 
over anhydrous MgSO4 and concentrated in vacuo.  After removal of the solvent, 
ninhydrin staining was used to show presence of the free amine. The free amine was 
then dissolved in 10% DCM: MeCN (20 mL). To this solution Fmoc-Cys-(Me)-OH 
(0.147g, 2.1 molar equivalents), HBTU (0.156 g, 2.1 molar equivalents) and Et3N 
(0.05 mL, 2.1 molar equivalents) were added at 0oC and stirred for 1 h at this 
temperature. The solution was then stirred at ambient temperature for a further 2 h. 
The reaction mixture was added to EtOAc (40 mL), washed with a 10% aqueous citric 
acid solution (3 x 10 mL), saturated aqueous NaHCO3 solution (3 x 10 mL), brine (3 
x 10 mL), dried over anhydrous MgSO4 and concentrated in vacuo. The resulting 
yellow solid was purified by flash column chromatography on silica gel using 
petroleum ether: ethyl acetate (4:1) which gave 45 as a clear oil (0.099 g, 72% yield). 
Rf: 0.37, petroleum ether: ethyl acetate (3:1); 1H NMR: (CDCl3) δ/ ppm; 7.76 (d, 2H, 
J = 7.6 Hz, A), 7.60 (d, 2H, J = 7.6 Hz, B), 7.41 (pseudo t, 2H, J = 7.3 Hz, C), 7.32 
(pseudo t, 2H, J = 7.3 Hz, D), 6.97 (br s, 1H, G), 5.89 (m, 1H, S), 5.38 (br s, 1H, K), 
5.32-5.26 (dd, 2H, J = 10.1 Hz and 9.7 Hz, T, U), 4.62 (m, 1H, R), 4.44 - 4.35 (m, 3H, 
E, F), 4.24 (apparent t, 1H, J = 7.1 Hz, H), 4.12 (q, 1H, J = 7.2 Hz, L), 3.07 (br s, 2H, 
I), 2.83 (m, 4H, M, P), 2.17 (br s, 3H, J), 1.49 (m, 2H, N), 1.43 (s, 9H, t-butyl, Q), 
1.35 (m, 2H, O); 13C NMR: 171.6 (C=O, ester), 156.0 (C=O, Boc), 155.8 (C=O, 
Fmoc), 150.4 (C=O, amide), 131.4 (S), 142.6 and 141.3 (Cq of Fmoc), 127.8 (B), 
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127.15 (C), 125.1 (D), 120.8 (A),  119.1 (T, U), 66.9 (F), 65.3 (R), 57.3 (H) 52.4 (L), 
47.6 (E), 40.5 (P), 36.7 (M), 33.8 (I), 31.8 (N), 29.5 (O), 28.3 (Q), 15.9 (J); IR (NaCl 
plate)/cm-1; 3327 (N-H), 3066 (C-H, aromatic), 2976 (C-H, alkene), 2939 (C-H, 
aliphatic), 1732 (C=O, ester), 1693 (C=O, carbamate), 1653 (C=O, amide), 848 (S-C, 
thioether); HRMS: ES+ for C33H43N3O7S calculated m/z [M+H]+ of 626.2899, 
observed m/z [M+H]+ at 626.2929. 
 






















H-Gly-O-tBu (0.30 g, 1.78 mmol), Fmoc-Cys-(Me)-OH (0.76 g, 1.20 molar 
equivalents), HBTU (0.81 g, 1.2 molar equivalents) and Et3N (0.29 mL, 1.20 molar 
equivalents) were added to 10% DCM: MeCN (20 mL) at 0oC in a 50 mL RBF and 
the solution was stirred for 1 h at this temperature. The solution was then stirred at 
ambient temperature for a further 2 h. The reaction mixture was added to EtOAc (40 
mL), washed with a 10% aqueous citric acid solution (3 x 10 mL), saturated aqueous 
NaHCO3 solution (3 x 10 mL), brine (3 x 10 mL), dried over anhydrous MgSO4 and 
concentrated in vacuo. The resulting yellow solid was purified by flash column 
chromatography on silica gel using petroleum ether: ethyl acetate (4:1), which gave 
48 as clear oil (0.671 g, 79% yield). 
Rf: 0.32, petroleum ether: ethyl acetate (3:1); 1H NMR: (CDCl3) δ/ ppm; 7.77 (d, 2H, 
J = 7.6 Hz, A), 7.60 (d, 2H, J = 7.6 Hz, B), 7.41 (pseudo t, 2H, J = 6.9 Hz, C), 7.32 
(pseudo t, 2H, J = 6.9 Hz, D), 6.83 (br s, 1H, K), 5.73 (br s, 1H, G), 4.44 (m, 3H, E, 
F), 4.13 (q, 1H, J = 7.2 Hz, H), 3.96 (m, 2H, L), 2.90 (br d, 2H, J = 7.4 Hz, I), 2.16 
(br s, 3H, J), 1.47 (s, 9H, t-butyl, M); 13C NMR: (CDCl3) δ/ ppm; 170.1 (C=O, amide), 
168 (C=O, ester), 154.6 (C=O, Fmoc), 149.6 (C=O, amide), 142.5 and 141.6 (Cq of 
Fmoc), 127.8 (B), 127.2 (C), 125.1 (D), 120.1 (A), 82.6 (t-butyl Cq), 67.1 (F), 56.6 
(H), 47.3 (E), 42.3 (L), 36.4 (I), 28.3 (M), 15.9 (J); IR (NaCl plate)/cm-1; 3304 (N-
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H), 2980 (C-H, aromatic), 2924 (C-H, aliphatic), 1735 (C=O, ester), 1687 (C=O, 
carbamate), 1650 (C=O, amide), 856 (S-C, thioether); HRMS: ES+ for C25H30N2O5S 
calculated m/z [M+H]+  of 470.1875, observed m/z [M+H]+ at 470.1866.  
 

























Using a similar method to that used for compound 48 the synthesis of 49 was 
undertaken using H-Ala-O-tBu (0.320 g, 1.76 mmol), Fmoc-Cys-(Me)-OH (0.755 g, 
1.2 molar equivalents), HBTU (0.80 g, 1.2 molar equivalents) and Et3N (0.29 mL, 1.2 
molar equivalents) were added to 10% DCM: MeCN (20 mL). The resulting yellow 
solid was purified by flash column chromatography on silica gel using petroleum 
ether: ethyl acetate (4:1), which gave 49 as a clear oil (0.614 g, 76% yield). 
Rf: 0.17, petroleum ether: ethyl acetate (3:1); 1H NMR: (CDCl3) δ/ ppm; 7.76 (d, 2H, 
J = 7.1 Hz, A), 7.60 (d, 2H, J = 7.1 Hz, B), 7.41 (pseudo t, 2H, J = 7.6 Hz, C), 7.32 
(pseudo t, 2H, J = 7.6 Hz, D), 6.97 (br s, 1H, K), 5.76 (br s, 1H, G), 4.43 (m, 3H, E, 
F), 4.32 (m, 1H, L), 4.13 (q, 1H, J = 7.1 Hz, H), 2.95 (br d, 2H, J = 8.1 Hz, I), 2.17 
(br s, 3H, J), 1.46 (s, 9H, N), 1.40 (d, 3H, J = 7.2 Hz, M); 13C NMR: (CDCl3) δ/ ppm; 
170.6 (C=O, amide), 168.5 (C=O, ester), 155.8 (C=O, Fmoc), 149.7 (C=O, amide), 
143.4 and 141.9 (Cq of Fmoc), 127.8 (B), 127.1 (C), 125.1 (D), 120.0 (A),  82.4 (Cq 
of t-butyl), 67.9 (F), 60.6 (H), 49.0 (L), 47.2 (E), 32.4 (I), 28.1 (N), 18.6 (M), 14.2 
(J); IR (NaCl plate)/cm-1; 3318 (N-H), 3059 (C-H, aromatic), 2980 (C-H, aliphatic), 
1732 (C=O, ester), 1691 (C=O, carbamate), 1655 (C=O, amide), 844 (S-C, thioether); 
HRMS: ES+ for C29H32N2O5S calculated m/z [M+H]+ of 485.2110, observed m/z 































Using a similar method to that shown for compound 48, the synthesis of 50 was 
undertaken using H-Phe-O-tBu (0.40 g, 1.55 mmol), Fmoc-Cys(Me)-OH (0.66 g, 1.1 
molar equivalents) HBTU (0.71 g, 1.1 molar equivalents) and Et3N (0.25 mL, 1.1 
molar equivalents) was added. The resulting yellow solid which was purified by flash 
chromatography on silica gel using petroleum ether: ethyl acetate (4:1), which gave 
50 as a clear oil (0.71 g, 81% yield). 
Rf: 0.17, petroleum ether: ethyl acetate (3:1); 1H NMR: (CDCl3) δ/ppm; 7.77 (d, 2H, 
J = 7.6 Hz, A), 7.59 (d, 2H, J = 7.6 Hz, B), 7.41 (pseudo t, 2H, J = 7.2 Hz, C), 7.32 
(pseudo t, 2H, J = 7.2 Hz, D), 7.25-7.15 (m, 5H, N-P), 6.81 (br s, 1H, K), 5.66 (br s, 
1H, G), 4.71 (q, 1H, J = 7.4 Hz, L), 4.35 (apparent t, 1H, J = 7.1 Hz, H), 4.35 (m, 2H, 
F), 4.23 (m, 1H, J = 7.7 Hz, E), 3.10 (t, 2H J = 5.7 Hz, I), 2.83 (m, 2H, M), 2.12 (br 
s, 3H, J), 1.41 (s, 9H, Q); 13C NMR: (CDCl3) δ/ppm; 171.3 (C=O, ester), 169.1 (C=O, 
amide), 155.3 (C=O, Fmoc), 150.2 (C=O, amide) 143.6 and 141.5 (Cq of Fmoc), 135.3 
(Cq, phenyl), 130.4 (N), 129.4 (O), 128.3 (P), 127.8 (B), 127.2 (C), 125.1 (D), 120.6 
(A),  82.5 (Cq of t-butyl), 67.3 (F), 59.2 (H), 53.6 (L), 47.1 (E), 37.6 (M), 36.4 (I), 
28.0 (Q), 15.7 (J); IR (NaCl plate)/cm-1; 3332 (N-H), 3064 (C-H, aromatic), 2972 (C-
H, aliphatic), 1718 (C=O, ester), 1697 (C=O, carbamate), 1647 (C=O, amide), 842 (S-
C, thioether); HRMS: ES+ for C32H36N2O5S calculated m/z of 560.7036, observed 










































A coupling solution of Fmoc-protected amino acid (3 molar eq. to resin loading), 
COMU (3 molar equivalents), Oxyma-pure (3 molar equivalents) and N-
methylmorpholine (6 molar equivalents) in DMF was pre-activated for 5 min. The 
solution was then transferred to the peptide reaction vessel containing pre-loaded Lys 
Wang resin. The reaction vessel was agitated for 1 hr at RT. A double coupling was 
performed for each step of the SPPS synthesis, with the reactants of the previous 
coupling reaction removed by washing with DMF (3 x 10 mL) and DCM (3 x 10 mL), 
followed by repeating the coupling step. The formation of Dha was carried out using 
methanesulfonyl chloride and Et3N (both in 6 molar equivalents) in dry DCM (5 mL) 
at RT, followed by elimination using DBU (6 molar equivalents). The capping/ 
acetylation of the N-terminus was done using 50:50, Ac2O: DMF (5 mL), with a 
catalytic amount of DMAP added to the solution.  The resin was washed with DMF 
(3 x 10 mL) and DCM (3 x 10 mL). Cleavage of the peptide from the resin was 
conducted using 10 mL of TFA: DCM: TIPS (96: 2: 2). A small sample of resin was 
taken after each coupling step and the peptide was cleaved from the resin and analysed 
by HRMS. Purification by semi-preparative HPLC gave tetrapeptides 67 and 68. 
Characterisation of tetrapeptide 67 
Yield: 30.8 mg, 28.9%; semi-preparative HPLC: 10:90 MeCN: H2O 0.1% TFA, peak 
eluted at 3.72 minutes. HRMS: ES+ for C22H38N7O7 calculated m/z of 512.2840, 
observed mass [M+H]+ at 512.2844. MS/MS: fragmentation of the 512.2844 m/z ion, 





1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 




Val 8.16 4.04 1.99 0.84    
Ser 8.38 4.62 3.06    OH not observed 
Lys 8.19 4.11 2.00 1.62 1.83 2.76 7.43 (NH3+) 
Table 47: 1H NMR assignment of Ac-His-Val-Ser-Lys-OH (67) 
The 1H NMR assignment of each peptide fragment was aided using 2D-TOCSY NMR 
spectroscopy. The C-terminal carboxylic acid proton (-COOH) was not observed in 
the 1H NMR spectrum. 
Characterisation of tetrapeptide 68 
Yield: 17.9 mg, 16.9%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 4.07 minutes, HRMS: ES+ for C22H36N7O6 calculated m/z of 494.2722, 
observed mass [M+H]+ at 494.2741. MS/MS: fragmentation of the 494.2741 m/z ion, 
b ions, 180.0690, 279.1294, 348.1612; y ions, 452.2616, 315.2027, 216.1271, 
147.1045.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 




Val 8.06 4.19 1.79 1.37    
Dha 9.68  5.66     
Lys 7.93 4.01 2.86 1.70 1.39 3.02 7.54 (NH3+) 
Table 48: 1H NMR assignment of Ac-His-Val-Dha-Lys-OH (68) 












































Using a similar method to that described for compound 67, the syntheses of 71 and 72 
were conducted. The reaction vessel was agitated for 1 hr at room temperature, and a 
double coupling was performed for each step of the SPPS synthesis. The resin was 
washed with DMF (3 x 10 mL) and DCM (3 x 10 mL). Purification by semi-
preparative HPLC gave pentapeptides 71 and 72. 
Characterisation of pentapeptide 71 
Yield: 20.5 mg, 14.8%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 4.22 minutes. HRMS: ES+ for C28H49N8O8 calculated m/z of 625.3668, 
observed mass [M+H]+ at 625.3689. MS/MS: fragmentation of the 625.3689 m/z ion, 
b ions, 180.0768, 279.1452, 366.1772; y ions, 470.2722, 333.2132, 234.1148, 
147.1128.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 
Ile 7.89 3.92 3.02 1.48 1.13   




Val 8.02 3.98 1.51 1.17    
Ser 8.17 4.18 3.56    OH not observed 
Lys 7.74 4.85 3.41 1.39 1.10 2.65 7.22 (NH3+) 
Table 49: 1H NMR assignment of Ac-Ile-His-Val-Ser-Lys-OH (71) 





Characterisation of pentapeptide 72 
Yield: 11.6 mg, 8.65%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 7.31 minutes. HRMS: ES+ for C28H47N8O7 calculated m/z of 607.3562, 
observed mass [M+H]+ at 607.3528. MS/MS: fragmentation of the 607.3528 m/z ion, 
b ions, 156.1058, 293.1650, 392.2322, 461.2522; y ions, 452.2637, 315.2060, 
216.1381, 147.1165.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 
Ile 8.35 4.37 1.96 1.85 1.54   




Val 8.28 4.16 2.15 0.96    
Dha 9.72  5.72     
Lys 8.10 4.06 1.76 1.70 0.84 3.01 7.22 (NH3+) 
Table 50: 1H NMR assignment of Ac-Ile-His-Val-Dha-Lys-OH (72) 


















































Using a similar method to that shown for compound 68, the syntheses of 73 and 74 
were conducted. The reaction vessel was agitated for 1 hr at room temperature, and a 
double coupling was performed for each step of the SPPS synthesis. The resin was 
washed with DMF (3 x 10 mL) and DCM (3 x 10 mL). Purification by semi-
preparative HPLC gave pentapeptides 73 and 74. 
Characterisation of pentapeptide 73 
Yield: 8.70 mg, 5.40%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 4.88 minutes. HRMS: ES+ for C28H44N9O8 calculated m/z of 634.3307, 
observed mass [M+H]+ at 634.3305. MS/MS: fragmentation of the 634.3305 m/z ion, 
b ions, 156.0827, 293.1676, 392.2360, 479.2613; y ions, 342.1839, 243.1152, 
156.0856.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ Exchangeable 
Ile 7.97 4.25 2.98 1.69 0.59  





Val 7.75 3.74 1.44 0.48   
Ser 8.14 4.13 3.48   OH not observed 





Table 51: 1H NMR assignment of Ac-Ile-His-Val-Ser-His-OH (73) 





Characterisation of pentapeptide 74 
Yield: 8.50 mg, 5.43%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 5.23 minutes. HRMS: ES+ for C28H42N9O7 calculated m/z of 616.3202, 
observed mass [M+H]+ at 616.3203. MS/MS: fragmentation of the 616.3203 m/z ion, 
b ions, 156.0829, 293.1669, 392.3348, 461.2551; y ions, 461.2551, 324.1718, 
225.1039.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ Exchangeable 

















Val 7.88 3.97 1.59 0.65  
Dha 9.53  5.55   




















































Using a similar method to that shown for compound 68, the syntheses of 75 and 76 
were conducted. The reaction vessel was agitated for 1 hr at room temperature, and a 
double coupling was performed for each step of the SPPS synthesis. The resin was 
washed with DMF (3 x 10 mL) and DCM (3 x 10 mL). Purification by semi-
preparative HPLC gave pentapeptides 75 and 76. 
Characterisation of pentapeptide 75 
Yield: 26.6 mg, 16.3%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 5.46 minutes. HRMS: ES+ for C32H53N9O9 calculated m/z of 616.4009, 
observed mass [M+H]+ at 616.4011. MS/MS: fragmentation of the 616.4011 m/z ion, 
b ions, 156.1019, 284.1967, 383.2653, 470.2968; y ions, 461.3081, 333.2133, 
234.1450, 147.1126.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue  N-H α β γ δ ε Exchangeable 
Ile 8.27 4.31 3.69 1.62 1.27   
Lys 7.92 4.25 1.65 1.33 1.03 3.70 7.36 (NH3+) 
Val 8.14 4.03 2.16 1.65    
Ser 8.07 4.09 3.82    OH not observed 
Lys 7.97 4.25 1.65 1.33 1.03 3.70 7.44 (NH3+) 
Table 53: 1H NMR assignment of Ac-Ile-Lys-Val-Ser-Lys-OH (75) 
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For pentapeptide 74, which has a serine residue in place of a Dha, the two lysine 
residues overlay, showing that they are chemically similar. The C-terminal carboxylic 
acid proton (-COOH) was not observed in the 1H NMR spectrum. 
Characterisation of pentapeptide 76 
Yield: 24.5 mg, 15.5%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 7.93 minutes. HRMS: ES+ for C28H52N7O7 calculated m/z of 598.3910, 
observed mass [M+H]+ at 598.3904. MS/MS: fragmentation of the 598.9304 m/z ion, 
b ions, 128.1058, 256.1850, 355.2697, 452.2852; y ions, 556.3817, 443.2969, 
315.2027, 216.1335, 147.1141.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue  N-H α β γ δ ε Exchangeable 
Ile 8.35 4.33 3.74 1.74 1.35   
Lys 8.13 4.22 1.67 1.37 0.85 4.05 7.44 (NH3+) 
Val 8.18 4.08 2.04 0.91    
Dha 9.59  5.62     
Lys 8.02 4.21 1.74 1.38 1.14 3.97 7.44 (NH3+) 
Table 54: 1H NMR assignment of Ac-Ile-Lys-Val-Dha-Lys-OH (76) 
 
Further NMR studies are required to distinguish the two lysine residues, but due to the 
limited amount of material it was not possible in our hands for both 75 and 76. The  
































Using a similar method to that shown for compound 68, the synthesis of 77 was 
conducted. The reaction vessel was agitated for 1 hr at room temperature, and a double 
coupling was performed for each step of the SPPS synthesis. The resin was washed 
with DMF (3 x 10 mL) and DCM (3 x 10 mL).  
Yield: 33.0 mg, 20.7%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 4.60 minutes. HRMS: ES+ for C31H54N9O10 calculated m/z of 712.3994, 
observed mass [M+H]+ at 712.4015. MS/MS: fragmentation of the 712.4015 m/z ion, 
b ions, 130.0821, 243.1261, 380.1879, 479.2563, 566.2881; y ions, 583.3512, 
470.2673, 333.2078, 234.1370, 147.1074.  
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 
Ser 8.41 4.40 3.72    OH not observed 
Ile 8.12 4.08 2.02 1.95 0.81   




Val 8.02 4.06 1.70 0.73    
Ser 8.23 4.32 3.75    OH not observed 
Lys 7.98 4.07 1.75 1.58 1.28 3.71 7.54 (NH3+) 
Table 55: 1H NMR assignment of Ac-Ser-Ile-His-Val-Ser-Lys-OH 77 






























Using a similar method to that shown for compound 68, the synthesis of 85 was 
conducted. The reaction vessel was agitated for 1 hr at room temperature, a double 
coupling was performed for each step of the SPPS synthesis. The resin was washed 
with DMF (3 x 10 mL) and DCM (3 x 10 mL).  
Yield: 70.2 mg, 50.0%; semi-preparative HPLC: 10:90 MeCN: H2O, 0.1% TFA, peak 
eluted at 5.95 minutes. HRMS: ES+ for C32H53N9O9 calculated m/z of 708.4039, 
observed mass [M+H]+ at 708.4049. MS/MS: fragmentation of the 708.4049 m/z ion, 
b ions, 130.0862, 243.1214, 380.1915, 479.2599, 562.2974; y ions, 562.2990, 
479.2622, 380.1934, 242.1340, 147.1076. 
1H NMR: (10% D2O: H2O) δ/ppm; 
1H 
Residue N-H α β γ δ ε Exchangeable 
C-terminus  
     
 8.85 (COOH) 
Ser 8.15 4.29 3.68 
  
 OH not Observed 
Ile 7.94 4.04 1.65 1.17 0.69  
 










AC3C 7.78  2.85 + 2.70 
    
Lys 7.53 4.20 2.83 1.74 1.54 1.22 7.35 (NH3+) 
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Experimental data and spectra from Chapter III - NMR and Circular Dichroism 
studies of Nisin A and Z and Chapter IV – pH Studies of Nisin A and Z by NMR 
Spectroscopy are presented in full form in a separate document. 
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